type sequence filename description text html head title title head body bgcolor white style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman align right execution version style margin margin bottom font size font family time roman align center certain confidential portion this exhibit nbsp were omitted replaced with nbsp complete version this exhibit nbsp been filed separately with secretary security exchange commission pursuant application requesting confidential treatment pursuant rule security exchange style margin margin bottom font size font family time roman align center amended restated style margin margin bottom font size font family time roman align center collaboration agreement style margin margin bottom font size font family time roman align center between style margin margin bottom font size font family time roman align center galapagos style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center abbvie agrave style margin margin bottom font size font family time roman align center dated april nbsp style page break before always size style color width align center style margin margin bottom font size font family time roman align center table content style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article definition valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article collaboration management valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman joint steering committee valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman joint research committee valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman joint development committee valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman joint commercialization committee valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman general provision applicable joint committee valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman discontinuation participation committee valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman interaction between committee internal team valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman working group valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman expense valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article discovery development regulatory valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman discovery work plan discovery activity valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman development activity valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman post development activity valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman development valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman galapagos territory development valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman design performance development activity generally valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman development back combination product valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman update amendment valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman clinical clinical supply product valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman subcontracting valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman provision technology documentation valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman regulatory matter valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman compliance valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman step right valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman record valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article promotion commercialization valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman general valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman galapagos territory commercialization plan valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman diligence valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman statement compliance with applicable valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman booking sale distribution valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman product trademark valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman marking valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman post commercial supply product valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman promotion valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article grant right valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman grant abbvie valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman grant galapagos valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman sublicenses valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman distributorships valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman promotion right valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman retention right valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman confirmatory patent license valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman third party license agreement valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman exclusivity with respect territory valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article payment record valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman upfront payment valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman development milestone valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman regulatory milestone valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman sale based milestone valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman royalty valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman royalty payment report valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman profit loss promotion territory valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman calculation payment profit loss share valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman record calculation valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman reconciliation development cost galapagos cost valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman third party payment valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman mode payment offset valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman other compensation valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman interest late payment valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman financial record valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman audit valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman audit dispute valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman confidentiality valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman order reimbursement credit payment valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman galapagos earnout compensation valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article intellectual property valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman ownership intellectual property valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman maintenance prosecution patent valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman enforcement patent valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman infringement claim third party valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman invalidity unenforceability defense action valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman third party license valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman product trademark valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman inventor remuneration valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman galapagos territory cost valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman patent valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article pharmacovigilance safety valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman pharmacovigilance valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman global safety database valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article confidentiality disclosure valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman product information valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman confidentiality obligation valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman permitted disclosure valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman name valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman public announcement valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman publication valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman return confidential information valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman survival valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article representation warranty valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman mutual representation warranty valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman additional representation warranty galapagos valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman additional representation warranty abbvie valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman disclaimer warranty valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article indemnity valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman indemnification galapagos valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman indemnification abbvie valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman certain loss valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman notice claim valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman control defense valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman special indirect other loss valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman insurance valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article term termination valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman term valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman termination material breach valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman additional termination right valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman termination bankruptcy insolvency similar event valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman right bankruptcy valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman termination entirety valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman termination more country valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman transition agreement valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman termination country abbvie galapagos valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman existing inventory valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman remedy valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman accrued right surviving obligation valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin margin bottom margin left text indent font size font family time roman article miscellaneous valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman force majeure valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman change control galapagos valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman export control valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman assignment valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman severability valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman governing service valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman dispute resolution valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman notice valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman entire agreement amendment valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman english language valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman waiver exclusion remedy valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman benefit third party valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman further assurance valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman relationship party valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman performance affiliate valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman counterpart facsimile execution valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman reference valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman schedule valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman construction valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman amendment restatement valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign colspan schedule style font size height height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman schedule valign bottom nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman approved country style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman schedule valign bottom nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman success criterion style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman schedule valign bottom nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman success criterion style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman schedule valign bottom nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman plan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman schedule valign bottom nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman combination product development plan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman schedule valign bottom nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman combination product post development plan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman schedule valign bottom nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman discovery work plan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman schedule valign bottom nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman existing potentiator patent style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman schedule valign bottom nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman galapagos corporate name style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman schedule valign bottom nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman schedule valign bottom nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman study plan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman schedule valign bottom nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman schedule valign bottom nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman manufacturing cost style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman schedule valign bottom nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman dual combination product success criterion table style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman schedule valign bottom nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman potentiator success criterion style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman schedule valign bottom nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman triple combination phase success criterion style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman schedule valign bottom nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman triple combination heterozygous success criterion style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman schedule valign bottom nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman triple combination homozygous success criterion style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman schedule nbsp valign bottom nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman sample reimbursement credit reimbursement payment calculation style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman schedule valign bottom nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman sample profit loss calculation style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman schedule valign bottom nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman existing patent style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman schedule valign bottom nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman existing third party license agreement style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman schedule valign bottom nbsp nbsp valign bottom style margin margin bottom margin left text indent font size font family time roman procedure table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center amended restated collaboration agreement style margin margin bottom text indent font size font family time roman this amended restated collaboration agreement this agreement made entered into effect april nbsp restatement date between galapagos corporation organized under belgium having principal place business generaal wittelaan mechelen belgium galapagos abbvie agrave corporation organized under luxembourg having principal place business boulevard royal luxembourg abbvie galapagos abbvie sometimes referred herein individually party collectively party style margin margin bottom font size font family time roman align center recital style margin margin bottom text indent font size font family time roman whereas galapagos abbvie desire collaborate discovery research development commercialization molecule defined herein product defined herein territory defined herein accordance with term condition forth herein style margin margin bottom text indent font size font family time roman whereas galapagos abbvie party that certain collaboration agreement dated september nbsp existing agreement style margin margin bottom text indent font size font family time roman whereas galapagos abbvie desire amend restate existing agreement entirety forth herein style margin margin bottom text indent font size font family time roman therefore consideration premise mutual promise condition hereinafter forth other good valuable consideration receipt sufficiency which hereby acknowledged party intending legally bound hereby agree follows style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center definition style margin margin bottom text indent font size font family time roman unless otherwise specifically provided herein following term shall have following meaning style margin margin bottom text indent font size font family time roman study meaning forth section nbsp style margin margin bottom text indent font size font family time roman abbvie meaning forth preamble hereto style margin margin bottom text indent font size font family time roman abbvie grantback know mean used connection with grant back license provided article that certain abbvie know that nbsp controlled abbvie affiliate effective date applicable termination this agreement entirety with respect nbsp more country nbsp generally known nbsp directed composition formulation method making using product nbsp each case solely with respect such product that subject development commercialization such country date such termination such product exists effective date such termination style margin margin bottom text indent font size font family time roman abbvie grantback patent mean used connection with grant back license provided article those certain abbvie patent that nbsp controlled abbvie affiliate effective date applicable termination this agreement entirety with respect nbsp more country nbsp include nbsp more claim that cover composition formulation method making using applicable product which this agreement been terminated addition abbvie grantback patent include only abbvie patent with claim that cover product that subject development commercialization applicable country date applicable termination this agreement such product exists effective date such termination style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman abbvie indemnitees meaning forth section nbsp style margin margin bottom text indent font size font family time roman abbvie know mean information that nbsp controlled abbvie affiliate effective date time during term nbsp generally known nbsp reasonably necessary useful performance discovery activity exploitation molecule product nbsp excluding joint know invention covered claim published abbvie patent joint patent style margin margin bottom text indent font size font family time roman abbvie patent mean patent that nbsp controlled abbvie affiliate effective date time during term nbsp reasonably necessary useful with respect patent application would reasonably necessary useful such patent application were issue patent performance discovery activity exploitation molecule product nbsp excluding joint patent style margin margin bottom text indent font size font family time roman abbvie prosecuted infringement meaning forth section nbsp style margin margin bottom text indent font size font family time roman abbvie territory mean entire territory except nbsp galapagos territory nbsp terminated territory style margin margin bottom text indent font size font family time roman acceptance mean nbsp with respect receipt written notice from indicating that such been accepted filing further review nbsp with respect receipt written notice validation from indicating that such been accepted filing further review style margin margin bottom text indent font size font family time roman accounting standard with respect party mean that such party shall maintain record book account accordance with nbsp united state generally accepted accounting principle nbsp extent applicable international financial reporting standard issued international accounting standard board style margin margin bottom text indent font size font family time roman meaning forth section nbsp style margin margin bottom text indent font size font family time roman adverse ruling meaning forth section nbsp style margin margin bottom text indent font size font family time roman affiliate mean with respect party person that directly indirectly through nbsp more intermediary control controlled under common control with such party purpose this definition control with correlative meaning term controlled under common control with mean nbsp possession directly indirectly power direct management policy person whether through ownership voting security contract relating voting right corporate governance otherwise nbsp ownership directly indirectly more than fifty percent nbsp voting security other ownership interest person with respect limited partnership other similar entity general partner controlling entity party acknowledge that case certain entity organized under certain country outside united state maximum percentage ownership permitted foreign investor than fifty percent that such case such lower percentage shall substituted preceding sentence provided that such foreign investor power direct management policy such entity style margin margin bottom text indent font size font family time roman agreement meaning forth preamble hereto style margin margin bottom text indent font size font family time roman alliance manager meaning forth section nbsp style margin margin bottom text indent font size font family time roman allowable expense mean style margin margin bottom text indent font size font family time roman anda meaning forth section nbsp style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman annual sale based milestone payment meaning forth section nbsp style margin margin bottom text indent font size font family time roman annual sale based milestone payment date meaning forth section nbsp style margin margin bottom text indent font size font family time roman annual sale based milestone table meaning forth section nbsp style margin margin bottom text indent font size font family time roman annual sale milestone threshold meaning forth section nbsp style margin margin bottom text indent font size font family time roman applicable mean federal state local national supra national statute rule regulation including rule regulation guideline other requirement regulatory authority major national security exchange major security listing organization that effect from time time during term applicable particular activity country other jurisdiction hereunder style margin margin bottom text indent font size font family time roman approved country mean nbsp each country identified schedule nbsp nbsp each other country that designated such style margin margin bottom text indent font size font family time roman audit arbitrator meaning forth section nbsp style margin margin bottom text indent font size font family time roman back combination product meaning forth section nbsp style margin margin bottom text indent font size font family time roman base quarterly discovery obligation meaning forth section nbsp style margin margin bottom text indent font size font family time roman base quarterly obligation meaning forth section nbsp style margin margin bottom text indent font size font family time roman base quarterly post obligation meaning forth section nbsp style margin margin bottom text indent font size font family time roman bayh dole mean patent trademark amendment amended codified amended well regulation promulgated pursuant thereto including part style margin margin bottom text indent font size font family time roman board director meaning forth definition change control style margin margin bottom text indent font size font family time roman brand element meaning forth section nbsp style margin margin bottom text indent font size font family time roman breaching party meaning forth section nbsp style margin margin bottom text indent font size font family time roman business combination transaction meaning forth section nbsp style margin margin bottom text indent font size font family time roman business mean other than saturday sunday which banking institution york york open business style margin margin bottom text indent font size font family time roman corrector molecule mean cftr corrector molecule resulting from discovery collaboration that nbsp improve trafficking cftr protein increase amount cftr protein expressed airway cell membrane nbsp function stabilizing cftr protein during early stage biogenesis within endoplasmic reticulum style margin margin bottom text indent font size font family time roman success criterion mean success criterion with respect corrector molecule forth schedule nbsp same amended from time time pursuant section nbsp style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman corrector molecule mean cftr corrector molecule resulting from discovery collaboration that nbsp improve trafficking cftr protein increase amount cftr protein expressed airway cell membrane nbsp function enhancing stabilization cftr protein combination with corrector molecule distinct complementary mechanism action such corrector molecule style margin margin bottom text indent font size font family time roman success criterion mean success criterion with respect corrector molecule forth schedule nbsp same amended from time time pursuant section nbsp style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman calendar quarter mean each successive period three nbsp calendar month commencing january nbsp nbsp april nbsp nbsp july nbsp october nbsp except that first calendar quarter term shall commence effective date immediately prior first occur january nbsp nbsp april nbsp nbsp july nbsp october nbsp after effective date last calendar quarter shall last term style margin margin bottom text indent font size font family time roman calendar year mean each successive period twelve nbsp calendar month commencing january nbsp ending december nbsp except that first calendar year term shall commence effective date december nbsp year which effective date occurs last calendar year term shall commence january nbsp year which term last term style margin margin bottom text indent font size font family time roman centralized approval procedure mean procedure through which filed with result single marketing authorization valid throughout european union style margin margin bottom text indent font size font family time roman mean cystic fibrosis style margin margin bottom text indent font size font family time roman cftr mean cystic fibrosis transmembrane conductance regulator style margin margin bottom text indent font size font family time roman change control with respect party shall deemed have occurred following occurs after effective date style margin margin bottom text indent font size font family time roman person group such term defined below nbsp becomes beneficial owner defined below directly indirectly share capital stock other interest including partnership interest such party then outstanding normally entitled without regard occurrence contingency vote election director manager similar supervisory position voting stock such party representing fifty percent nbsp more total voting power outstanding class voting stock such party nbsp power directly indirectly elect majority member party board director similar governing body board director style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman such party enters into merger consolidation similar transaction with another person whether such party surviving entity result such merger consolidation similar transaction nbsp member board director such party immediately prior such transaction constitute than majority member board director such party such surviving person immediately following such transaction nbsp person that beneficially owned directly indirectly share voting stock such party immediately prior such transaction cease beneficially directly indirectly share voting stock such party representing least majority total voting power outstanding class voting stock surviving person substantially same proportion their ownership voting stock such party immediately prior such transaction style margin margin bottom text indent font size font family time roman such party sell transfer third party nbsp more related transaction property asset representing substantially such party total asset which this agreement relates style margin margin bottom text indent font size font family time roman holder capital stock such party approve plan proposal liquidation dissolution such party style margin margin bottom font size font family time roman purpose this definition change control nbsp person group have meaning given such term under section nbsp united state security exchange term group includes group acting purpose acquiring holding disposing security within meaning rule under said nbsp beneficial owner shall determined accordance with rule under aforesaid nbsp term beneficially owned beneficially shall have meaning correlative that beneficial owner style margin margin bottom text indent font size font family time roman clinical data mean information with respect molecule product made collected otherwise generated under connection with clinical study phase study including data including data report result with respect thereto style margin margin bottom text indent font size font family time roman clinical study mean phase phase phase phase such other test study human subject that required applicable otherwise recommended regulatory authority obtain maintain regulatory approval product nbsp more indication including test study that intended expand product labeling such product with respect such indication style margin margin bottom text indent font size font family time roman clinical study report mean clinical study report other equivalent document series material constituting summary report clinical medical data resulting from clinical study prepared incorporation into filing submission seeking regulatory approval product includes statistical analysis statistical analysis plan interim analysis final analysis style margin margin bottom text indent font size font family time roman amendment mean amendment plan style margin margin bottom text indent font size font family time roman cost mean internal external cost incurred party affiliate after restatement date during term pursuant this agreement connection with performing obligation under plan style margin margin bottom text indent font size font family time roman development mean chemistry manufacturing control development activity with respect molecule product including active pharmaceutical ingredient formulation development test method development manufacture testing active pharmaceutical ingredient formulation including placebo clinical study quality assurance quality control development development manufacturing process product scale manufacturing process validation including validation batch manufacturing improvement qualification validation third party contract manufacturer style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman plan mean development plan attached hereto schedule nbsp same amended from time time pursuant section nbsp style margin margin bottom text indent font size font family time roman combination development failure mean failure triple combination product developed under combination product development plan after completion triple combination phase such triple combination product either nbsp satisfy triple combination phase success criterion nbsp elected abbvie continued development accordance section nbsp style margin margin bottom text indent font size font family time roman combination post development failure mean failure nbsp development activity under combination product post development plan after completion thereof such earlier time party otherwise agree support filing drug approval application triple combination product united state determined nbsp triple combination product developed under combination product post development plan receive regulatory approval united state within month such later date agree after filing drug approval application therefor with respect such country style margin margin bottom text indent font size font family time roman combination product mean dual combination product triple combination product developed under combination product development plan combination product post development plan style margin margin bottom text indent font size font family time roman combination product budget mean budget included combination product development plan style margin margin bottom text indent font size font family time roman combination product development plan mean development plan budget attached hereto schedule nbsp same amended from time time pursuant section nbsp unless otherwise mutually agreed party combination product development plan shall contemplate phase clinical study only triple combination product style margin margin bottom text indent font size font family time roman combination product post development budget mean each heterozygous population post development budget homozygous population post development budget style margin margin bottom text indent font size font family time roman combination product post development plan mean development plan budget attached hereto schedule nbsp same amended from time time pursuant section nbsp style margin margin bottom text indent font size font family time roman combination standard mean dual combination standard triple combination standard style margin margin bottom text indent font size font family time roman commercialization mean activity directed preparation sale offering sale sale product including activity related marketing promoting distributing importing exporting such product purpose setting forth right obligation party under this agreement shall deemed include conducting medical affair activity conducting phase study interacting with regulatory authority regarding foregoing when used verb commercialize commercializing mean engage commercialization commercialized corresponding meaning style margin margin bottom text indent font size font family time roman commercially reasonable effort mean with respect performance development commercialization manufacturing activity with respect molecule product style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman party level effort required carry obligation sustained active diligent manner consistent commercially reasonable effort shall determined country country jurisdiction jurisdiction where applicable product product basis except that party consider impact effort resource expended with respect country jurisdiction other country jurisdiction style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman conduct mean with respect clinical study nbsp sponsor support perform directly indirectly through third party such clinical study nbsp provide third party funding clinical supply including placebo such clinical study style margin margin bottom text indent font size font family time roman confidential information mean information provided orally visually writing other form behalf nbsp party affiliate such party other party affiliate such party connection with this agreement negotiation hereof whether prior after effective date including information relating term this agreement molecule product including regulatory documentation regulatory data exploitation molecule product know with respect thereto developed behalf disclosing party affiliate including abbvie know galapagos know applicable scientific regulatory business affair other activity either party notwithstanding foregoing joint know shall deemed confidential information both party both party shall deemed receiving party disclosing party with respect thereto style margin margin bottom text indent font size font family time roman control mean with respect item information regulatory documentation material patent other property right existing after effective date during term possession right whether directly indirectly whether ownership license covenant otherwise other than operation license other grant section grant license sublicense other right including right reference regulatory documentation under such information regulatory documentation material patent other property right provided herein without violating term agreement other arrangement with third party provided that except case third party license agreement neither party shall deemed control item information regulatory documentation material patent other property right third party access requires trigger payment obligation style margin margin bottom text indent font size font family time roman promotion agreement meaning forth section nbsp style margin margin bottom text indent font size font family time roman promotion option meaning forth section nbsp style margin margin bottom text indent font size font family time roman promotion period mean that period commencing effective date promotion agreement ending first date which galapagos promotion right with respect promotion product terminate pursuant this agreement promotion agreement style margin margin bottom text indent font size font family time roman promotion plan meaning forth section nbsp style margin margin bottom text indent font size font family time roman promotion product meaning forth section nbsp style margin margin bottom text indent font size font family time roman promotion territory mean only galapagos exercise promotion option belgium netherlands luxembourg clarity galapagos exercise promotion option there shall promotion territory style margin margin bottom text indent font size font family time roman corrector molecule mean corrector molecule corrector molecule style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman create meaning forth section nbsp style margin margin bottom text indent font size font family time roman default notice meaning forth section nbsp style margin margin bottom text indent font size font family time roman delivery system meaning forth definition sale style margin margin bottom text indent font size font family time roman detail mean with respect promotion product promotion territory face face contact between sale representative physician other medical professional during which primary position detail defined promotion agreement secondary position detail defined promotion agreement made such person each case measured each party internal recording such activity accordance with promotion agreement provided that such meeting consistent with accordance with requirement applicable this agreement when used verb detail mean engage detail style margin margin bottom text indent font size font family time roman development mean activity related discovery including lead identification lead optimization research clinical other clinical testing development clinical study statistical analysis report writing preparation submission drug approval application regulatory affair with respect foregoing other activity necessary reasonably useful otherwise requested required regulatory authority condition support obtaining maintaining regulatory approval when used verb develop mean engage development development shall exclude phase study purpose clarity development shall include submission activity required support thereof required applicable regulatory authority condition support obtaining pricing reimbursement approval approved product style margin margin bottom text indent font size font family time roman development cost mean style margin margin bottom text indent font size font family time roman development plan mean discovery work plan combination product development plan combination product post development plan potentiator post development plan plan study plan galapagos territory development plan style margin margin bottom text indent font size font family time roman discovery activity mean development activity performed during discovery term galapagos abbvie forth discovery work plan from time time style margin margin bottom text indent font size font family time roman discovery additional cost mean restatement date dollar style margin margin bottom text indent font size font family time roman discovery budget meaning forth section nbsp style margin margin bottom text indent font size font family time roman discovery collaboration mean performance discovery activity galapagos abbvie during discovery term accordance with discovery work plan this agreement style margin margin bottom text indent font size font family time roman discovery cost portion mean nbsp with respect abbvie percent nbsp with respect galapagos percent style margin margin bottom text indent font size font family time roman discovery increase funding date meaning forth section nbsp style margin margin bottom text indent font size font family time roman discovery reimbursement credit meaning forth section nbsp style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman discovery reimbursement payment meaning forth section nbsp style margin margin bottom text indent font size font family time roman discovery reimbursement premium percentage meaning forth section nbsp style margin margin bottom text indent font size font family time roman discovery term mean period commencing effective date ending anniversary effective date unless modified pursuant section nbsp style margin margin bottom text indent font size font family time roman discovery total cost mean style margin margin bottom text indent font size font family time roman discovery work plan mean development plan budget attached hereto schedule same amended from time time pursuant section nbsp style margin margin bottom text indent font size font family time roman dispute meaning forth section nbsp style margin margin bottom text indent font size font family time roman distribution cost mean style margin margin bottom text indent font size font family time roman distributor meaning forth section nbsp style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman dollar mean united state dollar style margin margin bottom text indent font size font family time roman drug approval application mean drug application defined ffdca corresponding foreign application territory including with respect european union marketing authorization application filed with pursuant centralized approval procedure with applicable regulatory authority country european union with respect mutual recognition other national approval procedure style margin margin bottom text indent font size font family time roman drug approval filing mean submission regulatory authority drug approval application style margin margin bottom text indent font size font family time roman dual combination product mean pharmaceutical product containing active ingredient nbsp nbsp corrector molecule nbsp potentiator molecule nbsp nbsp corrector molecule nbsp potentiator molecule nbsp nbsp corrector molecule nbsp corrector molecule style margin margin bottom text indent font size font family time roman dual combination standard meaning forth section nbsp style margin margin bottom text indent font size font family time roman effective date mean september nbsp style margin margin bottom text indent font size font family time roman mean european medicine agency successor agency authority having substantially same function style margin margin bottom text indent font size font family time roman euribor mean euro interbank offered rate unweighted average rate calculation according method having maturity nbsp month published bloomberg first frankfurt business every month style margin margin bottom text indent font size font family time roman european union mean economic scientific political organization member state known european union membership altered from time time successor thereto style margin margin bottom text indent font size font family time roman excess discovery cost meaning forth section nbsp style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman excess cost portion mean nbsp with respect abbvie percent nbsp with respect galapagos percent style margin margin bottom text indent font size font family time roman excess cost meaning forth section nbsp style margin margin bottom text indent font size font family time roman excess post cost meaning forth section nbsp style margin margin bottom text indent font size font family time roman exchange rate meaning forth section nbsp style margin margin bottom text indent font size font family time roman excluded know meaning forth section nbsp style margin margin bottom text indent font size font family time roman exclusive negotiation period meaning forth section nbsp style margin margin bottom text indent font size font family time roman existing agreement meaning forth recital hereto style margin margin bottom text indent font size font family time roman existing patent meaning forth section nbsp subject section nbsp style margin margin bottom text indent font size font family time roman existing potentiator molecule mean cftr potentiator molecule controlled galapagos effective date including cftr potentiator molecule claimed existing potentiator patent style margin margin bottom text indent font size font family time roman existing potentiator patent mean patent application forth schedule nbsp style margin margin bottom text indent font size font family time roman expanded galapagos field meaning forth section nbsp style margin margin bottom text indent font size font family time roman exploit exploitation mean make have made import sell offer sale including discover research develop commercialize register modify enhance improve manufacture have manufactured hold keep whether disposal otherwise formulate optimize have used export transport distribute promote market have sold otherwise dispose style margin margin bottom text indent font size font family time roman fcpa meaning forth section nbsp style margin margin bottom text indent font size font family time roman mean united state food drug administration successor agency authority having substantially same function style margin margin bottom text indent font size font family time roman ffdca mean united state federal food drug cosmetic amended from time time together with rule regulation requirement promulgated thereunder including addition supplement extension modification thereto style margin margin bottom text indent font size font family time roman field mean treatment diagnosis prediction detection prevention disease disorder state condition malady human animal style margin margin bottom text indent font size font family time roman first commercial sale mean with respect product country first sale monetary value consumption user such product such country after regulatory approval such product been obtained such country sale prior receipt regulatory approval such product such called treatment sale named patient sale compassionate sale shall construed first commercial sale style margin margin bottom text indent font size font family time roman mean equivalent work nbsp employee full time nbsp calendar year consisting least total hour calendar year work directly related discovery activity development commercialization manufacturing molecule product person devotes than hour calendar year such other number agreed applicable shall treated rata basis based upon actual number hour worked divided style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman cost mean with respect party period applicable rate multiplied applicable number ftes such party performing development commercialization manufacturing activity during such period accordance with applicable development plan promotion plan style margin margin bottom text indent font size font family time roman rate mean effective date rate dollar calendar year rate applicable activity undertaken either party subject adjustment effective january nbsp each calendar year based applicable employment cost index published united state department labor bureau labor statistic third quarter preceding calendar year style margin margin bottom text indent font size font family time roman galapagos meaning forth preamble hereto style margin margin bottom text indent font size font family time roman galapagos activity meaning forth section nbsp style margin margin bottom text indent font size font family time roman galapagos field mean nbsp nbsp such other patient population indication mutually agreed party pursuant section nbsp style margin margin bottom text indent font size font family time roman galapagos combo product mean pharmaceutical product that contains active ingredient combination with more other active ingredient excluding competing product including finished form presentation delivery system strength dosage formulation clarity galapagos combo product shall deemed potentiator product product style margin margin bottom text indent font size font family time roman galapagos manufacturing process meaning forth section nbsp style margin margin bottom text indent font size font family time roman galapagos product mean pharmaceutical product that contains sole active ingredient including finished form presentation delivery system strength dosage formulation clarity galapagos product shall deemed potentiator product product style margin margin bottom text indent font size font family time roman galapagos corporate name mean trademark logo identified schedule such other name logo galapagos designate writing from time time style margin margin bottom text indent font size font family time roman galapagos delivery system meaning forth definition galapagos sale style margin margin bottom text indent font size font family time roman galapagos earnout term mean with respect each galapagos product each country other jurisdiction world period beginning date galapagos first commercial sale such galapagos product such country other jurisdiction ending latest occur nbsp expiration invalidation abandonment date last galapagos patent patent joint patent that includes valid claim that cover manufacture sale such galapagos product that sold such country other jurisdiction nbsp anniversary galapagos first commercial sale such galapagos product such country other jurisdiction nbsp expiration galapagos regulatory exclusivity such galapagos product such country other jurisdiction style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman galapagos first commercial sale mean with respect galapagos product country first sale monetary value consumption user such galapagos product such country after regulatory approval such galapagos product been obtained such country sale prior receipt regulatory approval such galapagos product such called treatment sale named patient sale compassionate sale shall construed galapagos first commercial sale style margin margin bottom text indent font size font family time roman galapagos indemnitees meaning forth section nbsp style margin margin bottom text indent font size font family time roman galapagos cost mean style margin margin bottom text indent font size font family time roman galapagos know mean subject section nbsp section nbsp information that nbsp controlled galapagos affiliate effective date time during term nbsp generally known nbsp reasonably necessary useful performance discovery activity exploitation molecule product nbsp excluding joint know invention covered claim published galapagos patent joint patent style margin margin bottom text indent font size font family time roman galapagos sale mean page omitted style margin margin bottom text indent font size font family time roman galapagos patent mean subject section nbsp section nbsp patent that nbsp controlled galapagos affiliate effective date time during term nbsp reasonably necessary useful with respect patent application would reasonably necessary useful such patent application were issue patent performance discovery activity exploitation molecule product nbsp excluding joint patent galapagos patent include existing patent style margin margin bottom text indent font size font family time roman galapagos product mean each galapagos product each galapagos combo product style margin margin bottom text indent font size font family time roman galapagos regulatory exclusivity mean with respect country other jurisdiction world additional market protection other than patent protection granted regulatory authority such country other jurisdiction which confers exclusive commercialization period during which galapagos affiliate licensee have exclusive right market sell galapagos product such country other jurisdiction through regulatory exclusivity right chemical entity exclusivity indication exclusivity formulation exclusivity orphan drug exclusivity pediatric exclusivity applicable data exclusivity style margin margin bottom text indent font size font family time roman galapagos territory mean china south korea style margin margin bottom text indent font size font family time roman galapagos territory commercialization plan meaning forth section nbsp style margin margin bottom text indent font size font family time roman galapagos territory development plan meaning forth section nbsp style margin margin bottom text indent font size font family time roman generic competition mean country other jurisdiction galapagos product basis style margin margin bottom text indent font size font family time roman generic product mean with respect galapagos product product that nbsp sold third party that licensee galapagos affiliate their licensee sublicensees under drug approval application granted regulatory authority third party nbsp contains same active ingredient galapagos style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman product nbsp approved reliance whole part prior approval safety efficacy data submitted support prior approval such galapagos product determined applicable regulatory authority including product authorized sale nbsp pursuant section nbsp section nbsp ffdca respectively nbsp pursuant provision article parliament council directive amended including application under article parliament council regulation that relies content such provision nbsp other country jurisdiction pursuant equivalent such provision including amendment successor statute with respect subsection nbsp through nbsp thereto product licensed produced galapagos authorized generic product will constitute generic product style margin margin bottom text indent font size font family time roman generic competition meaning forth section nbsp style margin margin bottom text indent font size font family time roman generic product mean with respect product product that nbsp sold third party that licensee sublicensee abbvie affiliate their licensee sublicensees under drug approval application granted regulatory authority third party nbsp contains same active ingredient product nbsp approved reliance whole part prior approval safety efficacy data submitted support prior approval such product determined applicable regulatory authority including product authorized sale nbsp pursuant nbsp section section nbsp ffdca respectively nbsp pursuant provision article parliament council directive amended including application under article parliament council regulation that relies content such provision nbsp other country jurisdiction pursuant equivalent such provision including amendment successor statute with respect subsection nbsp through nbsp thereto product licensed produced abbvie authorized generic product will constitute generic product style margin margin bottom text indent font size font family time roman mean potentiator molecule known further described schedule style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman know meaning forth section nbsp style margin margin bottom text indent font size font family time roman patent meaning forth section nbsp style margin margin bottom text indent font size font family time roman study plan mean phase proof activity clinical study plan attached hereto schedule style margin margin bottom text indent font size font family time roman mean corrector molecule known further described schedule style margin margin bottom text indent font size font family time roman glpg seller meaning forth definition galapagos sale style margin margin bottom text indent font size font family time roman good manufacturing practice mean current good manufacturing practice applicable from time time manufacturing molecule product intermediate thereof pursuant applicable style margin margin bottom text indent font size font family time roman grantback option meaning forth section nbsp style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman grantback option terminated territory meaning forth section nbsp style margin margin bottom text indent font size font family time roman heterozygous population mean population patient style margin margin bottom text indent font size font family time roman heterozygous population post development budget mean budget activity under combination product post development plan that directed triple combination product heterozygous population style margin margin bottom text indent font size font family time roman heterozygous population post development cost mean aggregate amount heterozygous population post development budget included combination product post development plan attached hereto schedule nbsp together with increase thereto agreed party accordance with section nbsp provided that nbsp abbvie elect proceed with development triple combination product only heterozygous population then percent base cost identified combination product post development plan shall counted towards heterozygous population post development cost nbsp abbvie elect proceed with development triple combination product both heterozygous population homozygous population then percent such base cost shall counted towards heterozygous population post development cost percent such base cost shall counted towards homozygous population post development cost restatement date heterozygous population post development cost dollar abbvie elect proceed with development triple combination product only heterozygous population dollar abbvie elect proceed with development triple combination product both heterozygous population homozygous population style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman homozygous population mean population patient style margin margin bottom text indent font size font family time roman homozygous population post development budget mean budget activity under combination product post development plan that directed triple combination product homozygous population style margin margin bottom text indent font size font family time roman homozygous population post development cost mean aggregate amount homozygous population post development budget included combination product post development plan attached hereto schedule nbsp together with increase thereto agreed party accordance with section nbsp provided that nbsp abbvie elect proceed with development triple combination product only homozygous population then percent base cost identified combination product post development plan shall counted towards homozygous population post development cost nbsp abbvie elect proceed with development triple combination product both heterozygous population homozygous population then percent such base cost shall counted towards heterozygous population post development cost percent such base cost shall counted towards homozygous population post development cost restatement date homozygous population post development cost dollar abbvie elect proceed with development triple combination product only homozygous population dollar abbvie elect proceed with development triple combination product both heterozygous population homozygous population style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman improvement mean modification variation revision molecule compound product technology discovery technology device process formulation related such molecule compound product technology whether patented patentable including enhancement efficiency operation manufacture including manufacturing process ingredient preparation presentation formulation mean delivery packaging dosage such molecule compound product technology discovery development expanded indication such molecule compound product technology discovery development that improves stability safety efficacy such compound product technology style margin margin bottom text indent font size font family time roman meaning forth section nbsp style margin margin bottom text indent font size font family time roman mean application filed with regulatory authority authorization commence human clinical study including nbsp investigational drug application defined ffdca successor application procedure filed with nbsp equivalent united state other country regulatory jurisdiction nbsp supplement amendment variation extension renewal thereof that filed with respect foregoing style margin margin bottom text indent font size font family time roman acceptance belgium mean with respect molecule such molecule been accepted applicable regulatory authority belgium style margin margin bottom text indent font size font family time roman acceptance mean with respect molecule such molecule been rejected placed clinical hold within thirty nbsp after submission thereof style margin margin bottom text indent font size font family time roman indemnification claim notice meaning forth section nbsp style margin margin bottom text indent font size font family time roman indemnified party meaning forth section nbsp style margin margin bottom text indent font size font family time roman indirect meaning forth section nbsp style margin margin bottom text indent font size font family time roman information mean knowledge technical scientific business other nature including know technology mean method process practice formula instruction skill technique procedure experience idea technical assistance design drawing assembly procedure computer program apparatus specification data result other material regulatory data other biological chemical pharmacological toxicological pharmaceutical physical analytical clinical clinical safety manufacturing quality control data information including study design protocol reagent plasmid protein cell line assay compound biological methodology each case whether confidential proprietary patented patentable commercial advantage written electronic other form known hereafter developed style margin margin bottom text indent font size font family time roman initial abbvie ftes meaning forth section nbsp style margin margin bottom text indent font size font family time roman initial abbvie cost meaning forth section nbsp style margin margin bottom text indent font size font family time roman initial cost meaning forth section nbsp style margin margin bottom text indent font size font family time roman initial galapagos ftes meaning forth section nbsp style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman initial galapagos cost meaning forth section nbsp style margin margin bottom text indent font size font family time roman intellectual property meaning forth section nbsp style margin margin bottom text indent font size font family time roman joint commercialization committee meaning forth section nbsp style margin margin bottom text indent font size font family time roman joint committee mean collectively style margin margin bottom text indent font size font family time roman joint development committee meaning forth section nbsp style margin margin bottom text indent font size font family time roman joint know meaning forth section nbsp style margin margin bottom text indent font size font family time roman joint patent meaning forth section nbsp style margin margin bottom text indent font size font family time roman joint research committee meaning forth section nbsp style margin margin bottom text indent font size font family time roman joint steering committee meaning forth section nbsp style margin margin bottom text indent font size font family time roman knowledge mean chief executive officer chief financial officer vice president involved subject matter this agreement including vice president research vice president product development vice president clinical development vice president intellectual property head regulatory affair senior patent counsel general counsel chief medical officer chief scientific officer party personnel holding position equivalent such title only extent such position exist such party style margin margin bottom text indent font size font family time roman last agreed discovery meaning forth section nbsp style margin margin bottom text indent font size font family time roman last agreed meaning forth section nbsp style margin margin bottom text indent font size font family time roman last agreed post meaning forth section nbsp style margin margin bottom text indent font size font family time roman lead corrector molecule mean with respect each series corrector molecule corrector molecule such series which owed paid style margin margin bottom text indent font size font family time roman lead corrector molecule mean with respect each series corrector molecule corrector molecule such series which owed paid style margin margin bottom text indent font size font family time roman lead potentiator molecule mean with respect each series potentiator molecule potentiator molecule such series which owed paid style margin margin bottom text indent font size font family time roman licensee meaning forth section style margin margin bottom text indent font size font family time roman loss meaning forth section nbsp style margin margin bottom text indent font size font family time roman meaning forth definition drug approval application style margin margin bottom text indent font size font family time roman major regulatory filing meaning forth section nbsp style margin margin bottom text indent font size font family time roman manufacture manufacturing mean activity related synthesis making production processing purifying formulating filling finishing packaging labeling shipping holding molecule product intermediate thereof including quality assurance quality control style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman manufacturing cost with respect molecule product related placebo meaning forth schedule nbsp style margin margin bottom text indent font size font family time roman manufacturing process meaning forth section nbsp style margin margin bottom text indent font size font family time roman manufacturing technology transfer meaning forth section nbsp style margin margin bottom text indent font size font family time roman marking meaning forth section nbsp style margin margin bottom text indent font size font family time roman medical affair activity mean with respect country other jurisdiction territory coordination medical information request field based medical scientific liaison with respect molecule product including activity medical scientific liaison provision medical information service with respect molecule product style margin margin bottom text indent font size font family time roman medical affair cost mean those cost charged accordance with section nbsp incurred direct font style white space nowrap font style white space nowrap pocket font font cost including cost independent contractor engaged permitted under this agreement recorded party affiliate accordance with accounting standard after effective date during term pursuant this agreement provided that such cost specifically identifiable reasonably allocable medical affair activity with respect promotion product sold promotion territory style margin margin bottom text indent font size font family time roman merging party meaning forth section nbsp style margin margin bottom text indent font size font family time roman molecule mean corrector molecule potentiator molecule style margin margin bottom text indent font size font family time roman mono product meaning forth definition sale style margin margin bottom text indent font size font family time roman monthly average exchange rate meaning forth section nbsp style margin margin bottom text indent font size font family time roman multi active combination product mean triple combination product that contains nbsp more active ingredient addition corrector molecule potentiator molecule which product either single fixed dose formulation combined single package sold nbsp product style margin margin bottom text indent font size font family time roman multi active potentiator product mean potentiator product that contains nbsp more active ingredient addition which product either single fixed dose formulation combined single package sold nbsp product style margin margin bottom text indent font size font family time roman multi active product mean multi active combination product multi active potentiator product style margin margin bottom text indent font size font family time roman meaning forth definition drug approval application style margin margin bottom text indent font size font family time roman profit with correlative meaning loss mean style margin margin bottom text indent font size font family time roman sale mean page omitted style margin margin bottom text indent font size font family time roman neutral meaning forth schedule style margin margin bottom text indent font size font family time roman breaching party meaning forth section nbsp style margin margin bottom text indent font size font family time roman funding discovery party meaning forth section nbsp style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman funding party meaning forth section nbsp style margin margin bottom text indent font size font family time roman funding post party meaning forth section nbsp style margin margin bottom text indent font size font family time roman merging party meaning forth section nbsp style margin margin bottom text indent font size font family time roman performing party meaning forth section nbsp style margin margin bottom text indent font size font family time roman owned patent meaning forth section nbsp style margin margin bottom text indent font size font family time roman dual combination product mean pharmaceutical product containing nbsp corrector molecule nbsp potentiator molecule active ingredient style margin margin bottom text indent font size font family time roman dual combination product success criterion mean success criterion with respect dual combination product forth schedule nbsp that will measured after completion phase such dual combination product cohort conducted accordance with combination product development plan same amended from time time pursuant section nbsp style margin margin bottom text indent font size font family time roman party party meaning forth preamble hereto style margin margin bottom text indent font size font family time roman patent cost mean those cost font style white space nowrap house font legal counsel related personnel charged accordance with section nbsp incurred direct font style white space nowrap font style white space nowrap pocket font font cost including reasonable expense paid outside counsel other third party filing maintenance paid governmental authority recorded expense party affiliate accordance with accounting standard after effective date during term pursuant this agreement nbsp connection with prosecution maintenance right including cost patent interference opposition reissue font style white space nowrap examination font proceeding filing registration with respect galapagos patent joint patent abbvie patent each case extent that they claim composition matter article manufacture method method manufacture promotion product promotion territory nbsp cost litigation enforcement defense other proceeding under galapagos patent joint patent abbvie patent each case only extent related promotion product promotion territory reimbursed third party style margin margin bottom text indent font size font family time roman patent mean nbsp national regional international patent application including provisional patent application application claiming priority therefrom including divisionals continuation continuation part provisionals converted provisionals continued prosecution application nbsp national patent issued granted from foregoing patent application including utility patent utility model petty patent design patent certificate invention nbsp extension restoration existing future extension restoration mechanism including revalidations reissue examination extension including supplementary protection certificate like foregoing patent patent application nbsp similar right including called pipeline protection importation revalidation confirmation introduction patent registration patent patent addition such foregoing patent application patent style margin margin bottom text indent font size font family time roman patient population mean heterozygous population homozygous population style margin margin bottom text indent font size font family time roman payment date mean with respect required abbvie payment date which abbvie required make such required abbvie payment galapagos pursuant section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman person mean individual sole proprietorship partnership limited partnership limited liability partnership corporation limited liability company business trust joint stock company trust unincorporated association joint venture other similar entity organization including government political subdivision department agency government style margin margin bottom text indent font size font family time roman phase mean exploratory first human trial conducted accordance with guidance exploratory investigational drug study equivalent country other jurisdiction outside united state designed expedite development therapeutic imaging agent establishing very early whether agent behaves human subject anticipated from preclinical study style margin margin bottom text indent font size font family time roman phase mean human clinical trial molecule product principal purpose which preliminary determination safety tolerability pharmacological activity pharmacokinetics healthy individual patient similar clinical study prescribed regulatory authority including trial referred amended style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman phase mean human clinical trial molecule product principal purpose which determination safety efficacy target patient population which prospectively designed generate sufficient data that permit commencement pivotal clinical trial similar clinical study prescribed regulatory authority from time time pursuant applicable otherwise including trial referred amended notwithstanding foregoing triple combination phase clinical study shall treated phase purpose final decision making authority party forth section nbsp style margin margin bottom text indent font size font family time roman phase mean human clinical trial molecule product sufficient number subject indicated patient population that designed establish that such molecule product safe efficacious intended determine benefit risk relationship warning precaution adverse reaction that associated with such product dosage range prescribed which trial intended support marketing approval such molecule product including test study that required from time time pursuant applicable otherwise including trial referred amended style margin margin bottom text indent font size font family time roman phase cost mean those cost charged accordance with section nbsp nbsp incurred direct font style white space nowrap font style white space nowrap pocket font font cost recorded expense accordance with accounting standard behalf party affiliate after effective date during term pursuant this agreement nbsp specifically identifiable reasonably allocable phase study wherever conducted promotion product support commercialization such promotion product promotion territory subject foregoing phase cost shall include nbsp cost connection with preparation conduct phase study data collection analysis report writing clinical laboratory work nbsp related regulatory expense nbsp related manufacturing cost provided that such phase cost shall counted more than once allowable expense style margin margin bottom text indent font size font family time roman phase study mean post marketing human clinical study product with respect indication which regulatory approval been received that subject investigator initiated study program style margin margin bottom text indent font size font family time roman pmda mean japan pharmaceutical medical device agency successor agency authority having substantially same function style margin margin bottom text indent font size font family time roman cost mean aggregate amount combination product budget included combination product development plan attached hereto schedule nbsp together with increase thereto agreed party accordance with section nbsp restatement date cost dollar style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman increase funding date meaning forth section nbsp style margin margin bottom text indent font size font family time roman reimbursement credit meaning forth section nbsp style margin margin bottom text indent font size font family time roman reimbursement payment meaning forth section nbsp style margin margin bottom text indent font size font family time roman reimbursement premium percentage meaning forth section nbsp style margin margin bottom text indent font size font family time roman post development budget mean each nbsp heterozygous population post development budget nbsp homozygous population post development budget nbsp potentiator post development budget style margin margin bottom text indent font size font family time roman post development cost mean each nbsp heterozygous population post development cost nbsp homozygous population post development cost nbsp potentiator post development cost style margin margin bottom text indent font size font family time roman post development cost portion mean nbsp with respect abbvie percent nbsp with respect galapagos percent style margin margin bottom text indent font size font family time roman post development plan mean each potentiator post development plan combination product post development plan style margin margin bottom text indent font size font family time roman post increase funding date meaning forth section nbsp style margin margin bottom text indent font size font family time roman post reimbursement credit meaning forth section nbsp style margin margin bottom text indent font size font family time roman post reimbursement payment meaning forth section nbsp style margin margin bottom text indent font size font family time roman post reimbursement premium percentage meaning forth section nbsp style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman potentiator success criterion mean success criterion with respect potentiator molecule forth schedule nbsp same amended from time time pursuant section nbsp style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman potentiator molecule mean nbsp subject section nbsp existing potentiator molecule nbsp cftr potentiator molecule resulting from discovery collaboration that increasing probability open configuration cftr protein leading increase chloride transport activity clarity subject section nbsp potentiator molecule style margin margin bottom text indent font size font family time roman potentiator post development budget meaning forth section nbsp style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman potentiator post development cost mean aggregate amount potentiator post development budget initially approved accordance with section nbsp part potentiator post development plan together with increase thereto agreed party accordance with section nbsp style margin margin bottom text indent font size font family time roman potentiator post development plan meaning forth section nbsp style margin margin bottom text indent font size font family time roman potentiator product mean pharmaceutical product that contains active ingredient also contain corrector molecule active ingredient including finished form presentation delivery system strength dosage formulation which developed under potentiator post development plan style margin margin bottom text indent font size font family time roman product mean nbsp subject section nbsp section nbsp each potentiator product nbsp each combination product style margin margin bottom text indent font size font family time roman product information meaning forth section nbsp style margin margin bottom text indent font size font family time roman product labeling mean with respect product country other jurisdiction territory nbsp regulatory font style white space nowrap authority approved font full prescribing information such product such country other jurisdiction including required patient information nbsp label other written printed graphic matter upon container wrapper package insert utilized with such product such country other jurisdiction style margin margin bottom text indent font size font family time roman product patent mean each abbvie patent galapagos patent joint patent that claim composition matter article manufacture method method manufacture molecule product including existing potentiator patent style margin margin bottom text indent font size font family time roman product trademark mean trademark used abbvie galapagos their respective affiliate their their affiliate sublicensees development commercialization product territory registration thereof pending application relating thereto territory excluding event trademark service mark name logo that include corporate name logo party their affiliate style margin margin bottom text indent font size font family time roman proposed future third party licensed right meaning forth section style margin margin bottom text indent font size font family time roman proposed term meaning forth section nbsp style margin margin bottom text indent font size font family time roman quarterly discovery incurrence date meaning forth section nbsp style margin margin bottom text indent font size font family time roman quarterly incurrence date meaning forth section nbsp style margin margin bottom text indent font size font family time roman quarterly post incurrence date meaning forth section nbsp style margin margin bottom text indent font size font family time roman regulatory approval mean with respect product country other jurisdiction territory approval including approval drug approval application license registration authorization regulatory authority necessary commercialize such product such country other jurisdiction including where applicable nbsp pricing reimbursement approval such country other jurisdiction nbsp post approval marketing authorization including prerequisite manufacturing approval authorization related thereto nbsp approval product labeling style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman regulatory authority mean applicable supra national federal national regional state provincial local governmental regulatory authority agency department bureau commission council other entity pmda regulating otherwise exercising authority with respect activity contemplated this agreement including exploitation molecule product territory applicable exploitation galapagos product style margin margin bottom text indent font size font family time roman regulatory data meaning forth section nbsp style margin margin bottom text indent font size font family time roman regulatory documentation mean nbsp application including inds drug approval application other major regulatory filing registration license authorization approval including regulatory approval nbsp correspondence report submitted received from regulatory authority including minute official contact report relating communication with regulatory authority supporting document with respect thereto including regulatory drug list advertising promotion document adverse event file complaint file each case relating molecule product style margin margin bottom text indent font size font family time roman regulatory exclusivity mean with respect country other jurisdiction territory additional market protection other than patent protection granted regulatory authority such country other jurisdiction which confers exclusive commercialization period during which abbvie affiliate sublicensees have exclusive right market sell molecule product such country other jurisdiction through regulatory exclusivity right chemical entity exclusivity indication exclusivity formulation exclusivity orphan drug exclusivity pediatric exclusivity applicable data exclusivity style margin margin bottom text indent font size font family time roman regulatory expense mean those cost charged accordance with section nbsp nbsp incurred direct font style white space nowrap font style white space nowrap pocket font font cost including filing user maintenance other paid regulatory authority recorded expense accordance with accounting standard behalf abbvie affiliate after effective date during term pursuant this agreement nbsp specifically identifiable reasonably allocable preparation regulatory submission obtaining maintenance regulatory approval promotion product promotion territory including compliance with regulatory approval requirement such regulatory authority adverse event recordation reporting regulatory affair activity each case promotion territory provided that such cost shall counted more than once allowable expense style margin margin bottom text indent font size font family time roman reimbursement credit mean discovery reimbursement credit reimbursement credit post reimbursement credit style margin margin bottom text indent font size font family time roman reimbursement payment mean discovery reimbursement payment reimbursement payment post reimbursement payment style margin margin bottom text indent font size font family time roman required abbvie payment mean each payment payable abbvie galapagos pursuant section style margin margin bottom text indent font size font family time roman restatement date meaning forth preamble hereto style margin margin bottom text indent font size font family time roman royalty term mean with respect each product each country other jurisdiction royalty territory period beginning date first commercial sale such product such country other jurisdiction ending latest occur nbsp expiration invalidation abandonment date last galapagos patent joint patent that includes valid claim that cover manufacture sale such product that sold such country style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman other jurisdiction nbsp anniversary first commercial sale such product such country other jurisdiction nbsp expiration regulatory exclusivity such product such country other jurisdiction style margin margin bottom text indent font size font family time roman royalty territory mean country jurisdiction abbvie territory except promotion territory style margin margin bottom text indent font size font family time roman sale marketing cost mean page omitted style margin margin bottom text indent font size font family time roman seller meaning forth definition sale style margin margin bottom text indent font size font family time roman senior officer mean nbsp with respect galapagos chief executive officer designee nbsp with respect abbvie nbsp development manufacturing matter chief scientific officer equivalent position designee applicable nbsp commercialization matter executive vice president commercial operation designee style margin margin bottom text indent font size font family time roman series mean compound originating from structural chemotype which molecular similarity exceeds defined tanimoto shape similarity coefficient style margin margin bottom text indent font size font family time roman step party meaning forth section nbsp style margin margin bottom text indent font size font family time roman sublicensee mean person other than affiliate that granted nbsp sublicense abbvie under grant section nbsp permitted section nbsp nbsp sublicense galapagos under grant section nbsp permitted section nbsp style margin margin bottom text indent font size font family time roman support memorandum meaning forth section nbsp style margin margin bottom text indent font size font family time roman term meaning forth section nbsp style margin margin bottom text indent font size font family time roman terminated territory mean each country jurisdiction with respect which this agreement terminated pursuant section nbsp pursuant section nbsp this agreement terminated entirety entire territory style margin margin bottom text indent font size font family time roman territory mean entire world excluding terminated territory from after date termination thereof style margin margin bottom text indent font size font family time roman third party mean person other than galapagos abbvie their respective affiliate style margin margin bottom text indent font size font family time roman third party claim meaning forth section nbsp style margin margin bottom text indent font size font family time roman third party infringement meaning forth section nbsp style margin margin bottom text indent font size font family time roman third party license agreement mean nbsp each agreement listed schedule nbsp agreement between galapagos third party under which abbvie granted sublicense other right under this agreement provided section nbsp style margin margin bottom text indent font size font family time roman third party payment mean upfront payment milestone payment royalty other amount paid third party pursuant third party license agreement pursuant agreement with third party that abbvie affiliate sublicensees enter into pursuant accordance with section nbsp order obtain license right under patent intellectual property right owned controlled such third party order exploit molecule product style margin margin bottom text indent font size font family time roman third party provider meaning forth section nbsp style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman total discovery reimbursement balance meaning forth section nbsp style margin margin bottom text indent font size font family time roman total reimbursement balance meaning forth section nbsp style margin margin bottom text indent font size font family time roman total post reimbursement balance meaning forth section nbsp style margin margin bottom text indent font size font family time roman total quarterly discovery obligation meaning forth section nbsp style margin margin bottom text indent font size font family time roman total quarterly obligation meaning forth section nbsp style margin margin bottom text indent font size font family time roman total quarterly post obligation meaning forth section nbsp style margin margin bottom text indent font size font family time roman trademark mean word name symbol color designation device combination thereof that function source identifier including trademark trade dress brand mark service mark trade name brand name logo business symbol domain name whether registered style margin margin bottom text indent font size font family time roman trademark cost mean nbsp those cost font style white space nowrap house font legal counsel related personnel charged accordance with section nbsp nbsp incurred direct font style white space nowrap font style white space nowrap pocket font font cost including reasonable expense paid outside counsel other third party filing maintenance paid governmental authority recorded expense party affiliate accordance with accounting standard after effective date during term pursuant this agreement nbsp connection with prosecution maintenance right including filing registration with respect trademark promotion product promotion territory nbsp cost litigation enforcement defense other proceeding under trademark promotion product promotion territory only extent reimbursed third party style margin margin bottom text indent font size font family time roman transition agreement meaning forth section nbsp style margin margin bottom text indent font size font family time roman triple combination phase success criterion mean success criterion triple combination phase triple combination product forth schedule nbsp same amended from time time pursuant section nbsp style margin margin bottom text indent font size font family time roman triple combination heterozygous success criterion mean success criterion with respect triple combination product heterozygous population forth schedule nbsp same amended from time time pursuant section nbsp style margin margin bottom text indent font size font family time roman triple combination homozygous success criterion mean success criterion with respect triple combination product homozygous population forth schedule nbsp same amended from time time pursuant section nbsp style margin margin bottom text indent font size font family time roman triple combination phase mean phase study healthy individual evaluate multiple dose pharmacokinetics drug interaction assessment triple combination product prior evaluation patient style margin margin bottom text indent font size font family time roman triple combination phase clinical study mean clinical study evaluate safety tolerability pharmacokinetics including multiple pharmacokinetic sample sufficient number subject triple combination product homozygous population heterozygous population with without exploratory efficacy measure style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman triple combination phase clinical study heterozygous mean dose finding phase evaluating safety efficacy multiple dose combination component triple combination product heterozygous population order determine best dose combination take into phase heterozygous population style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman triple combination phase clinical study homozygous mean dose finding phase evaluating safety efficacy multiple dose combination component triple combination product homozygous population order determine best dose combination take into phase homozygous population style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman triple combination product mean pharmaceutical product containing nbsp corrector molecule nbsp corrector molecule nbsp potentiator molecule active ingredient which product either single fixed dose formulation combined single package sold nbsp product each case including finished form presentation delivery system strength dosage formulation style margin margin bottom text indent font size font family time roman triple combination standard meaning forth section nbsp style margin margin bottom text indent font size font family time roman unilateral discovery party meaning forth section nbsp style margin margin bottom text indent font size font family time roman unilateral discovery period meaning forth section nbsp style margin margin bottom text indent font size font family time roman unilateral party meaning forth section nbsp style margin margin bottom text indent font size font family time roman unilateral period meaning forth section nbsp style margin margin bottom text indent font size font family time roman unilateral post party meaning forth section nbsp style margin margin bottom text indent font size font family time roman unilateral post period meaning forth section nbsp style margin margin bottom text indent font size font family time roman united state mean united state america territory possession including district columbia puerto rico style margin margin bottom text indent font size font family time roman bankruptcy code meaning forth section nbsp style margin margin bottom text indent font size font family time roman valid claim mean claim issued patent which expired irretrievably lapsed been abandoned revoked dedicated public disclaimed adjudged invalid unenforceable result holding finding decision invalidity unenforceability patentability court governmental agency national regional patent office other appropriate body that competent jurisdiction such holding finding decision being final unappealable unappealed within time allowed appeal style margin margin bottom text indent font size font family time roman voting stock meaning forth definition change control style margin margin bottom text indent font size font family time roman withholding party meaning forth section nbsp style margin margin bottom text indent font size font family time roman working group meaning forth section nbsp style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center collaboration management style margin margin bottom text indent font size font family time roman joint steering committee style margin margin bottom text indent font size font family time roman formation restatement date party have established joint steering committee joint steering committee which shall nbsp manage oversee development commercialization other exploitation molecule product territory nbsp resolve dispute that arise accordance with section nbsp nbsp coordinate party activity under this agreement including oversight nbsp determine whether submit potentiator molecule corrector molecule combination product applicable country territory nbsp consider review approve amendment potentiator success criterion success criterion success criterion dual combination product success criterion triple combination phase success criterion triple combination heterozygous success criterion triple combination homozygous success criterion inclusion therein combination standard applicable nbsp perform such other function forth herein party mutually agree writing except where conflict with provision this agreement shall consist three nbsp representative from each party each with requisite experience seniority enable such person make decision behalf applicable party with respect issue falling within jurisdiction from time time each party substitute nbsp more representative written notice other party shall chaired annual rotating basis representative either abbvie galapagos applicable joint steering committee with providing first such chairperson chairperson shall appoint secretary joint steering committee shall representative other party shall serve same annual term such chairperson style margin margin bottom text indent font size font family time roman joint research committee style margin margin bottom text indent font size font family time roman formation restatement date party have established joint research committee joint research committee shall consist three nbsp representative from each party each with requisite experience seniority enable such person make decision behalf applicable party with respect issue falling within jurisdiction from time time each party substitute nbsp more representative written notice other party shall chaired annual rotating basis representative either abbvie galapagos applicable with providing first such chairperson style margin margin bottom text indent font size font family time roman specific responsibility shall manage coordinate oversee performance discovery activity party particular shall style margin margin bottom text indent font size font family time roman periodically often than quarterly review serve forum discussing discovery work plan review approve amendment thereto including amendment discovery budget style margin margin bottom text indent font size font family time roman oversee conduct discovery activity under discovery work plan style margin margin bottom text indent font size font family time roman consider approve modification length discovery term style margin margin bottom text indent font size font family time roman determine whether potentiator molecule satisfies potentiator success criterion style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman determine whether corrector molecule satisfies success criterion style margin margin bottom text indent font size font family time roman determine whether corrector molecule satisfies success criterion style margin margin bottom text indent font size font family time roman serve forum discussion result obtained from discovery collaboration style margin margin bottom text indent font size font family time roman viii establish secure access method such secure database other process each party exchange access discovery activity related information contemplated under this agreement style margin margin bottom text indent font size font family time roman discus extent provided section nbsp approve selection third party provider engaged support discovery activity review performance such third party provider style margin margin bottom text indent font size font family time roman perform such other function forth herein party mutually agree writing except where conflict with provision this agreement style margin margin bottom text indent font size font family time roman joint development committee style margin margin bottom text indent font size font family time roman formation restatement date party have established joint development committee joint development committee shall consist three nbsp representative from each party each with requisite experience seniority enable such person make decision behalf party with respect issue falling within jurisdiction from time time each party substitute nbsp more representative written notice other party shall chaired annual rotating basis representative either abbvie galapagos applicable with providing first such chairperson style margin margin bottom text indent font size font family time roman specific responsibility shall manage coordinate oversee party activity under combination product development plan combination product post development plan plan potentiator post development plan galapagos territory development plan particular shall style margin margin bottom text indent font size font family time roman develop approve potentiator post development plan accordance with term hereof style margin margin bottom text indent font size font family time roman periodically often than semi annually review serve forum discussing applicable combination product development plan combination product post development plan potentiator product post development plan review approve amendment thereto including amendment combination product budget combination product post development budget potentiator post development budget style margin margin bottom text indent font size font family time roman determine corrector molecule potentiator molecule dual combination product triple combination product developed phase phase under combination product development plan style margin margin bottom text indent font size font family time roman determine whether discontinue nbsp phase phase under combination product development plan with respect particular molecule particular molecule contained combination product select development phase phase under combination product development plan molecule combination product containing nbsp more molecule nbsp phase under potentiator post development plan style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman periodically often than semi annually review serve forum discussing plan review approve amendment style margin margin bottom text indent font size font family time roman determine whether dual combination product satisfies dual combination product success criterion style margin margin bottom text indent font size font family time roman determine whether triple combination product satisfies triple combination phase success criterion triple combination heterozygous success criterion triple combination homozygous success criterion applicable style margin margin bottom text indent font size font family time roman viii oversee conduct development activity applicable under combination product development plan combination product post development plan potentiator post development plan plan style margin margin bottom text indent font size font family time roman serve forum discussing strategy obtaining regulatory approval product territory style margin margin bottom text indent font size font family time roman determine whether development activity under combination product post development plan support filing drug approval application applicable combination product country jurisdiction territory whether drug approval filing with respect combination product shall made country jurisdiction territory style margin margin bottom text indent font size font family time roman determine occurrence combination post development failure style margin margin bottom text indent font size font family time roman determine whether development activity under potentiator post development plan support filing drug approval application potentiator product country jurisdiction territory whether drug approval filing with respect potentiator product shall made country jurisdiction territory style margin margin bottom text indent font size font family time roman xiii review approve initial galapagos territory development plan style margin margin bottom text indent font size font family time roman periodically often than semi annually review serve forum discussing galapagos territory development plan review approve amendment thereto style margin margin bottom text indent font size font family time roman establish secure access method such secure database other process each party exchange access regulatory documentation other development related information contemplated under this agreement style margin margin bottom text indent font size font family time roman discus extent provided section nbsp approve selection third party provider engaged support development activity review performance such third party provider style margin margin bottom text indent font size font family time roman xvii perform such other function forth herein party mutually agree writing except where conflict with provision this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman joint commercialization committee style margin margin bottom text indent font size font family time roman formation least month prior anticipated filing first drug approval application with applicable regulatory authority country promotion territory with with respect centralized approval procedure party shall establish joint commercialization committee joint commercialization committee shall consist three nbsp representative from each party each with requisite experience seniority enable such person make decision behalf applicable party with respect issue falling within jurisdiction from time time each party substitute nbsp more representative written notice other party abbvie shall select from representative chairperson from time time abbvie change representative will serve chairperson written notice galapagos style margin margin bottom text indent font size font family time roman specific responsibility shall develop strategy oversee commercialization promotion product promotion territory oversee high level commercialization activity galapagos territory with respect product particular shall style margin margin bottom text indent font size font family time roman periodically often than annually review serve forum discussing abbvie commercialization activity abbvie territory abbvie global brand plan product including marketing promotional material product messaging commercialization budget detailing effort style margin margin bottom text indent font size font family time roman establish strategy commercialization promotion product promotion territory style margin margin bottom text indent font size font family time roman review approve initial promotion plan style margin margin bottom text indent font size font family time roman periodically often than annually review serve forum discussing promotion plan review approve amendment thereto style margin margin bottom text indent font size font family time roman review approve manner which marking presented promotional material product labeling promotion product promotion territory style margin margin bottom text indent font size font family time roman review approve initial galapagos territory commercialization plan provided that abbvie shall ensure that representative unreasonably withhold such approval long initial galapagos territory commercialization plan consistent with abbvie then current global brand plan product other requirement this agreement style margin margin bottom text indent font size font family time roman oversee high level commercialization activity galapagos territory with respect product style margin margin bottom text indent font size font family time roman viii periodically often than annually review serve forum discussing galapagos territory commercialization plan implementation review approve amendment thereto provided that abbvie shall ensure that representative unreasonably withhold such approval long such amendment consistent with abbvie then current global brand plan product other requirement this agreement style margin margin bottom text indent font size font family time roman review approve form content marketing promotional material product messaging used galapagos territory with respect product style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman review approve form content training material used galapagos territory with respect product style margin margin bottom text indent font size font family time roman discus selection distributor third party promoter promoter engaged support commercialization activity galapagos territory review performance such third party style margin margin bottom text indent font size font family time roman perform such other function forth herein party mutually agree writing except where conflict with provision this agreement style margin margin bottom text indent font size font family time roman general provision applicable joint committee style margin margin bottom text indent font size font family time roman meeting minute shall meet frequently than semi annually shall meet quarterly each case otherwise agreed party with location such meeting alternating between location designated galapagos location designated abbvie chairperson applicable joint committee shall responsible calling meeting than thirty nbsp business notice each party shall make proposal agenda item shall provide appropriate information with respect such proposed item least nbsp business advance applicable meeting provided that under exigent circumstance requiring input joint committee party provide agenda item other party within shorter period time advance meeting propose that there specific agenda particular meeting long other party consent such later addition such agenda item absence specific agenda such meeting respective chairperson each joint committee case secretary shall prepare circulate review approval party minute each meeting within thirty nbsp after meeting party shall agree minute each meeting promptly event later than next meeting joint committee party agree content minute objecting party shall append notice objection with specific detail objection proposed minute style margin margin bottom text indent font size font family time roman procedural rule each joint committee shall have right adopt such standing rule shall necessary work extent that such rule inconsistent with this agreement quorum joint committee shall exist whenever there present meeting least nbsp representative appointed each party representative party joint committee attend meeting either person telephone video conference similar mean which each participant hear what said heard other participant representation proxy shall allowed subject applicable final decision making authority party forth section nbsp each joint committee shall take action unanimous agreement representative present meeting which quorum exists with each party having single vote irrespective number representative such party attendance written resolution signed least nbsp representative appointed each party employee consultant either party that representative party joint committee attend meeting such joint committee provided that such attendee nbsp shall vote otherwise participate decision making process joint committee nbsp bound obligation confidentiality disclosure equivalent those forth article style margin margin bottom text indent font size font family time roman joint committee dispute resolution reach unanimous agreement issue meeting within period business thereafter such other period party agree then dispute shall referred resolution special meeting called such purpose reach unanimous agreement issue including dispute arising from meeting within period business thereafter such other period party agree then dispute shall first referred senior officer party shall confer good faith resolution issue final decision mutually agreed senior officer shall conclusive binding party style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman senior officer able agree resolution such issue within after such issue first referred them then style margin margin bottom text indent font size font family time roman such dispute relates proposed amendment potentiator success criterion success criterion success criterion dual combination product success criterion triple combination phase success criterion triple combination heterozygous success criterion triple combination homozygous success criterion inclusion therein combination standard applicable such dispute shall resolved style margin margin bottom text indent font size font family time roman such dispute relates proposed modification length discovery term style margin margin bottom text indent font size font family time roman such dispute relates proposed amendment discovery work plan including discovery budget such dispute shall finally definitively resolved style margin margin bottom text indent font size font family time roman subject clause nbsp nbsp below such dispute relates proposed amendment combination product development plan including combination product budget such dispute shall finally definitively resolved style margin margin bottom text indent font size font family time roman such dispute relates nbsp corrector molecule potentiator molecule dual combination product triple combination product developed phase under combination product development plan nbsp whether discontinue phase under combination product development plan with respect particular molecule particular molecule contained combination product select development phase under combination product development plan molecule combination product containing nbsp more molecule each case such dispute shall finally definitively resolved style margin margin bottom text indent font size font family time roman such dispute relates nbsp corrector molecule potentiator molecule dual combination product triple combination product developed phase including triple combination phase clinical study under combination product development plan nbsp whether discontinue phase under potentiator post development plan with respect potentiator product phase including triple combination phase clinical study under combination product development plan with respect particular molecule particular molecule contained combination product select development phase including triple combination phase clinical study under combination product development plan molecule combination product containing nbsp more molecule each case such dispute shall finally definitively resolved style margin margin bottom text indent font size font family time roman such dispute relates proposed amendment combination product post development plan including heterozygous population post development budget homozygous population post development budget such dispute shall finally definitively resolved style margin margin bottom text indent font size font family time roman viii such dispute relates approval initial potentiator post development plan including potentiator post development budget amendment thereto such dispute shall finally definitively resolved style margin margin bottom text indent font size font family time roman such dispute relates approval amendment such dispute shall finally definitively resolved style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman such dispute relates approval initial galapagos territory development plan amendment thereto such dispute shall finally definitively resolved style margin margin bottom text indent font size font family time roman such dispute relates whether molecule satisfies potentiator success criterion success criterion success criterion applicable such dispute shall resolved style margin margin bottom text indent font size font family time roman such dispute relates whether dual combination product satisfies dual combination product success criterion such dispute shall resolved style margin margin bottom text indent font size font family time roman xiii such dispute relates whether triple combination product satisfies triple combination phase success criterion triple combination heterozygous success criterion triple combination homozygous success criterion applicable such dispute shall resolved style margin margin bottom text indent font size font family time roman such dispute relates whether will submitted potentiator molecule corrector molecule combination product applicable country territory such dispute shall finally definitively resolved style margin margin bottom text indent font size font family time roman such dispute relates whether development activity under combination product post development plan support filing drug approval application applicable triple combination product country jurisdiction abbvie territory whether drug approval filing with respect triple combination product will made country jurisdiction abbvie territory such dispute shall finally definitively resolved style margin margin bottom text indent font size font family time roman such dispute relates whether development activity under potentiator post development plan support filing drug approval application potentiator product country jurisdiction abbvie territory whether drug approval filing with respect potentiator product will made country jurisdiction abbvie territory such dispute shall finally definitively resolved style margin margin bottom text indent font size font family time roman xvii such dispute relates whether development activity under combination product post development plan galapagos territory development plan support filing drug approval application applicable triple combination product country jurisdiction galapagos territory whether drug approval filing with respect triple combination product will made country jurisdiction galapagos territory such dispute shall finally definitively resolved style margin margin bottom text indent font size font family time roman xviii such dispute relates whether development activity under potentiator post development plan support filing drug approval application potentiator product country jurisdiction galapagos territory whether drug approval filing with respect potentiator product will made country jurisdiction galapagos territory such dispute shall finally definitively resolved style margin margin bottom text indent font size font family time roman such dispute relates issue originally within jurisdiction including content promotion plan galapagos territory commercialization plan amendment thereto then such issue shall finally definitively resolved style margin margin bottom text indent font size font family time roman such dispute relates whether obtain third party license pursuant section nbsp party that will negotiate such license term such license then such issue shall finally definitively resolved style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman such dispute relates whether continue development back combination product under combination product post development plan contemplated section nbsp such issue shall finally definitively resolved style margin margin bottom text indent font size font family time roman xxii such dispute relates whether country shall designated approved country style margin margin bottom font size font family time roman except otherwise expressly forth this agreement dispute arising between party connection with relating this agreement document instrument delivered connection herewith that outside jurisdiction joint committee including alleged breach this agreement party shall resolved pursuant section nbsp style margin margin bottom text indent font size font family time roman limitation authority each party shall retain right power discretion granted under this agreement such right power discretion shall delegated vested joint committee unless such delegation vesting right expressly provided this agreement party expressly agree writing joint committee shall have power amend modify waive compliance with this agreement which only amended modified provided section nbsp compliance with which only waived provided section nbsp style margin margin bottom text indent font size font family time roman alliance manager each party shall appoint person shall oversee contact between party matter between meeting each joint committee shall have such other responsibility party agree writing after effective date each alliance manager each party replace alliance manager time notice writing other party style margin margin bottom text indent font size font family time roman discontinuation participation committee subject section nbsp each joint committee shall continue exist until first occur nbsp party mutually agreeing disband joint committee nbsp galapagos providing abbvie written notice intention disband longer participate such joint committee provided that galapagos shall give such written notice prior completion activity under discovery work plan combination product development plan notwithstanding anything herein contrary once galapagos provided such written notice such joint committee shall terminated shall have further right obligation under this agreement thereafter requirement either party provide information such joint committee shall deemed requirement provide such information other party abbvie shall have right solely decide without consultation with galapagos matter that subject review approval such joint committee hereunder style margin margin bottom text indent font size font family time roman interaction between committee internal team party recognize that each party posse internal structure including various committee team review board that will involved administering such party activity under this agreement nothing contained this article shall prevent party from making routine decision relating conduct those activity which performance other obligation hereunder each case manner consistent with then current applicable plan term condition this agreement style margin margin bottom text indent font size font family time roman working group from time time joint committee establish delegate duty committee directed team each working group needed basis oversee particular project activity joint project team joint finance group joint intellectual property group each such working group shall constituted shall operate joint committee determines provided that each working group shall have equal representation from each party unless otherwise mutually agreed working group established basis purpose specific project such other basis joint committee determine each style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman working group activity shall subject oversight review approval shall report joint committee that formed said working group event shall authority working group exceed that specified joint committee that formed working group this article decision working group shall unanimous agreement disagreement between designees abbvie galapagos working group shall referred joint committee that formed working group resolution style margin margin bottom text indent font size font family time roman expense each party shall responsible travel related cost expense member other representative attend meeting otherwise participate joint committee working group style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center discovery development regulatory style margin margin bottom text indent font size font family time roman discovery work plan discovery activity style margin margin bottom text indent font size font family time roman goal discovery collaboration party shall conduct discovery collaboration with goal identifying delivering nbsp least lead potentiator molecule which existing potentiator molecule which shall least backup potentiator molecule which existing potentiator molecule which shall each which satisfies potentiator success criterion used combination with corrector molecule corrector molecule combination product nbsp least lead corrector molecule backup corrector molecule each which satisfies success criterion used combination with potentiator molecule corrector molecule combination product nbsp least lead corrector molecule each from different series backup corrector molecule each lead corrector molecule each which satisfies success criterion used combination with potentiator molecule corrector molecule triple combination product style margin margin bottom text indent font size font family time roman discovery work plan success criterion style margin margin bottom text indent font size font family time roman discovery work plan effect restatement date attached hereto schedule either party directly through representative propose amendment discovery work plan from time time appropriate including light changed circumstance style margin margin bottom text indent font size font family time roman party agree that time during discovery term combination standard change from applicable standard care previously effect then then current potentiator success criterion success criterion success criterion shall include combination standard applicable time either party belief that combination standard changed required included potentiator success criterion success criterion success criterion applicable accordance with this section nbsp such party through representative propose that potentiator success criterion success criterion success criterion applicable include same proposal shall subject approval forth section nbsp subject dispute resolution procedure forth section nbsp style margin margin bottom text indent font size font family time roman discovery activity each party shall perform discovery activity assigned such party discovery work plan including providing ftes accordance with section nbsp shall accordance with discovery work plan including budget forth therein amended from time time accordance with term hereof discovery budget allocating sufficient time effort equipment skilled personnel complete such discovery activity successfully promptly style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman discovery diligence each party shall commercially reasonable effort undertaking discovery activity assigned such party discovery work plan without limiting generality foregoing each party shall commercially reasonable effort nbsp achieve goal stated section nbsp lead potentiator molecule nbsp achieve goal stated section nbsp backup potentiator molecule nbsp achieve goal stated section nbsp lead corrector molecule nbsp achieve goal stated section nbsp backup corrector molecule nbsp achieve goal stated section nbsp lead corrector molecule nbsp achieve goal stated section nbsp backup corrector molecule each party promptly shall share with other party through process established information generated result achieved conducting result conducting discovery activity shall such information result determine whether potentiator molecule satisfies potentiator success criterion whether corrector molecule satisfies success criterion whether corrector molecule satisfies success criterion style margin margin bottom text indent font size font family time roman initial discovery cost style margin margin bottom text indent font size font family time roman over course discovery term unless otherwise agreed party nbsp abbvie shall provide total ftes perform discovery activity initial abbvie ftes with allocation initial abbvie ftes with respect each calendar year during discovery term specified discovery work plan nbsp galapagos shall provide total ftes perform discovery activity initial galapagos ftes with allocation initial galapagos ftes with respect each calendar year during discovery term specified discovery work plan abbvie shall responsible shall bear cost with respect initial abbvie ftes initial abbvie cost galapagos shall responsible shall bear cost with respect initial galapagos ftes initial galapagos cost together with initial abbvie cost initial cost style margin margin bottom text indent font size font family time roman addition bearing portion initial cost forth section nbsp each party shall responsible shall bear discovery cost portion development cost other than initial cost incurred party their affiliate performing discovery activity which include cost discovery additional cost style margin margin bottom text indent font size font family time roman discovery cost increase style margin margin bottom text indent font size font family time roman date which party their affiliate have incurred aggregate development cost performing discovery activity amount equal discovery total cost effect restatement date nbsp discovery collaboration failed identify generate least nbsp corrector molecule that either nbsp satisfies success criterion elected abbvie continued development accordance with section nbsp nbsp discovery collaboration failed identify generate least nbsp corrector molecule that either nbsp satisfies success criterion elected abbvie continued development accordance with section nbsp nbsp discovery collaboration failed identify generate least nbsp potentiator molecule other than that either nbsp satisfies potentiator success criterion elected abbvie continued development accordance with section nbsp then case nbsp unless party otherwise agree nbsp then current discovery budget then current discovery total cost automatically shall increased amount equal percent such then current discovery budget nbsp each party shall responsible shall bear discovery cost portion development cost incurred party their affiliate performing discovery activity excess discovery total cost effect restatement date such increased discovery total cost style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman date which party their affiliate have incurred aggregate development cost performing discovery activity amount equal then current discovery total cost previously increased pursuant section nbsp discovery collaboration failed identify generate least nbsp corrector molecule that either nbsp satisfies success criterion elected abbvie continued development accordance with section nbsp nbsp discovery collaboration failed identify generate least nbsp corrector molecule that either nbsp satisfies success criterion elected abbvie continued development accordance with section nbsp nbsp discovery collaboration failed identify generate least nbsp potentiator molecule other than that either nbsp satisfies potentiator success criterion elected abbvie continued development accordance with section nbsp then case nbsp either party through representative propose increase discovery budget with respect discovery activity corrector molecule potentiator molecule applicable style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign party agree increase discovery budget with respect discovery activity corrector molecule potentiator molecule applicable same amount then current discovery total cost shall increased amount such agreed increase both party wish increase discovery budget with respect discovery activity corrector molecule potentiator molecule applicable senior officer pursuant section nbsp able agree amount such increase discovery budget shall increased amount proposed party proposing smaller increase discovery total cost shall increased amount such smaller increase either such case each party shall responsible shall bear discovery cost portion development cost incurred party their affiliate performing discovery activity excess then current discovery total cost increased from time time accordance with this section nbsp such increased discovery total cost table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign neither party wish increase discovery budget with respect discovery activity corrector molecule potentiator molecule applicable bear discovery cost portion such increased cost then party shall cease performing discovery activity corrector molecule potentiator molecule applicable table style margin margin bottom text indent font size font family time roman senior officer only nbsp party unilateral discovery party wish increase discovery budget with respect discovery activity corrector molecule potentiator molecule applicable proposed pursuant section nbsp then style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign discovery budget shall increased amount deemed appropriate unilateral discovery party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style margin margin bottom font family time roman font size during period unilateral discovery period commencing date that after date which such proposed increase first referred senior officer pursuant section nbsp such later date discovery increase funding date ending table style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign date when funding discovery party fully reimbursed total discovery reimbursement balance pursuant section nbsp case unilateral discovery party shall have final decision making authority under section nbsp with respect amendment discovery work plan including additional increase discovery budget provided that proposed amendment that would assign additional discovery activity funding discovery party shall subject funding discovery party written consent table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign unilateral discovery party shall initially responsible shall initially bear development cost excess discovery total cost last increased pursuant section last agreed discovery incurred party their affiliate performing discovery activity excess discovery cost subject reimbursement other party funding discovery party accordance with section applicable table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign first immediately following each calendar quarter quarterly discovery incurrence date from after discovery increase funding date funding discovery party shall incur repayment obligation equal aggregate amount total quarterly discovery obligation incurred with respect calendar quarter under this section nbsp referred herein total discovery reimbursement balance table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign galapagos funding discovery party abbvie shall entitled credit against each required abbvie payment that after discovery increase funding date amount discovery reimbursement credit equal amount discovery reimbursement credit sufficient satisfy fully then outstanding total discovery reimbursement balance such discovery reimbursement credit shall applied settle each outstanding total quarterly discovery obligation order with oldest outstanding total quarterly discovery obligation settled first portion discovery reimbursement credit applied settle particular outstanding total quarterly discovery obligation sufficient satisfy fully such outstanding total quarterly discovery obligation then amount such discovery reimbursement credit that applied reimbursement applicable base quarterly discovery obligation shall equal purpose clarity abbvie shall continue credit discovery reimbursement credit against required abbvie payment until total discovery reimbursement balance credited full table style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign abbvie funding discovery party abbvie shall galapagos payment date each required abbvie payment that after discovery increase funding date addition such required abbvie payment amount discovery reimbursement payment equal amount discovery reimbursement payment sufficient satisfy fully then outstanding total discovery reimbursement balance such discovery reimbursement payment shall applied settle each outstanding total quarterly discovery obligation order with oldest outstanding total quarterly discovery obligation settled first portion discovery reimbursement payment applied settle particular outstanding total quarterly discovery obligation sufficient satisfy fully such outstanding total quarterly discovery obligation then amount such discovery reimbursement payment that applied reimbursement applicable base quarterly discovery obligation shall equal purpose clarity abbvie shall continue make discovery reimbursement payment applicable payment date until total discovery reimbursement balance paid full table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign funding discovery party portion outstanding total discovery reimbursement balance unilateral discovery party time such payment sufficient settle outstanding total discovery reimbursement balance entirety such payment shall applied forth section nbsp applicable mutatis mutandis table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign nothing this section nbsp shall limit otherwise affect funding discovery party obligation fund development cost under combination product development plan pursuant section nbsp under combination product post development plan pursuant section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign sample calculation determining reimbursement credit reimbursement payment attached hereto schedule table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign used herein discovery reimbursement premium percentage mean table style margin margin bottom text indent font size font family time roman clarity provision section nbsp shall apply each proposed increase discovery budget after implementation section nbsp prior occurrence discovery increase funding date discovery total cost increased multiple time pursuant section nbsp from after occurrence discovery increase funding date during unilateral discovery period section nbsp shall apply proposed increase discovery budget increase discovery budget shall governed section nbsp style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman development activity style margin margin bottom text indent font size font family time roman potentiator development activity event that both nbsp either nbsp before such later date determined abbvie sole absolute discretion potentiator molecule determined have satisfied potentiator success criterion abbvie sole absolute discretion elect delivering written notice such election galapagos pursuant section nbsp continue development potentiator molecule that satisfy potentiator success criterion nbsp acceptance belgium received potentiator molecule then nbsp nbsp party shall commence performing development activity with respect potentiator molecule designated appropriate time combination product containing potentiator molecule designated each case pursuant accordance with combination product development plan style margin margin bottom text indent font size font family time roman corrector development activity event that both nbsp either nbsp before such later date determined abbvie sole absolute discretion corrector molecule determined have satisfied success criterion abbvie sole absolute discretion elect delivering written notice such election galapagos pursuant section nbsp continue development corrector molecule that satisfy success criterion nbsp either acceptance belgium acceptance received corrector molecule whichever occurs first then nbsp nbsp party shall commence performing development activity with respect corrector molecule designated appropriate time combination product containing corrector molecule designated each case pursuant accordance with combination product development plan style margin margin bottom text indent font size font family time roman corrector development activity event that both nbsp either nbsp before such later date determined abbvie sole absolute discretion corrector molecule determined have satisfied success criterion abbvie sole absolute discretion elect delivering written notice such election galapagos pursuant section nbsp continue development corrector molecule that satisfy success criterion nbsp either acceptance belgium acceptance received corrector molecule whichever occurs first then nbsp nbsp party shall commence performing development activity with respect corrector molecule designated appropriate time combination product containing corrector molecule designated each case pursuant accordance with combination product development plan style margin margin bottom text indent font size font family time roman amendment each party shall have right propose amendment combination product development plan through representative style margin margin bottom text indent font size font family time roman success criterion party agree that time during term standard care territory treatment using nbsp combination product containing nbsp cftr potentiator molecule nbsp cftr corrector molecule sole active ingredient dual combination standard change from applicable standard care previously effect then then current dual combination product success criterion shall include dual combination standard nbsp combination product containing nbsp cftr potentiator molecule nbsp cftr corrector molecule triple combination standard change from applicable standard care previously effect then then current triple combination heterozygous success criterion triple combination homozygous success criterion applicable shall include triple combination standard time either party belief that combination standard changed required included dual combination product success criterion triple combination heterozygous success criterion triple combination homozygous success criterion applicable accordance with this section nbsp such party through representative propose that dual combination product success criterion triple combination heterozygous success criterion style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman triple combination homozygous success criterion applicable include same such proposal shall subject approval forth section nbsp subject dispute resolution procedure forth section nbsp style margin margin bottom text indent font size font family time roman development activity each party shall perform development activity assigned such party combination product development plan shall accordance with such combination product development plan including combination product budget allocating sufficient time effort equipment skilled personnel complete such development activity successfully promptly without limiting generality foregoing unless otherwise agreed abbvie writing galapagos shall required incur development cost cost effect restatement date under combination product development plan performing activity under combination product development plan provided that prior time that galapagos incurred such minimum development cost both nbsp development activity forth combination product development plan have been completed accordance with term thereof nbsp triple combination product developed under combination product development plan determined have satisfied triple combination heterozygous success criterion triple combination homozygous success criterion then galapagos shall required incur additional development cost reach such minimum style margin margin bottom text indent font size font family time roman development diligence galapagos shall commercially reasonable effort undertaking development activity under combination product development plan without limiting generality foregoing galapagos shall commercially reasonable effort achieve dual combination product success criterion triple combination heterozygous success criterion triple combination homozygous success criterion galapagos promptly shall share with abbvie through process established information generated result achieved conducting result conducting development activity under combination product development plan shall such information result determine whether whether combination product satisfies triple combination phase success criterion triple combination heterozygous success criterion triple combination homozygous success criterion applicable clarity abbvie elect shall required proceed with development triple combination product such triple combination product satisfy triple combination phase success criterion which case such failure satisfy triple combination phase success criterion shall combination development failure style margin margin bottom text indent font size font family time roman initial development cost galapagos shall solely responsible shall bear development cost incurred party their affiliate connection with performance development activity forth combination product development plan applicable cost provided that party agree pursuant section nbsp conduct phase more than triple combination product under combination product development plan then increase combination product budget necessary provide funding conduct such phase style margin margin bottom text indent font size font family time roman cost increase style margin margin bottom text indent font size font family time roman date which galapagos incurred aggregate development cost performing development activity under combination product development plan amount equal cost effect restatement date either both nbsp development activity under combination product development plan have been completed accordance therewith nbsp applicable triple combination product developed under combination product development plan then been determined have satisfied both triple combination heterozygous success criterion triple combination homozygous success criterion then either both case unless party otherwise style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman agree nbsp then current combination product budget under combination product development plan then current cost under combination product development plan automatically shall increased amount equal percent then current combination product budget nbsp each party shall responsible shall bear excess cost portion development cost incurred party their affiliate performing development activity under combination product development plan excess cost effect restatement date such increased cost style margin margin bottom text indent font size font family time roman date which party their affiliate have incurred aggregate development cost performing development activity under combination product development plan amount equal then current cost thereunder previously increased pursuant section nbsp either both nbsp development activity under combination product development plan have been completed accordance therewith nbsp applicable triple combination product developed under combination product development plan then been determined have satisfied both triple combination heterozygous success criterion triple combination homozygous success criterion then either both case either party through representative propose increase combination product budget under such combination product development plan style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign party agree increase combination product budget same amount such combination product budget cost thereunder shall increased amount such agreed increase both party wish increase combination product budget senior officer pursuant section nbsp able agree amount such increase combination product budget shall increased amount proposed party proposing smaller increase applicable cost shall increased amount such smaller increase either such case each party shall responsible shall bear excess cost portion development cost incurred party their affiliate performing development activity under combination product development plan excess then current cost increased from time time accordance with this section nbsp such applicable increased cost table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign neither party wish increase combination product budget bear excess cost portion such increased cost then party shall cease development activity under combination product development plan provided that galapagos shall have right cease conducting funding clinical study initiated under combination product development plan once been commenced table style margin margin bottom text indent font size font family time roman senior officer only nbsp party unilateral party wish increase combination product budget proposed pursuant section nbsp then style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign combination product budget shall increased amount deemed appropriate unilateral party table style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign during period unilateral period commencing date that after date which such proposed increase first referred senior officer pursuant section nbsp such later date increase funding date ending date when funding party fully reimbursed total reimbursement balance pursuant section nbsp case unilateral party shall have final decision making authority under section nbsp with respect amendment combination product development plan including additional increase combination product budget provided that proposed amendment that would assign additional development activity funding party shall subject funding party written consent table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign unilateral party shall initially responsible shall initially bear development cost excess applicable cost last increased pursuant section nbsp last agreed incurred party their affiliate performing development activity under combination product development plan excess cost subject reimbursement other party funding party accordance with section nbsp applicable table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign first immediately following each calendar quarter quarterly incurrence date from after increase funding date funding party shall incur repayment obligation equal aggregate amount total quarterly obligation incurred with respect calendar quarter under this section nbsp referred herein total reimbursement balance table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign galapagos funding party abbvie shall entitled credit against each required abbvie payment that after increase funding date amount reimbursement credit equal amount reimbursement credit sufficient satisfy fully then outstanding total reimbursement balance such reimbursement credit shall applied settle each outstanding total quarterly obligation order with oldest outstanding total quarterly obligation settled first portion reimbursement credit applied settle particular outstanding total quarterly obligation sufficient satisfy fully such outstanding total quarterly obligation then amount such reimbursement credit that applied reimbursement applicable base quarterly obligation shall equal purpose clarity abbvie shall continue credit reimbursement credit against required abbvie payment until total reimbursement balance credited full table style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign abbvie funding party abbvie shall galapagos payment date each required abbvie payment that after increase funding date addition such required abbvie payment amount reimbursement payment equal amount reimbursement payment sufficient satisfy fully then outstanding total reimbursement balance such reimbursement payment shall applied settle each outstanding total quarterly obligation order with oldest outstanding total quarterly obligation settled first portion reimbursement payment applied settle particular outstanding total quarterly obligation sufficient satisfy fully such outstanding total quarterly obligation then amount such reimbursement payment that applied reimbursement applicable base quarterly obligation shall equal purpose clarity abbvie shall continue make reimbursement payment applicable payment date until total reimbursement balance paid full table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign funding party portion outstanding total reimbursement balance unilateral party time such payment sufficient settle outstanding total reimbursement balance entirety such payment shall applied forth section nbsp applicable mutatis mutandis table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign nothing this section nbsp shall limit otherwise affect funding party obligation fund development cost under discovery work plan pursuant section under combination product post development plan pursuant section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign sample calculation determining reimbursement credit reimbursement payment attached hereto schedule table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign used herein reimbursement premium percentage mean table style margin margin bottom text indent font size font family time roman clarity provision section nbsp shall apply each proposed increase combination product budget after implementation section nbsp prior occurrence increase funding date with respect combination product development plan applicable cost increased multiple time pursuant section nbsp from after occurrence increase funding date with respect combination product development plan during applicable unilateral period section nbsp shall apply proposed increase combination product budget increase combination product budget shall governed section nbsp style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman post development activity style margin margin bottom text indent font size font family time roman combination product post development plan style margin margin bottom text indent font size font family time roman event that nbsp before such later date determined abbvie sole absolute discretion triple combination product developed under combination product development plan determined have satisfied either both triple combination heterozygous success criterion triple combination homozygous success criterion nbsp abbvie sole absolute discretion elect pursuant section nbsp continue development triple combination product developed under combination product development plan that satisfy either triple combination heterozygous success criterion triple combination homozygous success criterion either both heterozygous population homozygous population then nbsp nbsp party shall commence phase with respect triple combination product designated abbvie applicable patient population pursuant accordance with combination product post development plan style margin margin bottom text indent font size font family time roman clarity abbvie commence prior occurrence event described section nbsp section nbsp nbsp clinical activity with respect molecule triple combination product designated abbvie nbsp phase with respect triple combination product designated abbvie each case pursuant accordance with combination product post development plan style margin margin bottom text indent font size font family time roman each party shall have right propose amendment combination product post development plan through representative such amendment shall subject approval forth section nbsp style margin margin bottom text indent font size font family time roman patient population election style margin margin bottom text indent font size font family time roman later than after later nbsp date which finally determined accordance with this agreement that triple combination product developed phase heterozygous population under combination product development plan satisfy triple combination heterozygous success criterion nbsp date which abbvie receives from galapagos pursuant section nbsp clinical data other information result analysis with respect such phase heterozygous population abbvie shall notify galapagos whether elect proceed with development such triple combination product heterozygous population abbvie deliver such election notice within such period then abbvie shall deemed have elected proceed with development such triple combination product heterozygous population style margin margin bottom text indent font size font family time roman later than after later nbsp date which finally determined accordance with this agreement that triple combination product developed phase homozygous population under combination product development plan satisfy triple combination homozygous success criterion nbsp date which abbvie receives from galapagos pursuant section nbsp clinical data other information result analysis with respect such phase homozygous population abbvie shall notify galapagos whether elect proceed with development such triple combination product homozygous population abbvie deliver such election notice within such period then abbvie shall deemed have elected proceed with development such triple combination product homozygous population style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman clarity nbsp abbvie elect shall required proceed with development triple combination product under section nbsp heterozygous population such triple combination product satisfy triple combination heterozygous success criterion nbsp abbvie elect shall required proceed with development triple combination product under section nbsp homozygous population such triple combination product satisfy triple combination homozygous success criterion style margin margin bottom text indent font size font family time roman nothing this section nbsp shall limit galapagos obligation under section nbsp style margin margin bottom text indent font size font family time roman potentiator post development plan event that abbvie elect continue development potentiator product pursuant section nbsp then accordance with section nbsp shall develop approve plan including budget therefor potentiator post development budget setting forth development activity conducted connection with remaining phase clinical study phase clinical study potentiator product potentiator post development plan each party shall have right propose amendment potentiator post development plan through representative such amendment shall subject approval forth section nbsp party shall also amend plan increase amount cost budgeted therein account activity planned under potentiator post development plan style margin margin bottom text indent font size font family time roman post development activity each party shall perform development activity assigned such party each post development plan shall accordance with such post development plan including applicable post development budget allocating sufficient time effort equipment skilled personnel complete such activity successfully promptly style margin margin bottom text indent font size font family time roman post development diligence each party shall commercially reasonable effort undertaking development activity assigned such party each post development plan style margin margin bottom text indent font size font family time roman post development cost each party shall responsible shall bear post development cost portion development cost incurred party their affiliate performing development activity under nbsp combination product post development plan patient population post development cost such patient population nbsp potentiator post development plan potentiator post development cost style margin margin bottom text indent font size font family time roman post development cost increase style margin margin bottom text indent font size font family time roman date which party their affiliate have incurred aggregate development cost performing development activity under combination product post development plan triple combination product patient population amount equal post development cost such patient population heterozygous population post development homozygous population post development effect restatement date either both nbsp development activity such triple combination product such patient population under combination product post development plan have been completed accordance therewith nbsp development activity under combination product post development plan support filing drug approval application triple combination product applicable patient population developed under combination product post development plan nbsp more united state france italy spain united kingdom germany determined then either both case unless party otherwise agree nbsp then current style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman combination product post development budget such patient population under such combination product post development plan then current post development cost such patient population under such combination product post development plan automatically shall increased amount equal percent such then current combination product post development budget such patient population nbsp each party shall responsible shall bear post development cost portion development cost incurred party their affiliate performing development activity under such combination product post development plan excess applicable post development cost effect restatement date such patient population such increased post development cost such patient population style margin margin bottom text indent font size font family time roman date which party their affiliate have incurred aggregate development cost performing development activity under potentiator post development plan amount equal initial potentiator post development cost either both nbsp development activity under potentiator post development plan have been completed accordance therewith nbsp development activity under potentiator post development plan support filing drug approval application potentiator product nbsp more united state france italy spain united kingdom germany determined then either both case unless party otherwise agree nbsp then current potentiator post development budget then current potentiator post development cost automatically shall increased amount equal percent such then current potentiator post development budget nbsp each party shall responsible shall bear post development cost portion development cost incurred party their affiliate performing development activity under potentiator post development plan excess applicable initial potentiator post development cost such increased potentiator post development cost style margin margin bottom text indent font size font family time roman date which party their affiliate have incurred aggregate development cost performing development activity under combination product post development plan triple combination product patient population amount equal then current post development cost such patient population thereunder previously increased pursuant section either both nbsp development activity under such combination product post development plan such triple combination product such patient population have been completed accordance therewith nbsp development activity under such combination product post development plan support filing drug approval application triple combination product applicable patient population developed under such combination product post development plan nbsp more united state france italy spain united kingdom germany determined then either both case either party through representative propose increase combination product post development budget such patient population under such combination product post development plan style margin margin bottom text indent font size font family time roman date which party their affiliate have incurred aggregate development cost performing development activity under potentiator post development plan amount equal then current potentiator post development cost previously increased pursuant section either both nbsp development activity under potentiator post development plan have been completed accordance therewith nbsp development activity under potentiator post development plan support filing drug approval application potentiator product nbsp more united state france italy spain united kingdom germany determined then either both case either party through representative propose increase potentiator product post development budget style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman with respect increase proposed pursuant section nbsp section nbsp style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign party agree increase applicable post development budget same amount such post development budget applicable post development cost thereunder shall increased amount such agreed increase both party wish increase applicable post development budget senior officer pursuant section nbsp able agree amount such increase applicable post development budget shall increased amount proposed party proposing smaller increase applicable post development cost shall increased amount such smaller increase either such case each party shall responsible shall bear post development cost portion development cost incurred party their affiliate performing development activity under applicable post development plan case combination product post development plan performing development activity applicable patient population under combination product post development plan excess then current applicable post development cost increased from time time accordance with this section nbsp such applicable increased post development cost table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign neither party wish increase applicable post development budget bear post development cost portion such increased cost then party shall cease development activity under applicable post development plan case combination product post development plan activity applicable patient population covered applicable post development budget provided that neither party shall have right cease conducting funding clinical study initiated under post development plan once been commenced table style margin margin bottom text indent font size font family time roman senior officer only nbsp party unilateral post party wish increase applicable post development budget proposed pursuant section nbsp section nbsp then style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign applicable post development budget shall increased amount deemed appropriate unilateral post party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style margin margin bottom font family time roman font size during period unilateral post period commencing date that after date which such proposed increase first referred senior officer pursuant section nbsp such later date post increase funding date ending date when funding post party fully reimbursed total post reimbursement balance table style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign pursuant section nbsp case unilateral post party shall have final decision making authority under section nbsp with respect amendment applicable post development plan case combination product post development plan amendment with respect activity applicable patient population including additional increase applicable post development budget provided that proposed amendment that would assign additional development activity funding post party shall subject funding post party written consent table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign unilateral post party shall initially responsible shall initially bear development cost excess applicable post development cost last increased pursuant section nbsp last agreed post incurred party their affiliate performing development activity under applicable post development plan case combination product post development plan development activity applicable patient population excess post cost subject reimbursement other party funding post party accordance with section applicable table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign first immediately following each calendar quarter quarterly post incurrence date from after post increase funding date funding post party shall incur repayment obligation equal aggregate amount total quarterly post obligation incurred with respect calendar quarter under this section nbsp referred herein total post reimbursement balance table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style margin margin bottom font family time roman font size galapagos funding post party abbvie shall entitled credit against each required abbvie payment that after post increase funding date amount post reimbursement credit equal amount post reimbursement credit sufficient satisfy fully then outstanding total post reimbursement balance such post reimbursement credit shall applied settle each outstanding total quarterly post obligation order with oldest outstanding total quarterly post obligation settled first portion post reimbursement credit applied settle particular outstanding total quarterly post obligation sufficient satisfy fully such outstanding total quarterly post obligation then amount such post reimbursement credit that applied reimbursement applicable base quarterly post obligation shall table style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign equal purpose clarity abbvie shall continue credit post reimbursement credit against required abbvie payment until total post reimbursement balance credited full table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign abbvie funding post party abbvie shall galapagos payment date each required abbvie payment that after post increase funding date addition such required abbvie payment amount post reimbursement payment equal amount post reimbursement payment sufficient satisfy fully then outstanding total post reimbursement balance such post reimbursement payment shall applied settle each outstanding total quarterly post obligation order with oldest outstanding total quarterly post obligation settled first portion post reimbursement payment applied settle particular outstanding total quarterly post obligation sufficient satisfy fully such outstanding total quarterly post obligation then amount such post reimbursement payment that applied reimbursement applicable base quarterly post obligation shall equal purpose clarity abbvie shall continue make post reimbursement payment applicable payment date until total post reimbursement balance paid full table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign funding post party portion outstanding total post reimbursement balance unilateral post party time such payment sufficient settle outstanding total post reimbursement balance entirety such payment shall applied forth section nbsp applicable mutatis mutandis table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign nothing this section nbsp shall limit otherwise affect funding post party obligation fund development cost under discovery work plan pursuant section under combination product development plan pursuant section table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign sample calculation determining reimbursement credit reimbursement payment attached hereto schedule table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign used herein post reimbursement premium percentage mean table style margin margin bottom text indent font size font family time roman clarity style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style margin margin bottom font family time roman font size provision section nbsp shall apply each proposed increase applicable combination product table style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign post development budget after implementation section nbsp prior occurrence post increase funding date with respect combination product post development plan patient population applicable post development cost increased multiple time pursuant section nbsp from after occurrence post increase funding date with respect combination product post development plan patient population during applicable unilateral post period section nbsp shall apply proposed increase applicable combination product post development budget increase applicable combination product post development budget shall governed section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign provision section nbsp shall apply each proposed increase potentiator post development budget after implementation section nbsp prior occurrence post increase funding date with respect potentiator post development plan potentiator post development cost increased multiple time pursuant section nbsp from after occurrence post increase funding date with respect potentiator post development plan during applicable unilateral post period section nbsp shall apply proposed increase potentiator post development budget increase potentiator post development budget shall governed section nbsp table style margin margin bottom text indent font size font family time roman post launch development style margin margin bottom text indent font size font family time roman notwithstanding anything herein contrary from after date first commercial sale potentiator product country abbvie territory abbvie shall have right obligation develop expense additional indication formulation dosage strength other improvement such potentiator product being understood clarity that such product shall potentiator product style margin margin bottom text indent font size font family time roman notwithstanding anything herein contrary from after date first commercial sale triple combination product country abbvie territory abbvie shall have right obligation develop expense style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign additional indication formulation dosage strength other improvement such triple combination product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign additional follow triple combination product that contain potentiator molecule more corrector molecule that different from potentiator molecule corrector molecule contained such initial triple combination product table style margin margin bottom font size font family time roman being understood clarity that product mentioned clause nbsp nbsp above shall triple combination product style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman development style margin margin bottom text indent font size font family time roman plan plan effect restatement date attached hereto schedule nbsp either party directly through representative propose amendment plan from time time appropriate including light changed circumstance style margin margin bottom text indent font size font family time roman development activity each party shall perform development activity manufacturing supply activity assigned such party plan shall accordance with plan allocating sufficient time effort equipment skilled personnel complete such activity successfully promptly style margin margin bottom text indent font size font family time roman development diligence each party shall commercially reasonable effort undertaking development activity manufacturing supply activity assigned such party plan style margin margin bottom text indent font size font family time roman cost each party shall responsible shall bear cost incurred after restatement date such party affiliate cost defined existing agreement incurred either party affiliate prior restatement date shall borne existing agreement style margin margin bottom text indent font size font family time roman galapagos territory development style margin margin bottom text indent font size font family time roman galapagos reasonably belief that clinical study addition clinical study conducted under combination product development plan study plan combination product post development plan potentiator post development plan necessary condition support obtaining maintaining regulatory approval country galapagos territory galapagos shall prepare provide consideration comprehensive development plan including protocol therefor galapagos territory development plan galapagos territory development plan amendment thereto shall subject approval subject section nbsp style margin margin bottom text indent font size font family time roman galapagos shall responsible shall bear cost incurred connection with conducting activity under approved galapagos territory development plan style margin margin bottom text indent font size font family time roman galapagos shall galapagos shall cause affiliate conduct clinical study perform other research development activity with respect molecule product galapagos territory except pursuant accordance with galapagos territory development plan style margin margin bottom text indent font size font family time roman design performance development activity generally development activity included development plan including clinical study shall designed implemented support filing drug approval application obtaining regulatory approval applicable product subject section nbsp party shall engage development activity molecule product only accordance with term condition this agreement applicable development plan style margin margin bottom text indent font size font family time roman development back combination product style margin margin bottom text indent font size font family time roman event that combination development failure occurs during term promptly after such occurrence party shall discus through their representative whether develop combination product that previously developed under combination product development plan back combination product style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman unless party otherwise agree such combination development failure occurs before date which party their affiliate have incurred aggregate development cost performing development activity under combination product development plan amount equal applicable last agreed then nbsp combination product development plan shall amended accordance with term hereof provide development thereunder back combination product containing molecule determined nbsp party shall develop such back combination product under such amended combination product development plan accordance with section nbsp including section nbsp other applicable term this agreement style margin margin bottom text indent font size font family time roman unless party otherwise agree such combination development failure occurs after date which party their affiliate have incurred aggregate development cost performing development activity under combination product development plan amount equal applicable last agreed then either party propose pursuant section nbsp amendment combination product development plan provide development thereunder back combination product molecule which shall designated combination product development plan amended party shall develop such back combination product under such amended combination product development plan accordance with section nbsp including section nbsp other applicable term this agreement style margin margin bottom text indent font size font family time roman event that combination post development failure occurs during term promptly after such occurrence party shall discus through their representative whether develop back combination product style margin margin bottom text indent font size font family time roman subject clause nbsp below unless party otherwise agree such combination post development failure occurs before date which party their affiliate have incurred aggregate development cost performing development activity under combination product development plan amount equal applicable last agreed then nbsp combination product development plan shall amended accordance with term hereof provide development thereunder back combination product containing molecule designated nbsp party shall develop such back combination product under such amended combination product development plan accordance with section nbsp including section nbsp other applicable term this agreement style margin margin bottom text indent font size font family time roman subject clause nbsp below unless party otherwise agree such combination post development failure occurs after date which party their affiliate have incurred aggregate development cost performing development activity under combination product development plan amount equal applicable last agreed then either party propose pursuant section nbsp amendment combination product development plan provide development thereunder back combination product molecule which shall designated combination product development plan amended party shall develop such back combination product under such amended combination product development plan accordance with section nbsp including section nbsp other applicable term this agreement style margin margin bottom text indent font size font family time roman date such combination post development failure triple combination product other than triple combination product that subject such combination post development failure developed under combination product development plan satisfies either both triple combination heterozygous success criterion triple combination homozygous success criterion then unless party otherwise agree section nbsp section nbsp shall apply such other triple combination product shall backup combination product section nbsp shall apply style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman applicable after completion development activity with respect back combination product under combination product development plan amended accordance with section nbsp section nbsp applies then either case shall determine whether continue development applicable back combination product under combination product post development plan style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign determines continue development such back combination product under combination product post development plan patient population such development would commence before date which party their affiliate have incurred aggregate development cost performing development activity such patient population under combination product post development plan amount equal applicable last agreed post such patient population then nbsp combination product post development plan shall amended accordance with term hereof provide development thereunder such back combination product such patient population nbsp party shall develop such back combination product under such amended combination product post development plan accordance with section nbsp including section nbsp other applicable term this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign determines continue development such back combination product under combination product post development plan patient population such development would commence after date which party their affiliate have incurred aggregate development cost performing development activity such patient population under combination product post development plan amount equal applicable last agreed post such patient population then either party propose pursuant section nbsp amendment combination product post development plan provide development thereunder such back combination product such patient population combination product post development plan amended party shall develop such back combination product under such amended combination product post development plan accordance with section nbsp including section nbsp other applicable term this agreement table style margin margin bottom text indent font size font family time roman update amendment shall review discovery work plan least quarterly shall review each other development plan other than study plan least semi annually purpose considering appropriate amendment thereto applicable shall manage have working group manage proposed updating amending each development plan other than study plan manner designed have initial draft following calendar year prepared june nbsp then current calendar year review input obtain approval applicable later than september nbsp then current calendar year addition either party through representative applicable propose amendment development plan other than study plan time style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman clinical clinical supply product style margin margin bottom text indent font size font family time roman supply each party shall comply with obligation assigned such party plan supply cause third party supply clinical clinical requirement molecule dual combination product triple combination product placebo other comparators party development molecule combination product contemplated discovery work plan combination product development plan style margin margin bottom text indent font size font family time roman manufacture molecule combination product placebo other comparators supplied behalf party other party pursuant section nbsp shall manufactured accordance with style margin margin bottom text indent font size font family time roman subcontracting each party shall have right subcontract discovery activity other development activity affiliate third party including contract research organization contract manufacturer third party provider provided with respect third party provider that subcontracting party furnishes applicable with advanced written notice thereof which notice shall specify work subcontracted applicable discus such third party provider provided further that proposed third party provider material discovery activity other development activity including contract research organization clinical study contract manufacturer drug substance drug product shall require approval applicable each case subcontracting party shall obtain written undertaking from third party provider that shall subject applicable term condition this agreement including intellectual property provision article confidentiality provision article style margin margin bottom text indent font size font family time roman provision technology documentation style margin margin bottom text indent font size font family time roman immediately after effective date galapagos shall shall cause affiliate without additional compensation disclose make available abbvie whatever form abbvie reasonably request galapagos know other information relating directly indirectly existing potentiator molecule performance abbvie obligation under discovery work plan including information related manufacturing extent done already thereafter during term galapagos shall shall cause affiliate without additional compensation disclose make available abbvie whatever form abbvie reasonably request regulatory documentation galapagos know joint know other information immediately upon availability thereof style margin margin bottom text indent font size font family time roman galapagos sole cost expense shall provide abbvie with reasonable assistance required order transfer abbvie regulatory documentation galapagos know joint know other information required produced pursuant section nbsp above each case timely manner shall reasonably assist abbvie with respect exploitation molecule product without prejudice generality foregoing visit galapagos representative abbvie facility reasonably requested abbvie purpose transferring regulatory documentation galapagos know joint know other information abbvie purpose abbvie acquiring expertise practical application such information assisting issue arising during such exploitation galapagos shall send appropriate representative abbvie facility which representative reasonable travel cost shall paid abbvie style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman regulatory matter style margin margin bottom text indent font size font family time roman regulatory activity abbvie territory style margin margin bottom text indent font size font family time roman galapagos shall have sole right responsibility prepare obtain maintain name inds necessary perform obligation under combination product development plan plan conduct communication with applicable regulatory authority with respect such inds provided that nbsp determination submit such subject approval pursuant section nbsp nbsp galapagos shall provide abbvie with reasonable opportunity review comment form content such inds communication prior their submission applicable regulatory authority galapagos shall consider good faith comment made abbvie with respect thereto provided further that provided further that nbsp galapagos shall hereby assign abbvie designee galapagos right title interest inds with respect such triple combination product nbsp promptly after galapagos shall hereby assign abbvie designee galapagos right title interest inds with respect potentiator product style margin margin bottom text indent font size font family time roman commencing upon assignment galapagos abbvie pursuant section nbsp abbvie shall have sole right responsibility maintain name such conduct communication with applicable regulatory authority with respect such without limiting foregoing abbvie shall have sole right responsibility prepare obtain maintain name other inds necessary perform obligation under post development plan conduct communication with applicable regulatory authority with respect such inds style margin margin bottom text indent font size font family time roman abbvie shall have sole right subject term this section nbsp prepare obtain maintain drug approval application including setting overall regulatory strategy therefor conduct communication with applicable regulatory authority molecule product country jurisdiction abbvie territory galapagos shall support abbvie reasonably necessary obtaining such regulatory approval product activity support thereof including providing necessary document other material required applicable obtain such regulatory approval each case accordance with term condition this agreement applicable development plan style margin margin bottom text indent font size font family time roman abbvie shall provide galapagos with reasonable opportunity review comment form content major regulatory filing document including inds drug approval application material labeling supplement regulatory authority meeting request core data sheet molecule product european union collectively major regulatory filing prior their submission applicable regulatory authority abbvie shall consider good faith comment made galapagos with respect thereto abbvie shall provide access interim draft such major regulatory filing galapagos access method such secure database established galapagos shall provide comment final draft such major regulatory filing proposed material action within business business drug approval application such other longer period time mutually agreed party regulatory authority establishes response deadline such major regulatory filing material action shorter than such business business period party shall work cooperatively ensure other party reasonable opportunity review comment within such deadline abbvie shall shall cause affiliate sublicensees consider good faith such comment galapagos style margin margin bottom text indent font size font family time roman subject immediately following sentence abbvie shall provide galapagos with nbsp access copy material written electronic correspondence other than style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman regulatory filing relating development commercialization molecule product received abbvie affiliate sublicensees from forwarded abbvie affiliate sublicensees regulatory authority european union nbsp copy meeting minute summary meeting conference discussion held abbvie affiliate sublicensees with regulatory authority relating development commercialization product european union including copy contact report produced abbvie affiliate sublicensees each case within business receipt forwarding production foregoing applicable such written electronic correspondence received from such regulatory authority relates withdrawal suspension revocation regulatory approval product prohibition suspension supply molecule product initiation investigation review inquiry such regulatory authority concerning safety molecule product abbvie shall notify galapagos provide galapagos with copy such written electronic correspondence soon practicable style margin margin bottom text indent font size font family time roman abbvie shall provide galapagos with prior written notice extent abbvie advance knowledge scheduled meeting conference discussion including advisory committee meeting with regulatory authority european union relating product reasonably promptly after abbvie affiliate sublicensee first receives notice scheduling such meeting conference discussion within such shorter period necessary order give galapagos reasonable opportunity attend such meeting conference discussion galapagos shall have right have nbsp employee attend observer participate such meeting conference discussion galapagos expense clarity abbvie shall lead phase meeting with each product seek scientific advice from with respect each product style margin margin bottom text indent font size font family time roman regulatory activity galapagos territory style margin margin bottom text indent font size font family time roman galapagos shall have sole right responsibility prepare obtain maintain name inds necessary perform obligation under galapagos territory development plan conduct communication with applicable regulatory authority with respect such inds provided that nbsp determination submit such subject approval pursuant section nbsp nbsp galapagos shall provide abbvie with reasonable opportunity review comment form content such inds communication prior their submission applicable regulatory authority galapagos shall consider good faith comment made abbvie with respect thereto style margin margin bottom text indent font size font family time roman galapagos shall have sole right responsibility prepare obtain maintain name drug approval application product galapagos territory other related regulatory submission product galapagos territory conduct communication with applicable regulatory authority galapagos territory with respect combination product provided that form content such drug approval application other regulatory submission communication shall subject review approval abbvie prior their submission style margin margin bottom text indent font size font family time roman subject immediately following sentence galapagos shall provide abbvie with nbsp access copy material written electronic correspondence other than regulatory filing relating development commercialization product galapagos territory received galapagos affiliate from forwarded galapagos affiliate regulatory authority galapagos territory nbsp copy meeting minute summary meeting conference discussion held galapagos affiliate with regulatory authority relating development commercialization product galapagos territory including copy contact report produced galapagos affiliate each case within business receipt forwarding production foregoing applicable such written electronic correspondence received from style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman such regulatory authority relates withdrawal suspension revocation regulatory approval product prohibition suspension supply molecule product initiation investigation review inquiry such regulatory authority concerning safety molecule product galapagos shall notify abbvie provide abbvie with copy such written electronic correspondence soon practicable style margin margin bottom text indent font size font family time roman galapagos shall provide abbvie with prior written notice scheduled meeting conference discussion including advisory committee meeting with regulatory authority galapagos territory promptly after galapagos affiliate first receives notice scheduling such meeting conference discussion within such shorter period necessary order give abbvie reasonable opportunity attend participate such meeting conference discussion abbvie shall have right have such number representative abbvie designate attend participate such meeting conference discussion event that regulatory authority galapagos territory request unscheduled meeting conference discussion with galapagos with respect development commercialization product galapagos territory galapagos shall participate such unscheduled meeting conference discussion unless appropriate representative abbvie afforded opportunity attend participate such unscheduled meeting conference discussion style margin margin bottom text indent font size font family time roman galapagos shall responsible bear cost activity contemplated this section nbsp including filing inds drug approval application regulatory approval expense galapagos related participation meeting with applicable regulatory authority galapagos territory clarity abbvie shall responsible bear cost expense abbvie related participation meeting with applicable regulatory authority galapagos territory style margin margin bottom text indent font size font family time roman recall abbvie shall make every reasonable effort notify galapagos promptly following determination that event incident circumstance occurred that result need recall market suspension market withdrawal product abbvie territory shall include such notice reasoning behind such determination supporting fact abbvie sublicensee shall have right make final determination whether voluntarily implement such recall market suspension market withdrawal abbvie territory event that either party belief that event incident circumstance occurred that result need recall market suspension market withdrawal product galapagos territory including requirement recommendation regulatory authority with respect recall market suspension market withdrawal such party shall immediately notify other party shall include such notice reasoning behind such belief supporting fact party shall discus attempt good faith reach agreement whether such recall market suspension market withdrawal necessary event that party reach prompt agreement with respect need recall market suspension market withdrawal product galapagos territory then such recall market suspension market withdrawal shall implemented recall market suspension market withdrawal product determined required accordance with this section nbsp nbsp galapagos sublicensee shall implement such recall market suspension market withdrawal galapagos territory nbsp abbvie sublicensee shall implement such recall market suspension market withdrawal other country territory each case compliance with applicable recall market suspension market withdrawal undertaken pursuant this section nbsp party responsible recall market suspension market withdrawal shall solely responsible execution thereof other party shall reasonably cooperate such recall effort subject article nbsp extent that recall market suspension market withdrawal resulted from party affiliate breach obligation hereunder from such party affiliate negligence willful misconduct such party shall bear expense such recall market suspension market withdrawal nbsp with respect recall market suspension market withdrawal promotion product promotion territory other style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman than described clause nbsp above expense incurred party result such recall market suspension market withdrawal shall included allowable expense hereunder shared party pursuant section nbsp nbsp with respect recall market suspension market withdrawal product galapagos territory other than described clause nbsp above galapagos shall responsible cost such recall market suspension market withdrawal nbsp with respect recall market suspension market withdrawal covered clause nbsp abbvie shall responsible cost such recall market suspension market withdrawal cost refund with respect recalled product shall deducted from sale pursuant article style margin margin bottom text indent font size font family time roman regulatory documentation data style margin margin bottom text indent font size font family time roman each party shall promptly provide other party copy access clinical data clinical data other information result analysis with respect development activity under development plan collectively regulatory data when such regulatory data becomes available style margin margin bottom text indent font size font family time roman galapagos shall support abbvie reasonably necessary appropriate obtaining regulatory approval product abbvie territory including providing necessary document other material required applicable obtain regulatory approval each case accordance with term condition this agreement applicable development plan style margin margin bottom text indent font size font family time roman abbvie shall support galapagos reasonably necessary appropriate obtaining regulatory approval product galapagos territory including providing necessary document other material required applicable obtain regulatory approval each case accordance with term condition this agreement galapagos territory development plan style margin margin bottom text indent font size font family time roman regulatory documentation including regulatory approval product labeling excluding inds when held galapagos pursuant section nbsp relating molecule product with respect abbvie territory shall owned shall sole property held name abbvie designated affiliate sublicensee designee galapagos shall hereby assign abbvie right title interest such regulatory documentation controlled galapagos from time time during term galapagos shall execute deliver cause duly executed delivered such instrument shall cause done such thing including filing such assignment agreement document instrument necessary under abbvie reasonably request connection with carry more effectively purpose better assure confirm unto abbvie right under this section nbsp style margin margin bottom text indent font size font family time roman regulatory documentation including regulatory approval product labeling relating molecule product with respect galapagos territory shall owned shall sole property held name galapagos designated affiliate permitted sublicensee style margin margin bottom text indent font size font family time roman compliance each party shall perform cause performed development activity under each development plan including discovery activity good scientific manner compliance with applicable style margin margin bottom text indent font size font family time roman step right either party performing party material breach obligation perform development activity assigned performing party development plan including providing ftes accordance with discovery work plan fails remedy such breach within after written notice thereof from other party step party step party shall have right step party sole election style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman without limitation other right remedy available step party assume complete some such development activity step party elect assume complete development activity originally assigned performing party extent requested step party writing performing party shall assign step party third party agreement relating such development activity including agreement with contract research organization clinical site investigator such event with respect such activity that involve clinical study step party option performing party shall either nbsp such clinical study with respect enrolled subject orderly prompt manner accordance with applicable including required follow treatment with previously enrolled subject nbsp transfer control step party designee such clinical study cooperate with step party ensure smooth orderly transition thereof that will involve disruption such study event that step party elect accordance with this section nbsp assume complete development activity originally assigned performing party performing party shall reimburse step party nbsp development cost including cost incurred step party connection with performance such development activity pursuant section nbsp nbsp reasonable internal external cost which shall consistent with budget forth plan incurred step party connection with performance such development activity assigned performing party under plan style margin margin bottom text indent font size font family time roman record style margin margin bottom text indent font size font family time roman each galapagos abbvie shall shall ensure that third party provider maintain record sufficient detail good scientific manner appropriate patent regulatory purpose compliance with applicable which shall complete accurate shall properly reflect work done result achieved performance designated development activity which shall record only such activity shall include commingled with record activity outside scope this agreement such record shall retained galapagos abbvie case least year after termination this agreement such longer period required applicable style margin margin bottom text indent font size font family time roman each party shall have right during normal business hour upon reasonable notice inspect copy record other party maintained pursuant section nbsp inspecting party shall maintain such record information disclosed therein confidence accordance with article style margin margin bottom text indent font size font family time roman without limiting section nbsp shall determine what report shall generated track development activity including content timing thereof party shall promptly share such report with style margin margin bottom text indent font size font family time roman three page omitted style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center promotion commercialization style margin margin bottom text indent font size font family time roman general subject applicable term condition this agreement nbsp abbvie itself through affiliate sublicensees shall have sole right subject promotion galapagos promotion territory commercialize product abbvie territory cost expense except otherwise expressly forth herein including with respect sharing profit loss promotion territory nbsp galapagos itself through affiliate shall have sole right commercialize product galapagos territory cost expense style margin margin bottom text indent font size font family time roman galapagos territory commercialization plan least month prior anticipated date first commercial sale product country galapagos style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman territory galapagos shall propose comprehensive plan govern commercialization product galapagos territory galapagos territory commercialization plan galapagos territory commercialization plan shall include style margin margin bottom text indent font size font family time roman general plan strategy used galapagos commercialization product galapagos territory style margin margin bottom text indent font size font family time roman distinctive color logo image symbol product trademark used galapagos territory with commercialization each product which shall generally consistent with those used abbvie abbvie territory brand element style margin margin bottom text indent font size font family time roman phase study conducted product galapagos territory style margin margin bottom text indent font size font family time roman such other information related commercialization product galapagos galapagos territory abbvie reasonably request style margin margin bottom text indent font size font family time roman diligence style margin margin bottom text indent font size font family time roman abbvie style margin margin bottom text indent font size font family time roman abbvie shall commercially reasonable effort commercialize each france italy spain united kingdom germany each product which regulatory approval obtained such country abbvie shall have right satisfy diligence obligation under this section through affiliate sublicensees time galapagos reasonable basis believe that abbvie material breach material obligation under this section then galapagos shall notify abbvie specifying basis belief party shall meet within after such notice discus good faith galapagos concern abbvie commercialization plan with respect product style margin margin bottom text indent font size font family time roman abbvie shall shall ensure that affiliate distributor sublicensees sell distribute product only abbvie territory abbvie shall shall cause affiliate distributor sublicensees sell distribute product directly indirectly nbsp person outside abbvie territory nbsp person inside abbvie territory that nbsp reasonably likely directly indirectly sell distribute product outside abbvie territory assist another person foregoing nbsp directly indirectly sold distributed product outside abbvie territory assisted another person foregoing abbvie affiliate receive order product outside abbvie territory abbvie shall promptly refer such order galapagos style margin margin bottom text indent font size font family time roman galapagos style margin margin bottom text indent font size font family time roman galapagos shall commercially reasonable effort commercialize each country galapagos territory each product which regulatory approval obtained such country galapagos shall have right satisfy diligence obligation under this section nbsp through affiliate permitted sublicensees time abbvie reasonable basis believe that galapagos material breach material obligation under this section then abbvie shall notify galapagos specifying basis belief party shall meet within after such notice discus good faith abbvie concern galapagos commercialization plan with respect product galapagos territory style margin margin bottom text indent font size font family time roman commercializing product galapagos territory galapagos shall only brand element included then approved galapagos territory commercialization plan only marketing promotional material product messaging training material approved style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman galapagos shall shall ensure that affiliate distributor sublicensees sell distribute product only galapagos territory galapagos shall shall cause affiliate distributor sublicensees sell distribute product directly indirectly nbsp person outside galapagos territory nbsp person inside galapagos territory that nbsp reasonably likely directly indirectly sell distribute product outside galapagos territory assist another person foregoing nbsp directly indirectly sold distributed product outside galapagos territory assisted another person foregoing galapagos affiliate receive order product outside galapagos territory galapagos shall promptly refer such order abbvie style margin margin bottom text indent font size font family time roman statement compliance with applicable style margin margin bottom text indent font size font family time roman each party shall shall cause affiliate comply material respect with applicable with respect commercialization product style margin margin bottom text indent font size font family time roman without limiting foregoing each party shall respect comply with applicable applicable guideline concerning advertising sale marketing prescription drug product commercializing product under this agreement including foreign corrupt practice amended fcpa applicable local anti bribery each party represents warrant other party that effective date affiliate have system internal accounting control nbsp place that sufficient provide reasonable assurance compliance required fcpa each party affiliate shall maintain such control throughout term shall promptly notify other party writing with respect material compliance regarding commercialization product style margin margin bottom text indent font size font family time roman booking sale distribution style margin margin bottom text indent font size font family time roman abbvie abbvie shall have sole right invoice book sale establish term sale including pricing discount warehousing distribute product including promotion product abbvie territory perform cause performed related service abbvie shall handle return recall withdrawal order processing invoicing collection distribution inventory management with respect product including promotion product abbvie territory style margin margin bottom text indent font size font family time roman galapagos galapagos shall have sole right invoice book sale establish term sale including pricing discount warehousing distribute product galapagos territory perform cause performed related service galapagos shall handle return recall withdrawal order processing invoicing collection distribution inventory management with respect product galapagos territory style margin margin bottom text indent font size font family time roman product trademark style margin margin bottom text indent font size font family time roman subject section nbsp abbvie shall have sole right determine product trademark used with respect exploitation product worldwide basis including galapagos territory style margin margin bottom text indent font size font family time roman each party covenant that affiliate shall nbsp their respective business trademark that confusingly similar misleading deceptive with respect that dilutes part product trademark nbsp which endangers destroys similarly affect material respect value goodwill pertaining product trademark nbsp conform nbsp customary industry standard protection product trademark product such guideline abbvie with respect manner provided writing galapagos abbvie product trademark nbsp maintain quality standard abbvie with respect good sold service provided connection with such product trademark style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman each party covenant that affiliate shall nbsp that endangers destroys similarly affect material respect value goodwill pertaining product trademark nbsp attack dispute contest validity ownership such product trademark anywhere territory registration issued issuing with respect thereto style margin margin bottom text indent font size font family time roman marking style margin margin bottom text indent font size font family time roman promotional material product labeling product used party their respective affiliate connection with product promotion territory shall contain nbsp galapagos corporate name nbsp abbvie corporate name logo collectively marking except extent precluded applicable style margin margin bottom text indent font size font family time roman promotional material product labeling product used galapagos connection with product galapagos territory shall contain nbsp galapagos corporate name only style margin margin bottom text indent font size font family time roman only extent required applicable other country other jurisdiction territory promotional material product labeling product used abbvie affiliate connection with product such country other jurisdiction shall contain addition abbvie corporate name logo nbsp galapagos corporate name nbsp logo corporate name manufacturer other than abbvie affiliate clarity capsule tablet other form drug product shall required bear galapagos corporate name style margin margin bottom text indent font size font family time roman post commercial supply product style margin margin bottom text indent font size font family time roman post commercial supply molecule product style margin margin bottom text indent font size font family time roman abbvie shall have sole right obligation manufacture have manufactured supply clinical requirement molecule product development activity conducted under combination product post development plan potentiator post development plan forth plan under galapagos territory development plan molecule product commercial sale territory nbsp abbvie affiliate sublicensees nbsp galapagos affiliate sublicensees with respect supply product abbvie galapagos under galapagos territory development plan commercial sale galapagos territory party shall enter into supply agreement substantially consistent with abbvie standard term condition supply product third party provided that purchase price such product shall equal style margin margin bottom text indent font size font family time roman later than month after first commercial sale product abbvie shall initiate process identify qualify validate second source supply molecule product abbvie shall commercially reasonable effort complete qualification validation such second source supply soon reasonably practicable provided that galapagos shall reimburse abbvie amount equal percent reasonable cost incurred abbvie connection with identification qualification validation such second source supply later than after abbvie provides galapagos reasonable documentation incurrence such cost abbvie shall consider engaging galapagos serve such second source supply molecule product notwithstanding foregoing abbvie shall commercially reasonable effort maintain time from first commercial sale product reasonable safety stock such product assure uninterrupted supply such product style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman manufacturing technology transfer upon abbvie request abbvie shall have right upon least prior written notice which notice given prior date that after effective date require galapagos effect full transfer abbvie designee which designee affiliate third party manufacturer which third party manufacturer backup manufacturer second manufacturer molecule product galapagos know joint know relating then current process manufacture molecule product manufacturing process implement manufacturing process facility designated abbvie such transfer implementation more fully described this section nbsp manufacturing technology transfer galapagos shall provide shall commercially reasonable effort cause third party manufacturer provide including using commercially reasonable effort negotiate contractual obligation such third party manufacturer under agreement entered into following effective date reasonable assistance requested abbvie enable abbvie affiliate designated third party manufacturer applicable implement manufacturing process facility designated abbvie requested abbvie such assistance shall include facilitating entering into agreement with applicable third party supplier relating molecule product without limitation foregoing connection with each manufacturing technology transfer style margin margin bottom text indent font size font family time roman galapagos shall make available shall commercially reasonable effort cause third party manufacturer make available including using commercially reasonable effort negotiate contractual obligation such third party manufacturer under agreement entered into following effective date abbvie affiliate designated third party manufacturer applicable from time time abbvie request manufacturing related galapagos know joint know information material relating manufacturing process including method process testing characterization information documentation constituting material support performance advice shop practice standard operating procedure specification material used control method that reasonably necessary useful enable abbvie affiliate designated third party manufacturer applicable practice manufacturing process style margin margin bottom text indent font size font family time roman galapagos shall cause appropriate employee representative galapagos affiliate meet with shall commercially reasonable effort cause appropriate employee representative third party manufacturer meet with including using commercially reasonable effort negotiate contractual obligation such third party manufacturer under agreement entered into following effective date employee representative abbvie affiliate designated third party manufacturer applicable applicable manufacturing facility mutually convenient time assist with working manufacturing process with training personnel abbvie affiliate designated third party manufacturer applicable extent reasonably necessary useful enable abbvie affiliate designated third party manufacturer applicable practice manufacturing process style margin margin bottom text indent font size font family time roman without limiting generality clause nbsp above galapagos shall cause appropriate analytical quality control laboratory employee representative galapagos affiliate meet with shall commercially reasonable effort cause appropriate analytical quality control employee representative third party manufacturer meet with including using commercially reasonable effort negotiate contractual obligation such third party manufacturer under agreement entered into following effective date employee representative abbvie affiliate designated third party manufacturer applicable applicable manufacturing facility make available necessary equipment mutually convenient time support execute transfer style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman applicable analytical method validation thereof including applicable galapagos know joint know method validation document other documentation material sufficient supply primary other reference standard style margin margin bottom text indent font size font family time roman galapagos shall take such step shall commercially reasonable effort cause third party manufacturer take such step including using commercially reasonable effort negotiate contractual obligation such third party manufacturer under agreement entered into following effective date reasonably necessary useful assist reasonable respect abbvie affiliate designated third party manufacturer applicable obtaining necessary license permit approval from regulatory authority with respect manufacture molecule product applicable facility style margin margin bottom text indent font size font family time roman galapagos shall provide shall commercially reasonable effort cause third party manufacturer provide including using commercially reasonable effort negotiate contractual obligation such third party manufacturer under agreement entered into following effective date such other assistance abbvie affiliate designated third party manufacturer applicable reasonably request enable abbvie affiliate designated third party manufacturer applicable practice manufacturing process otherwise manufacture molecule product style margin margin bottom text indent font size font family time roman subsequent manufacturing technology transfer without limiting foregoing section nbsp galapagos make improvement relating manufacture molecule product during term after initial technology transfer pursuant section nbsp galapagos shall promptly disclose such improvement abbvie shall abbvie request perform technology transfer with respect such improvement same manner provided section nbsp style margin margin bottom text indent font size font family time roman promotion style margin margin bottom text indent font size font family time roman promotion option without limitation abbvie right under section nbsp outside promotion territory galapagos shall have exclusive right promotion option elect assume percent promotion effort than country promotion territory than product which regulatory approval received each such country promotion territory promotion product abbvie shall provide galapagos with least year prior written notice anticipated filing date first drug approval application promotion product with applicable regulatory authority country promotion territory with with respect centralized approval procedure style margin margin bottom text indent font size font family time roman notice order exercise promotion option later than month prior anticipated filing first drug approval application with applicable regulatory authority country promotion territory with with respect centralized approval procedure galapagos must provide abbvie with written notice election exercise promotion option with respect promotion territory following delivery such notice party shall negotiate promotion agreement reasonably good faith with such diligence required execute deliver promotion agreement date that month following date such notice such other period party agree writing style margin margin bottom text indent font size font family time roman term promotion agreement term condition such promotion arrangement including percentage total detail promotion territory provided galapagos abbvie shall forth promotion agreement promotion agreement entered into between party forth this section nbsp promotion agreement shall include such provision usual customary abbvie style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman contract sale force agreement including with respect diligence obligation galapagos abbvie except that except provided section nbsp abbvie shall galapagos additional consideration performance promotion obligation excess amount payable pursuant article under promotion agreement abbvie shall have right make final decision with respect promotion arrangement including promotional material used training testing applicable such sale representative restriction with respect ability such sale representative detail other product purpose this agreement promote promotion mean detailing promotion product galapagos affiliate under relevant regulatory approval product trademark shall mean sale distribution promotion product galapagos affiliate clarity promotion promotion product promotion territory galapagos shall solely performed employee galapagos affiliate galapagos shall outsource subcontract promotion right obligation hereunder third party without prior written consent abbvie style margin margin bottom text indent font size font family time roman compensation promotion party shall share pursuant section nbsp cost expense incurred party with respect promotion under promotion agreement solely extent that such cost expense included profit loss provided that each party shall bear cost with respect promotion internal sale force such cost shall included calculation sale marketing cost allowable expense hereunder abbvie shall have other obligation compensate galapagos with respect promotion promotion product style margin margin bottom text indent font size font family time roman commercialization commercialization promotion product promotion territory shall conducted pursuant comprehensive multi year plan budget which shall include inter alia promotion plan least month prior anticipated filing first drug approval application with applicable regulatory authority country promotion territory with with respect centralized approval procedure such other period party agree writing abbvie shall propose initial promotion plan such plan shall allocate responsibility commercialization each promotion product promotion territory which activity case detailing shall allocated equally each party each country promotion territory without limiting foregoing commercialization party each promotion product promotion territory shall conducted pursuant promotion plan including clarity budget forth therein shall review approve promotion plan within after receipt thereafter least annually shall make amendment thereto style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center grant right style margin margin bottom text indent font size font family time roman grant abbvie galapagos behalf itself affiliate hereby grant abbvie style margin margin bottom text indent font size font family time roman subject section nbsp exclusive including with regard galapagos affiliate except provided section nbsp license sublicense case with right grant sublicenses accordance with section nbsp under galapagos patent galapagos know galapagos interest joint patent joint know right reference regulatory documentation controlled galapagos affiliate each case perform discovery activity exploit molecule product field territory style margin margin bottom text indent font size font family time roman subject section nbsp exclusive license with right grant sublicenses accordance with section nbsp galapagos corporate name solely required exploit molecule product field territory other purpose style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman grant galapagos abbvie grant galapagos style margin margin bottom text indent font size font family time roman exclusive including with regard abbvie affiliate license sublicense case with right grant sublicenses accordance with section nbsp under abbvie patent abbvie know abbvie interest joint patent joint know right granted abbvie section nbsp right reference regulatory documentation controlled abbvie affiliate solely style margin margin bottom text indent font size font family time roman develop product solely obtain regulatory approval product galapagos territory pursuant accordance with galapagos territory development plan style margin margin bottom text indent font size font family time roman commercialize product field galapagos territory accordance with galapagos territory commercialization plan section nbsp style margin margin bottom text indent font size font family time roman exclusive royalty free license with right grant sublicenses accordance with section nbsp under abbvie patent abbvie know abbvie interest joint patent joint know develop molecule product solely purpose performing obligation forth subject discovery work plan plan combination product development plan combination product post development plan potentiator post development plan study plan style margin margin bottom text indent font size font family time roman exclusive royalty free license with right grant sublicenses accordance with section nbsp under abbvie patent abbvie know abbvie interest joint patent joint know manufacture have manufactured molecule product solely purpose performing obligation forth subject discovery work plan plan combination product development plan combination product post development plan potentiator post development plan study plan style margin margin bottom text indent font size font family time roman sublicenses style margin margin bottom text indent font size font family time roman abbvie abbvie shall have right grant sublicenses further right reference through multiple tier sublicensees under license right reference granted section nbsp section nbsp affiliate other person provided that such sublicenses shall consistent with term condition this agreement style margin margin bottom text indent font size font family time roman galapagos style margin margin bottom text indent font size font family time roman development subcontractor galapagos shall have right grant sublicenses under license granted section nbsp third party provider solely extent necessary permit such third party provider perform discovery activity other development activity subcontracted galapagos accordance with section nbsp provided that such third party provider sublicense shall comply with section nbsp style margin margin bottom text indent font size font family time roman manufacturing subcontractor galapagos shall have right grant sublicenses under license granted section nbsp third party provider solely purpose forth such section nbsp provided that such third party provider sublicense shall comply with section nbsp style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman affiliate galapagos shall have right grant sublicenses under license granted section nbsp affiliate provided that such affiliate sublicense shall comply with section nbsp style margin margin bottom text indent font size font family time roman third party style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign time galapagos wish grant sublicense under license granted section nbsp person other than affiliate galapagos shall notify abbvie thereof later than after receipt such notice from galapagos abbvie shall notify galapagos whether abbvie affiliate wish take such sublicense abbvie notify galapagos within such response period that abbvie affiliate wish take such sublicense then galapagos shall free negotiate enter into sublicense under license granted section nbsp with third party such term galapagos determine provided that such third party sublicense shall comply with section nbsp clarity prior providing notice abbvie under this section nbsp during response period after providing such notice galapagos shall nbsp grant sublicense under license granted section nbsp third party nbsp negotiate with third party directly indirectly through person offer enter into with third party sublicense under license granted section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign abbvie notifies galapagos within such response period that abbvie wish take sublicense under license granted section nbsp then during period commencing date delivery such notice abbvie such longer period party agree exclusive negotiation period abbvie affiliate galapagos shall negotiate good faith term condition which abbvie affiliate galapagos shall enter into such sublicense clarity during exclusive negotiation period galapagos shall nbsp grant sublicense under license granted section nbsp third party nbsp negotiate with third party directly indirectly through person offer enter into with third party sublicense under license granted section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style margin margin bottom font family time roman font size abbvie affiliate galapagos execute deliver such sublicense prior exclusive negotiation period then galapagos shall free negotiate enter into sublicense under license granted section nbsp with third party provided that galapagos shall enter such third party sublicense term condition that taken whole equal favorable galapagos than term condition last proposed abbvie affiliate galapagos during exclusive negotiation period provided further that such third party sublicense shall comply with section nbsp table style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign galapagos promptly shall provide abbvie complete accurate copy each third party sublicense entered into galapagos subject reasonable protection applicable third party proprietary information provided that event galapagos redact financial term third party sublicense provided abbvie table style margin margin bottom text indent font size font family time roman galapagos shall cause each sublicensee permitted under this section nbsp comply with term applicable permitted sublicense comply with applicable term condition this agreement grant such sublicense shall relieve galapagos obligation under this agreement except extent they satisfactorily performed such sublicensee such permitted sublicenses shall consistent with subject term condition this agreement style margin margin bottom text indent font size font family time roman distributorships style margin margin bottom text indent font size font family time roman abbvie shall have right sole discretion appoint affiliate abbvie affiliate shall have right their sole discretion appoint third party commercialize product country abbvie territory with without packaging right circumstance where person purchase requirement product from abbvie affiliate term packaging right this section nbsp mean right distributor package product supplied unpackaged bulk form into individual ready sale pack style margin margin bottom text indent font size font family time roman galapagos shall have right appoint affiliate galapagos affiliate shall have right appoint third party commercialize product country galapagos territory circumstance where person purchase requirement product from galapagos affiliate provided that galapagos furnishes with advanced written notice thereof which notice shall specify work subcontracted discus qualification such distributor style margin margin bottom text indent font size font family time roman where party affiliate appoint person distribute market sell product circumstance where person purchase requirement product from such party affiliate such person affiliate such party that person shall distributor purpose this agreement style margin margin bottom text indent font size font family time roman promotion right style margin margin bottom text indent font size font family time roman subject galapagos exclusive promotion right pursuant section nbsp abbvie affiliate shall have right their sole discretion promote product with third party appoint nbsp more third party promote product without abbvie part abbvie territory style margin margin bottom text indent font size font family time roman galapagos affiliate shall have right promote product with third party appoint nbsp more third party promote product without galapagos part galapagos territory provided that galapagos furnishes with advanced written notice thereof which notice shall specify work subcontracted discus qualification such third party style margin margin bottom text indent font size font family time roman retention right style margin margin bottom text indent font size font family time roman notwithstanding exclusive license granted abbvie pursuant section nbsp galapagos retains right practice under galapagos patent galapagos know galapagos interest joint patent joint know regulatory approval style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman other regulatory documentation perform obligation under this agreement including development detailing promotion product making having made supply molecule product abbvie applicable except expressly provided herein galapagos grant other right license including right license galapagos patent galapagos know galapagos corporate name joint patent joint know other patent intellectual property right otherwise expressly granted herein style margin margin bottom text indent font size font family time roman except expressly provided herein abbvie grant other right license including right license abbvie patent abbvie know joint patent joint know regulatory documentation other patent intellectual property right otherwise expressly granted herein style margin margin bottom text indent font size font family time roman confirmatory patent license galapagos shall requested abbvie immediately enter into confirmatory license agreement form substantially form reasonably requested abbvie purpose recording license granted under this agreement with such patent office territory abbvie considers appropriate provided that case shall galapagos required execute such license agreement legal effect thereof would transfer ownership galapagos patent licensed thereunder abbvie which event galapagos abbvie would mutually agree alternate solution address need confirmatory license without materially damaging interest either party until execution such confirmatory license alternate solution legally possible galapagos abbvie shall have same right respect galapagos patent under same obligation each other respect said confirmatory license alternate solution been executed style margin margin bottom text indent font size font family time roman third party license agreement during term neither galapagos affiliate shall without abbvie prior written consent enter into agreement with third party related information regulatory documentation patent other intellectual property right affecting molecule product galapagos shall consult with abbvie seek abbvie comment draft proposal exchanged between galapagos prospective licensor with respect such license galapagos affiliate party license sublicense other agreement additional right with right sublicense under patent information make sell offer sell import molecule product permitted aforementioned sentence then galapagos shall inform abbvie shall provide abbvie with copy which redacted pertinent part such license sublicense other agreement proposed future third party licensed right abbvie notifies galapagos writing that wish bound assume right obligation proposed future third party licensed right they apply abbvie this agreement then proposed future third party licensed right shall automatically included galapagos patent galapagos know applicable hereunder abbvie agrees abide applicable term condition such license sublicense other agreement relates abbvie this agreement abbvie decline bound assume right obligation proposed future third party licensed right they apply abbvie this agreement abbvie discretion negotiate conclude separate agreement with applicable licensor style margin margin bottom text indent font size font family time roman exclusivity with respect territory style margin margin bottom text indent font size font family time roman during term neither party shall each party shall cause affiliate nbsp directly indirectly develop commercialize otherwise exploit country territory nbsp license authorize appoint otherwise enable third party directly indirectly develop commercialize otherwise exploit country territory each case except nbsp molecule product accordance with term this agreement nbsp style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center payment record style margin margin bottom text indent font size font family time roman upfront payment party acknowledge agree that payment that required section nbsp existing agreement paid full further upfront payment hereunder style margin margin bottom text indent font size font family time roman development milestone further consideration license right granted under existing patent related galapagos know galapagos abbvie pursuant section nbsp subject term condition forth this agreement abbvie shall galapagos milestone payment within after achievement each following milestone calculated follows style margin margin bottom text indent font size font family time roman upon million dollar style margin margin bottom text indent font size font family time roman upon dollar style margin margin bottom text indent font size font family time roman upon dollar style margin margin bottom text indent font size font family time roman upon dollar style margin margin bottom text indent font size font family time roman upon dollar style margin margin bottom text indent font size font family time roman upon dollar style margin margin bottom text indent font size font family time roman upon dollar style margin margin bottom text indent font size font family time roman upon dollar style margin margin bottom text indent font size font family time roman upon dollar style margin margin bottom text indent font size font family time roman upon dollar style margin margin bottom text indent font size font family time roman upon dollar style margin margin bottom text indent font size font family time roman upon dollar provided that style margin margin bottom text indent font size font family time roman upon dollar provided that style margin margin bottom text indent font size font family time roman upon dollar style margin margin bottom text indent font size font family time roman upon dollar style margin margin bottom text indent font size font family time roman upon dollar style margin margin bottom text indent font size font family time roman upon dollar style margin margin bottom text indent font size font family time roman only dollar style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman payment condition style margin margin bottom text indent font size font family time roman each milestone payment this section nbsp shall refundable creditable style margin margin bottom text indent font size font family time roman each shall payable only once with respect each series potentiator molecule only with respect potentiator molecule such series shall payable with respect each potentiator molecule series that achieves milestone forth section nbsp shall only payable once with respect particular potentiator molecule style margin margin bottom text indent font size font family time roman each shall payable only once with respect each series corrector molecule only with respect corrector molecule such series shall payable with respect each corrector molecule series that achieves milestone forth section nbsp shall only payable once with respect particular corrector molecule style margin margin bottom text indent font size font family time roman each shall payable only once with respect each series corrector molecule only with respect corrector molecule such series shall payable with respect each corrector molecule series that achieves milestone forth section nbsp shall only payable once with respect particular corrector molecule style margin margin bottom text indent font size font family time roman each shall payable only once with respect each series corrector molecule only with respect corrector molecule such series shall payable with respect each corrector molecule series that achieves milestone forth section nbsp shall only payable once with respect particular corrector molecule style margin margin bottom text indent font size font family time roman each shall payable only once with respect each series corrector molecule only with respect corrector molecule such series shall payable with respect each corrector molecule series that achieves milestone forth section nbsp shall only payable once with respect particular corrector molecule style margin margin bottom text indent font size font family time roman clarity payment nbsp with respect particular corrector molecule pursuant section nbsp applicable shall relieve abbvie obligation other such milestone with respect such corrector molecule when such other milestone earned with respect such corrector molecule accordance with section nbsp applicable nbsp with respect particular corrector molecule pursuant section nbsp applicable shall relieve abbvie obligation other such milestone with respect such corrector molecule when such other milestone earned with respect such corrector molecule accordance with section nbsp applicable nbsp with respect particular corrector molecule pursuant section nbsp applicable shall relieve abbvie obligation other such milestone with respect such corrector molecule when such other milestone earned with respect such corrector molecule accordance with section nbsp applicable nbsp with respect particular corrector molecule pursuant section nbsp applicable shall relieve abbvie obligation other such milestone with respect such corrector molecule when such other milestone earned with respect such corrector molecule accordance with section nbsp applicable style margin margin bottom text indent font size font family time roman viii shall payable only once upon first achievement milestone forth section nbsp amount shall same triple combination product different triple combination product style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman shall payable only once upon first achievement milestone forth section nbsp amount shall subsequent repeated achievement such milestone different triple combination product style margin margin bottom text indent font size font family time roman shall payable only once upon first achievement milestone forth section nbsp amount shall subsequent repeated achievement such milestone different triple combination product style margin margin bottom text indent font size font family time roman shall payable only once only abbvie make election under section nbsp style margin margin bottom text indent font size font family time roman shall payable only once shall payable abbvie make election under section nbsp style margin margin bottom text indent font size font family time roman existing agreement payment party acknowledge agree that payment that required under section nbsp existing agreement paid full with respect further payment pursuant such section nbsp existing agreement restatement date style margin margin bottom text indent font size font family time roman glpg payment party acknowledge agree that million dollar made abbvie galapagos january nbsp with respect glpg consideration license right granted galapagos abbvie under existing patent related galapagos know hereunder further milestone payment with respect glpg payable abbvie pursuant section nbsp style margin margin bottom text indent font size font family time roman regulatory milestone further consideration license right granted under existing patent related galapagos know galapagos abbvie hereunder pursuant section nbsp subject term condition forth this agreement abbvie shall galapagos milestone payment within nbsp after achievement each following milestone calculated follows style margin margin bottom text indent font size font family time roman upon dollar style margin margin bottom text indent font size font family time roman upon dollar style margin margin bottom text indent font size font family time roman upon dollar style margin margin bottom text indent font size font family time roman upon dollar style margin margin bottom text indent font size font family time roman upon dollar style margin margin bottom text indent font size font family time roman upon dollar style margin margin bottom text indent font size font family time roman each milestone payment this section nbsp shall refundable creditable payable only once upon first achievement such milestone amount shall subsequent repeated achievement such milestone whether same different product clarity maximum aggregate amount payable abbvie pursuant this section nbsp dollar style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman sale based milestone style margin margin bottom text indent font size font family time roman further consideration license right under galapagos patent related galapagos know galapagos interest joint patent related joint know granted galapagos abbvie hereunder pursuant section nbsp subject section nbsp sale product royalty territory given calendar year exceed threshold each annual sale milestone threshold forth left hand column table immediately below annual sale based milestone table abbvie shall galapagos milestone payment each annual sale based milestone payment corresponding amount forth right hand column annual sale based milestone table given calendar year more than nbsp annual sale milestone threshold exceeded abbvie shall galapagos separate annual sale based milestone payment with respect each annual sale milestone threshold that exceeded such calendar year each such milestone payment shall within first achievement such milestone each annual sale based milestone payment date style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman threshold annual sale level valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid payment nbsp amount valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman dollar valign bottom nbsp nbsp valign bottom valign bottom align right nowrap valign bottom nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman dollar valign bottom nbsp nbsp valign bottom valign bottom align right nowrap valign bottom nbsp table style margin margin bottom text indent font size font family time roman notwithstanding anything contained section nbsp each milestone payment this section nbsp shall payable only once upon first achievement such milestone amount shall subsequent repeated achievement such milestone subsequent calendar year clarity maximum aggregate amount payable abbvie pursuant this section nbsp dollar style margin margin bottom text indent font size font family time roman royalty style margin margin bottom text indent font size font family time roman royalty rate further consideration license right under galapagos patent related galapagos know galapagos interest joint patent related joint know granted galapagos abbvie hereunder pursuant section nbsp subject section commencing upon first commercial sale product royalty territory abbvie shall galapagos royalty aggregate sale product sold royalty territory excluding sale each such product sold country other jurisdiction royalty territory which royalty term such product sold such country other jurisdiction expired during each calendar year following rate style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom style margin margin bottom font size font family time roman sale product royalty territory style margin margin bottom font size font family time roman calendar year valign bottom nbsp nbsp valign bottom colspan align center royalty nbsp rate valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp table style margin margin bottom text indent font size font family time roman exclusion sale notwithstanding foregoing sale attributable sale promotion product promotion territory shall excluded from aggregate sale purpose this section nbsp such sale shall subject royalty under this section nbsp with respect each product each country other jurisdiction royalty territory from after expiration royalty term such product that sold such country other jurisdiction sale such product such country other jurisdiction shall excluded purpose calculating sale threshold ceiling forth this section nbsp style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman royalty term abbvie shall have obligation royalty with respect sale product country other jurisdiction after royalty term such product that sold such country other jurisdiction expired style margin margin bottom text indent font size font family time roman reduction notwithstanding foregoing style margin margin bottom text indent font size font family time roman country other jurisdiction royalty territory during royalty term product there generic competition resulting style margin margin bottom text indent font size font family time roman court governmental agency competent jurisdiction requires abbvie affiliate sublicensees grant compulsory license third party permitting such third party make sell product country other jurisdiction royalty territory then purpose calculating royalty payable with respect such product under section nbsp style margin margin bottom text indent font size font family time roman such case from after date which product exploited country other jurisdiction making using offer sale sale such product sold such country other jurisdiction covered valid claim galapagos patent product patent then royalty rate forth section nbsp with respect such sale product such country other jurisdiction purpose calculation under section nbsp each shall reduced percent style margin margin bottom text indent font size font family time roman abbvie shall have right deduct cost accordance with section style margin margin bottom font size font family time roman case shall deduction allowable under this section nbsp alone cumulatively reduce royalty paid galapagos more than percent royalty under section nbsp style margin margin bottom text indent font size font family time roman royalty payment report abbvie shall calculate amount payable galapagos pursuant section nbsp each calendar quarter which amount shall converted dollar accordance with section nbsp abbvie shall galapagos royalty amount with respect given calendar quarter within after such calendar quarter each payment royalty galapagos shall accompanied statement amount sale each product each country other jurisdiction royalty territory during applicable calendar quarter including such amount expressed local currency converted dollar calculation amount royalty payment such sale such calendar quarter style margin margin bottom text indent font size font family time roman profit loss promotion territory galapagos exercise promotion option term condition this section nbsp shall govern each party right obligation with respect profit loss relating promotion product promotion territory subject section nbsp galapagos shall receive percent profit bear percent loss applicable with respect font style white space nowrap promotion font product promotion territory nbsp abbvie shall receive percent profit bear percent loss applicable with respect font style white space nowrap promotion font product promotion territory galapagos shall bear share profit loss with respect promotion product regardless date exercise promotion option style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman calculation payment profit loss share style margin margin bottom text indent font size font family time roman report payment general upon initiation promotion with respect promotion product each party shall report other party within after each calendar quarter following such initiation with regard sale allowable expense incurred such party such promotion product during such calendar quarter promotion territory manner sufficient enable other party comply with reporting requirement provided that case first calendar quarter which such report each party shall additionally report allowable expense incurred such party prior such calendar quarter with respect such promotion product such report shall specify reasonable detail deduction allowed calculation such sale expense included allowable expense within after each calendar quarter last calendar quarter calendar year after such calendar quarter party shall reconcile sale allowable expense ascertain whether there profit loss payment shall made forth subsection nbsp nbsp below applicable style margin margin bottom text indent font size font family time roman there profit such calendar quarter then abbvie shall reimburse galapagos allowable expense incurred galapagos such calendar quarter shall galapagos amount equal percent profit such calendar quarter within after each calendar quarter style margin margin bottom text indent font size font family time roman there loss such calendar quarter then party that borne than share allowable expense such calendar quarter shall make reconciling payment other party within after each calendar quarter assure that each party bear share such allowable expense during such calendar quarter style margin margin bottom font size font family time roman sample calculation determining profit loss attached hereto schedule nbsp style margin margin bottom text indent font size font family time roman last calendar quarter separate payment shall made last calendar quarter calendar year instead each such calendar year final reconciliation shall conducted comparing share profit loss which party otherwise entitled such calendar year pursuant section against amount previously paid retained such party prior calendar quarter during such calendar year party shall make reconciling payment another later than after such calendar quarter necessary ensure that each party receives such calendar year share profit bear share loss accordance with section nbsp style margin margin bottom text indent font size font family time roman record calculation each party shall calculate maintain record effort incurred same manner used other product developed such party unless instructed employ other procedure which case such other procedure shall applied equally both party style margin margin bottom text indent font size font family time roman reconciliation development cost galapagos cost with respect nbsp development cost incurred connection with discovery activity activity performed under development plan other than study plan development activity performed step party pursuant section nbsp other than development activity nbsp galapagos cost incurred abbvie such cost initially shall borne party incurring cost expense thereafter shall subject reimbursement accordance with cost sharing reimbursement allocation forth section nbsp applicable each party shall report other party within after each calendar quarter development cost galapagos cost incurred such party during such calendar quarter such report shall specify reasonable detail amount included such development cost galapagos cost during such calendar quarter each such report shall style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman enable receiving party compare reported cost against applicable development plan applicable both quarterly basis cumulative basis each activity party shall seek resolve question related such accounting statement within following receipt each party other party report hereunder within after each calendar quarter last calendar quarter calendar year within after such calendar year party that paid than share development cost galapagos cost during such calendar quarter performing party shall make reconciling payment other party achieve appropriate allocation reimbursement such cost provided section applicable style margin margin bottom text indent font size font family time roman third party payment style margin margin bottom text indent font size font family time roman galapagos shall reimburse abbvie amount equal percent third party payment made abbvie with respect abbvie territory later than after abbvie provides galapagos reasonable documentation such payment style margin margin bottom text indent font size font family time roman third party payment with respect galapagos territory style margin margin bottom text indent font size font family time roman mode payment offset payment either party under this agreement shall made electronic transfer dollar requisite amount such bank account receiving party from time time designate notice paying party purpose calculating under otherwise reimbursable pursuant this agreement including calculation sale galapagos sale expressed currency other than dollar party shall convert amount expressed foreign currency into dollar equivalent using affiliate sublicensee licensee standard conversion methodology consistent with accounting standard such standard conversion methodology shall based upon monthly average exchange rate monthly average exchange rate mean simple average prior month exchange rate current month exchange rate based central time bloomberg screen penultimate business corresponding month exchange rate mean with respect business spot rate currency spot rate currency conversion applicable country other jurisdiction currency dollar reported central time bloomberg screen penultimate business abbvie shall have right offset amount that owed galapagos paid more than after date against payment owed abbvie under this agreement style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman withholding where paid either party hereunder subject withholding similar party shall their commercially reasonable effort such thing sign such document will enable them take advantage applicable double taxation agreement treaty there applicable double taxation agreement treaty applicable double taxation agreement treaty reduces eliminate such withholding similar payor shall remit such withholding similar appropriate government authority deduct amount paid from amount payee secure send payee best available evidence payment such withholding similar withholding similar paid government authority each party will provide other party such assistance reasonably required obtain refund withheld similar obtain credit with respect such paid event that government authority retroactively determines that payment made party other party pursuant this agreement should have been subject withholding similar additional withholding similar such party withholding party remit such withholding similar government authority withholding party will have right nbsp offset such amount including interest penalty that imposed thereon except extent such interest penalty result from negligence withholding party against future payment obligation withholding style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman party under this agreement nbsp invoice other party such amount which shall payable other party within receipt such invoice nbsp pursue reimbursement other available remedy style margin margin bottom text indent font size font family time roman indirect payment exclusive value added sale consumption other similar indirect indirect chargeable respect payment paying party shall such indirect applicable rate respect such payment following receipt where applicable indirect invoice appropriate form issued receiving party respect those payment party shall issue invoice amount payable under this agreement consistent with indirect requirement irrespective whether netted settlement purpose indirect originally paid otherwise borne paying party whole part subsequently determined have been chargeable necessary step will taken receiving party receive refund these undue indirect from applicable governmental authority other fiscal authority amount undue indirect repaid such authority receiving party will transferred paying party within receipt style margin margin bottom text indent font size font family time roman other compensation each party hereby agrees that term this agreement fully define consideration compensation benefit monetary otherwise paid granted delivered nbsp party other party connection with transaction contemplated herein promotion agreement neither party previously paid entered into other commitment whether orally writing other party employee directly indirectly consideration compensation benefit monetary otherwise connection with transaction contemplated herein style margin margin bottom text indent font size font family time roman interest late payment payment either party under this agreement paid when then such paying party shall interest thereon before after judgment annual rate with interest accruing daily basis basis point above euribor such interest from date which payment such became until payment thereof full together with such interest style margin margin bottom text indent font size font family time roman financial record each party shall shall cause affiliate keep complete accurate book record pertaining sale galapagos sale profit loss with respect promotion product during term each case including allowable expense applicable development molecule product including book record actual expenditure with respect budget forth each development plan galapagos cost third party payment other amount shared hereunder sufficient detail calculate amount payable hereunder verify compliance with obligation under this agreement such book record shall retained such party affiliate until later nbsp year after period which such book record pertain nbsp expiration applicable statute limitation extension thereof such longer period required applicable style margin margin bottom text indent font size font family time roman audit request other party each party shall shall cause affiliate permit independent public accounting firm internationally recognized standing designated other party reasonably acceptable audited party reasonable time during normal business hour upon reasonable notice audit book record maintained pursuant section nbsp ensure accuracy report payment made hereunder such examination nbsp conducted calendar quarter more than year after such quarter nbsp conducted more than once twelve month period unless previous audit during such twelve month period revealed underpayment with respect such period nbsp repeated calendar quarter accounting firm shall disclose only whether report correct specific detail concerning discrepancy other information shall shared except provided below cost this audit shall borne auditing party unless audit reveals variance more than percent from style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman reported amount which case audited party shall bear cost audit unless disputed pursuant section nbsp below such audit concludes that nbsp additional amount were owed audited party audited party shall additional amount with interest from date originally nbsp excess payment were made audited party auditing party shall reimburse such excess payment either case within after date which such audit completed auditing party style margin margin bottom text indent font size font family time roman audit dispute event dispute with respect audit under section nbsp galapagos abbvie shall work good faith resolve disagreement party unable reach mutually acceptable resolution such dispute within dispute shall submitted resolution certified public accounting firm jointly selected each party certified public accountant such other person party shall mutually agree audit arbitrator abbvie galapagos shall enter into engagement letter with audit arbitrator shall provide book record necessary permit audit arbitrator reach conclusion decision audit arbitrator shall final cost such arbitration well initial audit shall borne between party such manner audit arbitrator shall determine later than after such decision accordance with such decision audited party shall additional amount auditing party shall reimburse excess payment applicable style margin margin bottom text indent font size font family time roman confidentiality receiving party shall treat information subject review under this article nbsp accordance with confidentiality provision article party shall cause audit arbitrator enter into reasonably acceptable confidentiality agreement with audited party obligating such firm retain such financial information confidence pursuant such confidentiality agreement style margin margin bottom text indent font size font family time roman order reimbursement credit payment style margin margin bottom text indent font size font family time roman event that required abbvie payment subject more than nbsp type reimbursement credit such required abbvie payment sufficient satisfy such reimbursement credit then nbsp discovery reimbursement credit shall applied fully first nbsp reimbursement credit shall applied fully second nbsp post reimbursement credit shall applied last event shall abbvie entitled take aggregate reimbursement credit against required abbvie payment amount greater than such required abbvie payment style margin margin bottom text indent font size font family time roman event that required abbvie payment subject more than nbsp type reimbursement payment amount such required abbvie payment equal greater than aggregate amount such reimbursement payment then nbsp discovery reimbursement payment shall paid fully first nbsp reimbursement payment shall paid fully second nbsp post reimbursement payment shall paid last event shall abbvie required aggregate reimbursement payment with respect required abbvie payment amount greater than such required abbvie payment style margin margin bottom text indent font size font family time roman event that required abbvie payment subject both nbsp nbsp more reimbursement credit nbsp nbsp more reimbursement payment then aggregate amount such reimbursement credit aggregate amount such reimbursement payment shall offset against each other nbsp aggregate amount such reimbursement credit exceeds aggregate amount such reimbursement payment abbvie shall make reimbursement payment with respect such required abbvie payment only such excess amount shall applied reimbursement credit against such required abbvie payment accordance with section nbsp nbsp aggregate amount such reimbursement payment exceeds aggregate amount such reimbursement credit abbvie shall take reimbursement credit against such required abbvie payment only such excess amount shall paid reimbursement payment addition such required abbvie payment accordance with section nbsp style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman clarity total discovery reimbursement balance total reimbursement balance total post reimbursement balance applicable shall only settled through style margin margin bottom text indent font size font family time roman crediting reimbursement credit against required abbvie payment pursuant section nbsp applicable style margin margin bottom text indent font size font family time roman payment reimbursement payment addition required abbvie payment pursuant section nbsp applicable style margin margin bottom text indent font size font family time roman voluntary reimbursement payment pursuant section nbsp applicable style margin margin bottom text indent font size font family time roman party shall required make other payment connection with such total discovery reimbursement balance total reimbursement balance total post reimbursement balance style margin margin bottom text indent font size font family time roman galapagos earnout compensation style margin margin bottom text indent font size font family time roman only abbvie make applicable deemed have made election under either section nbsp section nbsp then consideration relinquishment abbvie right license develop commercialize exploit potentiator product funding participation development abbvie hereunder prior such election commencing upon galapagos first commercial sale galapagos product anywhere world galapagos shall abbvie earnout compensation amount equal percent aggregate galapagos sale galapagos product excluding galapagos sale each such galapagos product sold country other jurisdiction which galapagos earnout term such galapagos product sold such country other jurisdiction expired style margin margin bottom text indent font size font family time roman galapagos shall have obligation earnout compensation with respect galapagos sale galapagos product country other jurisdiction after galapagos earnout term such galapagos product that sold such country other jurisdiction expired style margin margin bottom text indent font size font family time roman notwithstanding foregoing style margin margin bottom text indent font size font family time roman country other jurisdiction during galapagos earnout term galapagos product there generic competition resulting least percent loss market share unit galapagos product such country other jurisdiction then each such country other jurisdiction earnout compensation payable abbvie galapagos sale such galapagos product such country other jurisdiction shall reduced percent earnout compensation rate forth section nbsp style margin margin bottom text indent font size font family time roman court governmental agency competent jurisdiction requires galapagos affiliate licensee grant compulsory license third party permitting such third party make sell galapagos product country other jurisdiction then purpose calculating earnout compensation payable with respect such galapagos product under section nbsp percent royalty paid such third party compulsory licensee shall paid abbvie lieu earnout compensation galapagos sale such compulsory licensed galapagos product style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman such country other jurisdiction percent galapagos sale such galapagos product such country other than sale such compulsory licensed galapagos product shall disregarded style margin margin bottom text indent font size font family time roman such case from after date which galapagos product exploited country other jurisdiction making using offer sale sale such galapagos product sold such country other jurisdiction covered valid claim galapagos patent patent then earnout compensation rate forth section nbsp with respect such sale galapagos product such country other jurisdiction purpose calculation under section nbsp shall reduced percent style margin margin bottom text indent font size font family time roman galapagos shall have right deduct reasonable pocket attorney court cost borne galapagos defending claim suit proceeding brought third party alleging that galapagos product galapagos manufacturing process infringe nbsp more patent controlled third party such deduction shall applied given calendar quarter from earnout compensation abbvie pursuant section nbsp recovery galapagos sanction awarded galapagos against party asserting claim referred under this section nbsp shall applied follows such recovery shall applied first nbsp reimburse galapagos reasonable pocket cost defending such claim suit proceeding extent deducted from earnout compensation pursuant previous sentence nbsp reimburse abbvie earnout compensation deduction pursuant previous sentence balance such recovery shall retained provided galapagos included calculation galapagos sale relevant galapagos product purpose herein galapagos manufacturing process mean process synthesis making production processing purifying formulating filling finishing packaging labeling shipping holding galapagos product intermediate thereof including quality assurance quality control style margin margin bottom text indent font size font family time roman case shall deduction allowable under this section nbsp alone cumulatively reduce earnout compensation paid abbvie more than percent earnout compensation under section nbsp style margin margin bottom text indent font size font family time roman galapagos shall calculate amount payable abbvie pursuant section nbsp each calendar quarter which amount shall converted dollar accordance with section nbsp galapagos shall abbvie earnout amount with respect given calendar quarter within after such calendar quarter each earnout payment abbvie shall accompanied statement amount galapagos sale each galapagos product each country other jurisdiction during applicable calendar quarter including such amount expressed local currency converted dollar calculation amount earnout payment such galapagos sale such calendar quarter style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center intellectual property style margin margin bottom text indent font size font family time roman ownership intellectual property style margin margin bottom text indent font size font family time roman ownership joint know joint patent between party party shall each equal undivided interest nbsp information that discovered developed invention whether patentable conceived made behalf either party affiliate sublicensees subcontractor whether solely jointly with behalf other party affiliate sublicensees subcontractor connection with work activity conducted under connection with this agreement including discovery activity other development activity commercialization activity joint know style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman nbsp patent claiming such joint know joint patent each party shall promptly disclose other party writing shall cause affiliate licensee sublicensees disclose development making conception reduction practice joint know joint patent subject license right reference granted under section each party shall have right exploit joint know joint patent without duty seeking consent accounting other party particular country consent owner required owner grant license right under otherwise exploit joint know joint patent provided previous sentence each party hereby consent such license grant exploit such joint know joint patent such country without duty share profit with provide accounting other party with respect such exploitation style margin margin bottom text indent font size font family time roman ownership other know patent subject section nbsp right granted section between party nbsp abbvie shall right title interest abbvie know abbvie patent nbsp galapagos shall right title interest galapagos know galapagos patent know patent nbsp each party shall retain right title interest information invention patent other intellectual property right that controlled other than pursuant license grant forth section nbsp such party affiliate licensee sublicensees style margin margin bottom text indent font size font family time roman united state determination whether invention conceived made behalf party purpose allocating proprietary right therein shall purpose this agreement made accordance with applicable united state such exists effective date irrespective where such conception making occurs style margin margin bottom text indent font size font family time roman assignment obligation each party shall cause person perform development activity manufacturing activity commercialization activity such party under this agreement under obligation assign such party unable cause such person agree such assignment obligation despite such party using commercially reasonable effort negotiate such assignment obligation provide license under their right information invention such party except where applicable requires otherwise except case governmental profit public institution which have standard policy against such assignment which case suitable license right obtain such license shall obtained style margin margin bottom text indent font size font family time roman ownership galapagos corporate name between party galapagos shall retain right title interest galapagos corporate name style margin margin bottom text indent font size font family time roman maintenance prosecution patent style margin margin bottom text indent font size font family time roman patent prosecution maintenance galapagos patent other than product patent consultation with abbvie galapagos shall have right obligation through internal outside counsel reasonably acceptable abbvie prepare file prosecute maintain galapagos patent excluding galapagos patent that product patent prosecution maintenance which shall governed section nbsp worldwide galapagos sole cost expense galapagos shall keep abbvie fully informed step with regard preparation filing prosecution maintenance such galapagos patent territory including providing abbvie with copy material communication from patent authority regarding such galapagos patent providing abbvie draft material filing response made such patent authority sufficiently advance submitting such filing response allow reasonable opportunity abbvie review comment thereon galapagos shall consider good faith request suggestion abbvie with respect such galapagos draft with respect strategy filing prosecuting galapagos patent territory notwithstanding foregoing galapagos shall promptly inform abbvie style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman adversarial patent office proceeding sponte filing including request filing declaration interference opposition third party observation derivation proceeding post grant review supplementary examination reissue inter parte parte reexamination relating galapagos patent territory party shall thereafter consult cooperate determine course action with respect such proceeding territory galapagos shall consider good faith comment request suggestion provided abbvie galapagos shall initiate such adversarial patent office proceeding relating galapagos patent territory without first consulting abbvie galapagos decides prepare file prosecute maintain galapagos patent country other jurisdiction territory galapagos shall provide reasonable prior written notice abbvie such intention which notice shall event given later than earliest reasonable date applicable deadline shorter than prior next deadline action that taken with respect such galapagos patent such country other jurisdiction abbvie shall thereupon have option sole discretion assume control direction preparation filing prosecution maintenance such galapagos patent expense such country other jurisdiction except extent such cost expense allocable galapagos territory which event such cost expense shall reimbursed galapagos accordance with section nbsp provided that abbvie shall have right offset percent such expense borne abbvie against amount owed galapagos under this agreement given calendar quarter from sale based milestone galapagos pursuant section nbsp royalty galapagos pursuant section nbsp such calendar quarter with balance then remaining carried over subsequent calendar quarter applied against such sale based milestone royalty with respect such subsequent calendar quarter maximum amount each calendar quarter percent amount owed respect such subsequent calendar quarter upon abbvie written acceptance such option abbvie shall assume responsibility control preparation filing prosecution maintenance such specific galapagos patent galapagos shall reasonably cooperate with abbvie such country other jurisdiction provided under section nbsp style margin margin bottom text indent font size font family time roman patent prosecution maintenance abbvie patent product patent joint patent abbvie shall have right obligation prepare file prosecute maintain abbvie patent joint patent galapagos patent that product patent worldwide abbvie sole cost expense except extent such cost expense allocable galapagos territory which event such cost expense shall reimbursed galapagos accordance with section nbsp abbvie shall keep galapagos fully informed step with regard preparation filing prosecution maintenance abbvie patent joint patent product patent including providing galapagos with copy material communication from patent authority territory regarding such abbvie patent joint patent product patent providing galapagos draft material filing response made such patent authority territory sufficiently advance submitting such filing response allow reasonable opportunity galapagos review comment thereon abbvie shall consider good faith request suggestion galapagos with respect such abbvie draft with respect strategy filing prosecuting abbvie patent joint patent product patent territory abbvie decides prepare file prosecute maintain abbvie patent joint patent product patent country other jurisdiction territory abbvie shall provide reasonable prior written notice galapagos such intention which notice shall event given later than prior next deadline action that taken with respect such abbvie patent joint patent product patent such country other jurisdiction earliest reasonable date applicable deadline shorter than galapagos shall thereupon have option sole discretion assume control direction preparation filing prosecution maintenance such abbvie patent joint patent product patent expense such country other jurisdiction upon galapagos written acceptance such option galapagos shall assume responsibility control preparation filing prosecution maintenance such specific abbvie patent joint patent product patent such event abbvie shall reasonably cooperate with galapagos such country other jurisdiction provided under section nbsp style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman cooperation party agree cooperate fully preparation filing prosecution maintenance galapagos patent abbvie patent joint patent territory under this agreement cooperation shall include style margin margin bottom text indent font size font family time roman executing paper instrument requiring employee contractor execute such paper instrument nbsp effectuate ownership intellectual property forth section nbsp nbsp enable other party apply prosecute patent application territory nbsp obtain maintain patent extension supplementary protection certificate like with respect galapagos patent abbvie patent joint patent territory each case extent provided this agreement style margin margin bottom text indent font size font family time roman consistent with this agreement assisting license registration process with applicable governmental authority that available territory protection party interest this agreement style margin margin bottom text indent font size font family time roman promptly informing other party matter coming such party attention that materially affect preparation filing prosecution maintenance such galapagos patent abbvie patent joint patent territory style margin margin bottom text indent font size font family time roman patent term extension supplementary protection certificate style margin margin bottom text indent font size font family time roman except provided section nbsp abbvie shall responsible making decision regarding patent term extension including supplementary protection certificate other extension that become available future wherever applicable galapagos patent abbvie patent joint patent country other jurisdiction provided that dispute with respect thereto shall finally definitively resolved abbvie style margin margin bottom text indent font size font family time roman abbvie shall have responsibility applying extension supplementary protection certificate with respect galapagos patent abbvie patent joint patent territory abbvie shall keep galapagos fully informed effort obtain such extension supplementary protection certificate galapagos shall provide prompt reasonable assistance requested abbvie including taking such action patent holder required under applicable obtain such patent extension supplementary protection certificate style margin margin bottom text indent font size font family time roman abbvie shall expense regard obtaining extension supplementary protection certificate territory except extent such cost expense allocable galapagos territory which event such cost expense shall reimbursed galapagos accordance with section nbsp style margin margin bottom text indent font size font family time roman common ownership under joint research agreement notwithstanding anything contrary this article neither party shall have right make election under cooperative research technology enhancement public stat codified applicable create when exercising right under this article without prior written consent other party with respect such permitted election party shall coordinate their activity with respect submission filing other activity support thereof party acknowledge agree that this agreement joint research agreement defined create applicable style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman patent listing abbvie shall have sole right make filing with regulatory authority abbvie territory with respect galapagos patent abbvie patent joint patent including required allowed nbsp united state orange book nbsp outside united state under national implementation article directive other international equivalent galapagos shall nbsp provide abbvie correct complete list galapagos patent covering product otherwise necessary reasonably useful enable abbvie make such filing with regulatory authority territory with respect such patent nbsp cooperate with abbvie reasonable request connection therewith with joint patent including meeting submission deadline each case extent required permitted applicable filing with regulatory authority galapagos territory with respect galapagos patent abbvie patent joint patent shall subject review approval abbvie style margin margin bottom text indent font size font family time roman enforcement patent style margin margin bottom text indent font size font family time roman enforcement galapagos patent joint patent each party shall promptly notify other party writing alleged threatened infringement galapagos patent joint patent third party territory which such party becomes aware including alleged threatened infringement based development commercialization application market product territory third party infringement abbvie shall have first right obligation abate third party infringement territory abbvie prosecuted infringement sole expense except extent such cost expense allocable galapagos territory which event such cost expense shall reimbursed galapagos accordance with section nbsp litigation otherwise abbvie shall retain control prosecution such proceeding abbvie prosecutes abbvie prosecuted infringement galapagos shall have right join party such claim suit proceeding territory participate with counsel expense provided that abbvie shall retain control prosecution such claim suit proceeding during such claim suit proceeding abbvie shall nbsp provide galapagos with draft official paper statement whether written oral prior their submission such claim suit proceeding sufficient time allow galapagos review consider substantively comment thereon nbsp reasonably consider taking action incorporate galapagos comment such official paper statement nbsp allow galapagos opportunity participate preparation witness other participant such claim suit proceeding abbvie take commercially reasonable step prosecute abbvie prosecuted infringement nbsp within following first notice provided above with respect abbvie prosecuted infringement nbsp provided such date occurs after first such notice abbvie prosecuted infringement provided business before time limit forth appropriate regulation filing such action whichever come first then galapagos prosecute abbvie prosecuted infringement expense style margin margin bottom text indent font size font family time roman enforcement abbvie patent each party shall promptly notify other party writing alleged threatened infringement abbvie patent third party territory which such party becomes aware including alleged threatened infringement based development commercialization application market product territory abbvie shall have first right obligation abate such infringement territory sole expense except extent such cost expense allocable galapagos territory which event such cost expense shall reimbursed galapagos accordance with section nbsp litigation otherwise abbvie shall retain control prosecution such proceeding abbvie prosecutes such infringement galapagos shall have right join party such claim suit proceeding territory participate with counsel expense provided that abbvie shall retain control prosecution such claim suit proceeding abbvie take commercially reasonable step prosecute alleged threatened infringement territory with respect such abbvie patent nbsp within following first notice provided above with respect such alleged infringement style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman nbsp provided such date occurs after first such notice infringement provided business before time limit forth appropriate regulation filing such action whichever come first then galapagos prosecute alleged threatened infringement territory expense style margin margin bottom text indent font size font family time roman generic competition notwithstanding foregoing either party nbsp reasonably belief that third party filing preparing seeking file generic abridged drug approval application that refers relies regulatory documentation submitted either party regulatory authority whether such filing infringe galapagos patent abbvie patent joint patent nbsp receives notice certification regarding galapagos patent abbvie patent joint patent pursuant drug price competition patent term restoration united state code anda claiming that such patent invalid unenforceable claiming that such patent will infringed manufacture marketing sale product which application under anda filed nbsp receives equivalent similar certification notice other jurisdiction shall nbsp notify other party writing identifying alleged applicant potential applicant furnishing information upon which determination based nbsp provide with copy such notice certification within date receipt party right obligation with respect legal action result such certification shall forth section applicable provided that abbvie elect bring suit against third party providing notice such certification within receipt such notice galapagos shall have right obligation bring suit against such third party join abbvie party plaintiff necessary bring such suit which event galapagos shall hold abbvie harmless from against cost expense such litigation including reasonable attorney expense style margin margin bottom text indent font size font family time roman cooperation party agree cooperate fully infringement action pursuant this section nbsp where party brings such action other party shall where necessary furnish power attorney solely such purpose shall join named necessary party such action unless otherwise forth herein party entitled bring patent infringement litigation accordance with this section nbsp shall have right settle such claim provided that neither party shall have right settle patent infringement litigation under this section nbsp manner that diminishes material adverse effect right interest other party manner that imposes cost liability involves admission other party without express written consent such other party party commencing litigation shall provide other party with copy pleading other document filed with court shall consider reasonable input from other party during course proceeding provided further that abbvie shall settle patent infringement litigation under this section nbsp with respect galapagos territory without express written consent galapagos style margin margin bottom text indent font size font family time roman recovery except otherwise agreed party cost sharing arrangement recovery realized result litigation described section whether settlement otherwise shall first allocated reimburse party their cost expense making such recovery which amount shall allocated rata insufficient cover totality such expense remainder after such reimbursement made shall retained party that exercised right bring enforcement action provided that extent that award settlement whether judgment otherwise attributable reasonable royalty loss sale with respect product abbvie territory party shall negotiate good faith appropriate allocation such remainder reflect economic interest party under this agreement with respect such product provided further that extent that award settlement whether judgment otherwise attributable galapagos territory such remainder shall retained provided galapagos style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman infringement claim third party manufacture commercialization molecule product territory pursuant this agreement result result claim suit proceeding third party alleging patent infringement abbvie galapagos their respective affiliate sublicensees party first receiving notice such claim suit proceeding shall promptly notify other party thereof writing abbvie shall defend control defense such claim suit proceeding expense except extent such cost expense allocable galapagos territory which event such cost expense extent reasonable reasonably incurred shall reimbursed galapagos accordance with section nbsp using counsel choice galapagos participate such claim suit proceeding with counsel choice expense without limitation foregoing abbvie find necessary desirable join galapagos party such action galapagos shall execute paper perform such shall reasonably required abbvie expense each party shall keep other party reasonably informed material development connection with such claim suit proceeding unless otherwise forth herein abbvie shall have right settle such claim including entering into license agreement pursuant section nbsp provided that abbvie shall settle litigation under this section nbsp manner that diminishes material adverse effect right interest galapagos manner that imposes cost except forth immediately following proviso liability involves admission galapagos without galapagos express written consent provided further that entering into agreement with such third party pursuant section nbsp shall require consent galapagos each party agrees provide other party with copy pleading filed such action allow other party reasonable opportunity participate defense claim abbvie shall entitled deduct percent reasonable pocket attorney court cost borne abbvie reimbursed galapagos pursuant section nbsp defending such claim suit proceeding brought third party alleging that molecule product manufacturing process which manufacturing process abbvie modified substantial part pertinent asserted claim said proceeding infringe nbsp more patent controlled third party such deduction shall applied given calendar quarter from sale based milestone galapagos pursuant section nbsp extent exhausted within month period deducted from royalty galapagos pursuant section nbsp recovery abbvie sanction awarded abbvie against party asserting claim being defended under this section nbsp shall applied follows such recovery shall applied first nbsp reimburse abbvie reasonable pocket cost defending such claim suit proceeding extent deducted from sale based milestone pursuant previous sentence nbsp reimburse galapagos sale based milestone deduction pursuant previous sentence balance such recovery shall retained provided abbvie included calculation sale relevant product except extent such recovery attributable galapagos territory which event shall retained provided galapagos style margin margin bottom text indent font size font family time roman invalidity unenforceability defense action style margin margin bottom text indent font size font family time roman notice each party shall promptly notify other party writing alleged threatened assertion invalidity unenforceability galapagos patent abbvie patent joint patent third party each case territory which such party becomes aware style margin margin bottom text indent font size font family time roman galapagos patent joint patent abbvie shall have first right obligation defend control defense validity enforceability galapagos patent joint patent expense except extent such cost expense allocable galapagos territory which event such cost expense shall reimbursed galapagos accordance with section nbsp territory galapagos participate such claim suit proceeding territory with counsel choice expense provided that abbvie shall retain control defense such claim suit proceeding abbvie elect defend control defense galapagos patent joint patent suit brought territory otherwise fails initiate maintain defense such claim suit proceeding then galapagos conduct control defense such claim suit proceeding expense style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman abbvie patent abbvie shall have first right obligation defend control defense validity enforceability abbvie patent expense except extent such cost expense allocable galapagos territory which event such cost expense shall reimbursed galapagos accordance with section nbsp territory galapagos participate such claim suit proceeding territory related abbvie patent that product patent with counsel choice expense provided that abbvie shall retain control defense such claim suit proceeding abbvie elect defend control defense abbvie patent suit brought territory otherwise fails initiate maintain defense such claim suit proceeding then galapagos conduct control defense such claim suit proceeding expense provided that galapagos shall obtain written consent abbvie prior settling compromising such claim suit proceeding style margin margin bottom text indent font size font family time roman cooperation each party shall assist cooperate with other party such other party reasonably request from time time connection with activity forth this section nbsp including being joined party plaintiff such action proceeding providing access relevant document other evidence making employee available reasonable business hour connection with such defense claim counterclaim controlling party shall consider good faith comment from other party shall keep other party reasonably informed step taken shall provide copy document filed connection with such defense claim counterclaim connection with activity forth this section nbsp each party shall consult with other strategy defense galapagos patent abbvie patent joint patent style margin margin bottom text indent font size font family time roman cost expense abbvie shall entitled offset reasonable attorney court cost defending such claim suit proceeding under this section nbsp that borne abbvie reimbursed galapagos pursuant section nbsp given calendar quarter solely extent reasonably allocable galapagos patent product patent joint patent against sale based milestone galapagos pursuant section nbsp maximum amount percent amount owed with respect each calendar quarter style margin margin bottom text indent font size font family time roman third party license either party reasonably belief that development manufacture commercialization molecule product such party affiliate affiliate sublicensees misappropriates trade secret infringes patent other intellectual property right third party country other jurisdiction territory such that such party affiliate affiliate sublicensees exploit such molecule product such country other jurisdiction without using said trade secret infringing such patent other intellectual property right such third party then party shall discus through their representative working group thereof appointed such purpose whether negotiate obtain license from such third party necessary such party affiliate affiliate sublicensees such country other jurisdiction such working group shall determine whether obtain such license which party shall responsible negotiating such license term such license provided that term such license shall permit party obtaining such license grant other party sublicense thereunder practice under such license within territory required accordance with term hereof style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman product trademark style margin margin bottom text indent font size font family time roman ownership prosecution product trademark abbvie shall right title interest product trademark territory including galapagos territory shall responsible registration prosecution maintenance thereof cost expense registering prosecuting maintaining product trademark shall borne solely abbvie except extent such cost expense allocable galapagos territory which event such cost expense shall reimbursed galapagos accordance with section nbsp galapagos shall provide assistance document reasonably requested abbvie support prosecution registration maintenance product trademark style margin margin bottom text indent font size font family time roman enforcement product trademark abbvie shall have sole right responsibility taking such action abbvie deems necessary against third party based alleged threatened actual infringement dilution misappropriation other violation unfair trade practice other like offense relating product trademark third party territory abbvie shall bear cost expense relating enforcement action commenced pursuant this section nbsp settlement judgment with respect thereto except extent such cost expense allocable galapagos territory which event such cost expense shall reimbursed galapagos accordance with section nbsp abbvie shall retain damage other amount collected connection therewith provided that extent that such damage other amount attributable galapagos territory such damage other amount shall provided galapagos style margin margin bottom text indent font size font family time roman third party claim abbvie shall have sole right responsibility defending against alleged threatened actual claim third party that registration product trademark territory infringes dilutes misappropriates otherwise violates trademark other right that third party constitutes unfair trade practice other like offense other claim brought third party against party connection with product trademark with respect product territory abbvie shall have right settle such claim including entering into trademark related license agreement pursuant section nbsp provided that abbvie shall settle litigation under this section nbsp manner that diminishes material adverse effect right interest galapagos manner that imposes cost except forth immediately following proviso liability such offering license galapagos trademark involves admission galapagos without galapagos express written consent provided further that entering into agreement with such third party pursuant section nbsp shall require consent galapagos abbvie shall bear cost expense relating defense commenced pursuant this section nbsp settlement judgment with respect thereto except extent such cost expense settlement judgment allocable galapagos territory which event such cost expense shall reimbursed galapagos accordance with section nbsp abbvie shall retain damage other amount collected connection therewith provided that extent that such damage other amount attributable galapagos territory such damage other amount shall provided galapagos style margin margin bottom text indent font size font family time roman notice cooperation each party shall provide other party prompt written notice actual threatened infringement product trademark territory actual threatened claim that product trademark territory violates right third party each party agrees cooperate fully with other party with respect enforcement action defense commenced pursuant this section nbsp style margin margin bottom text indent font size font family time roman inventor remuneration each party shall solely responsible remuneration that such party inventor under applicable inventor remuneration style margin margin bottom text indent font size font family time roman galapagos territory cost style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman patent galapagos shall have sole right obligation prepare file prosecute maintain enforce defend patent worldwide galapagos sole cost expense style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center pharmacovigilance safety style margin margin bottom text indent font size font family time roman pharmacovigilance later than earlier nbsp commencement first clinical study party under post development plan nbsp commencement activity galapagos affiliate party shall enter into agreement initiate process each party collect maintain exchange safety data with respect applicable molecule product including post marketing spontaneous report received each party affiliate mutually agreed format order monitor safety product meet reporting requirement with applicable regulatory authority such safety data exchange agreement shall provide galapagos maintain safety database with respect safety data obtained galapagos territory style margin margin bottom text indent font size font family time roman global safety database style margin margin bottom text indent font size font family time roman galapagos initially shall hold maintain accordance with applicable galapagos sole cost expense global safety database each applicable molecule product with respect safety data obtained connection with activity under combination product development plan study plan style margin margin bottom text indent font size font family time roman promptly after nbsp case triple combination product payment first paid event later than after such payment nbsp case potentiator product abbvie election under section nbsp payment event later than after such payment galapagos shall transfer abbvie electronic format complete content safety database maintained galapagos pursuant section nbsp applicable molecule product thereafter abbvie shall maintain accordance with applicable abbvie sole cost expense subject last sentence this subsection global safety database each applicable molecule product abbvie affiliate cost incurred connection with receiving recording reviewing communicating reporting responding adverse event promotion territory shall included allowable expense calculated cost direct pocket basis style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center confidentiality disclosure style margin margin bottom text indent font size font family time roman product information galapagos recognizes that reason inter alia abbvie status exclusive licensee pursuant grant under section nbsp abbvie interest galapagos retention confidence certain information galapagos accordingly during term galapagos shall shall cause affiliate their respective officer director employee agent keep completely confidential publish otherwise disclose directly indirectly purpose other than fulfill galapagos obligation hereunder information controlled galapagos affiliate specifically relating molecule product exploitation foregoing product information except extent nbsp product information public domain through fault galapagos affiliate their respective officer director employee agent nbsp such disclosure expressly permitted under section nbsp nbsp such disclosure otherwise expressly permitted term this agreement purpose section nbsp abbvie shall deemed disclosing party with respect product information under section nbsp galapagos shall deemed receiving party with respect thereto further clarification nbsp without limiting this section nbsp extent product information disclosed galapagos abbvie pursuant style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman this agreement such information shall subject other term condition this article also constitute confidential information galapagos with respect disclosure such information abbvie galapagos shall deemed disclosing party with respect product information under section nbsp abbvie shall deemed receiving party with respect thereto nbsp disclosure galapagos abbvie product information shall cause such information cease subject provision this section nbsp with respect disclosure such confidential information galapagos this agreement terminated entirety with respect terminated territory result such termination galapagos obtains license with respect terminated territory pursuant section this section nbsp shall have continuing force effect with respect disclosure such information solely connection with exploitation molecule product benefit terminated territory product information extent disclosed galapagos abbvie hereunder shall continue confidential information galapagos subject term section purpose surviving provision this agreement style margin margin bottom text indent font size font family time roman confidentiality obligation time during term period year following termination expiration hereof entirety each party shall shall cause affiliate their respective officer director employee agent keep confidential publish otherwise disclose third party directly indirectly purpose confidential information furnished otherwise made known directly indirectly other party except extent such disclosure expressly permitted term this agreement reasonably necessary useful performance exercise such party right under this agreement notwithstanding foregoing extent receiving party demonstrate documentation other competent proof confidentiality obligation under this section nbsp with respect confidential information shall include information that style margin margin bottom text indent font size font family time roman been published third party otherwise hereafter becomes part public domain public publication general knowledge like through wrongful fault negligence part receiving party style margin margin bottom text indent font size font family time roman been receiving party possession prior disclosure disclosing party without obligation confidentiality with respect such information style margin margin bottom text indent font size font family time roman subsequently received receiving party from third party without restriction without breach agreement between such third party disclosing party style margin margin bottom text indent font size font family time roman generally made available third party disclosing party without restriction disclosure style margin margin bottom text indent font size font family time roman been independently developed receiving party without reference disclosure disclosing party confidential information style margin margin bottom text indent font size font family time roman permitted disclosure receiving party disclose disclosing party confidential information extent that such disclosure style margin margin bottom text indent font size font family time roman reasonable opinion receiving party legal counsel required disclosed pursuant regulation valid order court competent jurisdiction other supra national federal national regional state provincial local governmental body competent jurisdiction including reason filing with security regulator subject section nbsp provided that receiving party shall first have given prompt written notice extent possible least business notice disclosing party given disclosing party reasonable opportunity cost expense take whatever action deems necessary protect confidential information example quash such order obtain style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman protective order confidential treatment requiring that confidential information document that subject such order held confidence such court governmental body disclosed used only purpose which order issued protective order other remedy obtained disclosing party waif compliance with term this agreement receiving party shall furnish only that portion confidential information which receiving party advised counsel legally required disclosed style margin margin bottom text indent font size font family time roman made behalf receiving party regulatory authority required connection with filing application request regulatory approval accordance with term this agreement provided that reasonable measure shall taken assure confidential treatment such confidential information extent practicable consistent with applicable style margin margin bottom text indent font size font family time roman made behalf receiving party patent authority reasonably necessary useful purpose obtaining defending enforcing patent accordance with term this agreement provided that reasonable measure shall taken assure confidential treatment such confidential information extent such protection available style margin margin bottom text indent font size font family time roman made affiliate financial legal advisor have need know such disclosing party confidential information either under professional code conduct giving rise expectation confidentiality under written agreement confidentiality each case least restrictive those forth this agreement provided that receiving party shall remain responsible failure such financial legal advisor treat such confidential information required under this article style margin margin bottom text indent font size font family time roman made abbvie affiliate sublicensees their advisor consultant clinician vendor service provider contractor existing prospective collaboration partner licensee sublicensees other third party necessary useful connection with performance discovery activity exploitation molecule product otherwise connection with performance obligation exercise right contemplated this agreement provided that such person shall subject obligation confidentiality with respect such confidential information substantially similar obligation confidentiality receiving party pursuant this article nbsp with duration confidentiality obligation appropriate that than year from date disclosure style margin margin bottom text indent font size font family time roman made galapagos affiliate sublicensees their advisor consultant clinician vendor service provider contractor existing prospective collaboration partner licensee sublicensees other third party necessary useful connection with galapagos activity contemplated this agreement provided that such person shall subject obligation confidentiality with respect such confidential information abbvie substantially similar obligation confidentiality galapagos pursuant this article nbsp with duration confidentiality obligation appropriate that than year from date disclosure style margin margin bottom text indent font size font family time roman made either party third party necessary reasonable connection with exercise right under last sentence section nbsp provided that such third party shall subject obligation confidentiality with respect such confidential information substantially similar obligation confidentiality receiving party pursuant this article nbsp with duration confidentiality obligation appropriate that than year from date disclosure style margin margin bottom text indent font size font family time roman section nbsp shall apply mutatis mutandis galapagos with respect confidential information abbvie solely extent applicable product being developed commercialized galapagos pursuant license forth section applicable style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman name except expressly provided herein neither party shall mention otherwise name logo trademark other party affiliate abbreviation adaptation thereof publication press release marketing promotional material other form publicity without prior written approval such other party each instance restriction imposed this section nbsp shall prohibit either party from making disclosure identifying other party that opinion disclosing party counsel required applicable provided that such party shall submit proposed disclosure well specific applicable which disclosure required identifying other party writing other party advance reasonably practicable event than business prior anticipated date disclosure provide reasonable opportunity comment thereon style margin margin bottom text indent font size font family time roman public announcement neither party shall issue other public announcement press release other public disclosure regarding this agreement subject matter without other party prior written consent except such disclosure that opinion disclosing party counsel required applicable rule stock exchange which security disclosing party listed party opinion counsel required applicable rule stock exchange which security listed make such public disclosure such party shall submit proposed disclosure well specific applicable rule stock exchange which disclosure required writing other party advance reasonably practicable event than business prior anticipated date disclosure provide reasonable opportunity comment thereon party desiring make such public disclosure shall consider good faith comment provided other party with respect such disclosure notwithstanding foregoing abbvie sublicensees their respective affiliate shall have right publicly announce make press release make other public disclosure research development commercial information including with respect regulatory matter regarding product provided that nbsp such disclosure subject provision section through with respect galapagos confidential information nbsp abbvie shall name galapagos insignia contraction abbreviation adaptation thereof without galapagos prior written consent style margin margin bottom text indent font size font family time roman publication style margin margin bottom text indent font size font family time roman galapagos shall publish present otherwise disclose shall cause affiliate third party provider their employee agent disclose material specifically related exploitation molecule product without prior written consent abbvie style margin margin bottom text indent font size font family time roman abbvie affiliate their respective sublicensees shall have right publish present otherwise disclose material related exploitation molecule product provided that nbsp such disclosure subject provision section through with respect galapagos confidential information nbsp abbvie shall name galapagos insignia contraction abbreviation adaptation thereof without galapagos prior written consent style margin margin bottom text indent font size font family time roman return confidential information upon effective date termination this agreement reason either party request writing other party shall either with respect confidential information event termination this agreement with respect nbsp more terminated territory entirety solely extent relating specifically exclusively such terminated territory which such first party retain right under surviving provision this agreement nbsp soon reasonably practicable destroy copy such confidential information possession other party confirm such destruction style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman writing requesting party nbsp soon reasonably practicable deliver requesting party other party expense copy such confidential information possession other party provided that other party shall permitted retain nbsp copy such confidential information sole purpose performing continuing obligation hereunder required applicable archival purpose notwithstanding foregoing such other party also shall permitted retain such additional copy computer record file containing such confidential information that have been created solely such party automatic archiving back procedure extent created retained manner consistent with such other party standard archiving back procedure other purpose style margin margin bottom text indent font size font family time roman survival confidential information shall continue subject term this agreement period forth section nbsp style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center representation warranty style margin margin bottom text indent font size font family time roman mutual representation warranty galapagos abbvie represent warrant covenant each other restatement date follows style margin margin bottom text indent font size font family time roman organization corporation duly organized validly existing good standing under jurisdiction organization requisite power authority corporate otherwise execute deliver perform this agreement style margin margin bottom text indent font size font family time roman authorization execution delivery this agreement performance transaction contemplated hereby have been duly authorized necessary corporate action violate nbsp such party charter document bylaw other organizational document nbsp material respect agreement instrument contractual obligation which such party bound nbsp requirement applicable nbsp order writ judgment injunction decree determination award court governmental agency presently effect applicable such party style margin margin bottom text indent font size font family time roman binding agreement this agreement legal valid binding obligation such party enforceable against accordance with term condition subject effect bankruptcy insolvency other general application affecting enforcement creditor right judicial principle affecting availability specific performance general principle equity whether enforceability considered proceeding equity style margin margin bottom text indent font size font family time roman inconsistent obligation restatement date under obligation contractual otherwise person that conflict with inconsistent material respect with term this agreement that would impede diligent complete fulfillment obligation hereunder style margin margin bottom text indent font size font family time roman performance during term shall have available necessary sufficient mean ensure performance proper execution obligation under this agreement style margin margin bottom text indent font size font family time roman additional representation warranty galapagos galapagos further represents warrant covenant abbvie follows style margin margin bottom text indent font size font family time roman galapagos patent existing effective date including existing potentiator patent listed schedule existing patent existing patent subsisting invalid unenforceable whole part being diligently prosecuted respective patent office territory accordance with applicable have been filed maintained properly correctly applicable have been paid before date payment existing patent represent patent within galapagos affiliate control including claim covering making using composition matter molecule product exploitation thereof effective date style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman effective date best galapagos knowledge there claim judgment settlement against amount with respect thereto owed galapagos affiliate relating existing patent galapagos know effective date claim litigation been brought threatened person alleging galapagos knowledge claim whether asserted that nbsp existing patent galapagos know invalid unenforceable nbsp existing patent galapagos know disclosing copying making assigning licensing existing patent galapagos know development manufacture commercialization other exploitation molecule product contemplated herein will violate infringe misappropriate otherwise conflict interfere with patent other intellectual property proprietary right third party effective date galapagos knowledge person infringing threatening infringe misappropriating threatening misappropriate existing patent galapagos know style margin margin bottom text indent font size font family time roman galapagos sole exclusive owner entire right title interest existing patent listed schedule owned patent galapagos know free encumbrance lien claim ownership third party galapagos entitled grant license specified herein style margin margin bottom text indent font size font family time roman during term neither galapagos affiliate shall encumber diminish right granted abbvie hereunder with respect galapagos patent galapagos know joint patent joint know including nbsp committing permitting occurrence omission that would cause breach termination third party license agreement nbsp amending otherwise modifying permitting amended modified third party license agreement galapagos shall promptly provide abbvie with notice alleged threatened actual breach third party license agreement agreement with third party pursuant which galapagos affiliate license galapagos patent galapagos know effective date listed schedule none galapagos affiliate third party breach existing third party license agreement each existing third party license agreement full force effect style margin margin bottom text indent font size font family time roman best galapagos knowledge galapagos provided made available abbvie prior effective date true complete correct copy file wrapper other document material relating prosecution defense maintenance validity enforceability owned patent extent requested abbvie style margin margin bottom text indent font size font family time roman best galapagos knowledge galapagos affiliate have presented will present prior pertinent patent office deadline relevant reference document information which inventor aware relevant patent examiner pertinent patent office connection with prosecution pending patent application included existing patent style margin margin bottom text indent font size font family time roman best galapagos knowledge each existing patent properly identifies each every inventor claim thereof determined accordance with jurisdiction which such existing patent issued such application pending style margin margin bottom text indent font size font family time roman each person best galapagos knowledge right owned patent galapagos know assigned executed agreement assigning entire right title interest such owned patent galapagos know galapagos best galapagos knowledge current officer employee agent consultant galapagos affiliate violation term assignment other agreement regarding protection patent other intellectual property proprietary style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman information galapagos such affiliate employment contract relating relationship such person with galapagos best galapagos knowledge each person right know sublicensed hereunder assigned executed agreement assigning entire right title interest such patent know licensor third party license agreement style margin margin bottom text indent font size font family time roman best galapagos knowledge work authorship other material subject copyright protection included galapagos know original were either created employee galapagos affiliate within scope their employment otherwise work made hire right title interest such material have been legally fully assigned transferred galapagos such affiliate right invention discovery made developed conceived employee independent contractor galapagos affiliate during course their employment other retention galapagos such affiliate relating included galapagos know that subject nbsp more existing patent have been will assigned writing galapagos such affiliate style margin margin bottom text indent font size font family time roman galapagos obtained right including under patent other intellectual property right information other material including formulation manufacturing process procedure developed delivered third party under agreement between galapagos such third party with respect molecule galapagos right under each such agreement transfer such information other material abbvie designees grant abbvie right such know other material development commercialization molecule product without restriction style margin margin bottom text indent font size font family time roman galapagos know been kept confidential been disclosed third party only under term confidentiality best galapagos knowledge affiliate breach such confidentiality been committed third party style margin margin bottom text indent font size font family time roman effective date neither galapagos affiliate made submission regulatory authority territory with respect molecule style margin margin bottom text indent font size font family time roman best galapagos knowledge galapagos affiliate have conducted their respective contractor consultant have conducted development molecule that they have conducted prior effective date accordance with applicable best galapagos knowledge galapagos affiliate have employed with respect such test study that galapagos will perform will employ person with appropriate education knowledge experience conduct oversee conduct clinical clinical study with respect molecule product style margin margin bottom text indent font size font family time roman there amount that will required paid third party result development manufacture commercialization molecule product that arise agreement which galapagos affiliate party effective date style margin margin bottom text indent font size font family time roman effective date neither galapagos affiliate knowledge scientific technical fact circumstance that have been disclosed abbvie that would adversely affect scientific therapeutic commercial potential molecule product effective date neither galapagos affiliate knowledge anything that been disclosed abbvie that could adversely affect acceptance subsequent approval regulatory authority filing application request regulatory approval style margin margin bottom text indent font size font family time roman effective date neither galapagos employee agent performing hereunder have ever been currently subject proceeding that could lead such employee agent becoming applicable debarred entity debarred individual excluded entity excluded individual convicted entity convicted individual listed disqualified restricted list style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman during term galapagos employee agent performing hereunder become subject proceeding that could lead person becoming applicable debarred entity debarred individual excluded entity excluded individual convicted entity convicted individual added disqualified restricted list galapagos shall immediately notify abbvie abbvie shall have option sole discretion either nbsp prohibit such person from performing work under this agreement nbsp terminate work being performed performed galapagos pursuant this agreement this provision shall survive termination expiration this agreement purpose this agreement following definition shall apply style margin margin bottom text indent font size font family time roman debarred individual individual been debarred pursuant nbsp nbsp from providing service capacity person that approved pending drug biological product application style margin margin bottom text indent font size font family time roman debarred entity corporation partnership association that been debarred pursuant nbsp nbsp from submitting assisting submission abbreviated drug application subsidiary affiliate debarred entity style margin margin bottom text indent font size font family time roman excluded individual excluded entity nbsp individual entity applicable been excluded debarred suspended otherwise ineligible participate federal health care program such medicare medicaid office inspector general department health human service nbsp individual entity applicable been excluded debarred suspended otherwise ineligible participate federal procurement procurement program including those produced general service administration style margin margin bottom text indent font size font family time roman convicted individual convicted entity individual entity applicable been convicted criminal offense that fall within ambit been excluded debarred suspended otherwise declared ineligible style margin margin bottom text indent font size font family time roman disqualified restricted list list clinical investigator restricted from receiving investigational drug biologics device determined that investigator have repeatedly deliberately failed comply with regulatory requirement study have submitted false information study sponsor style margin margin bottom text indent font size font family time roman galapagos obtained from affiliate sublicensees employee agent from employee agent affiliate sublicensees agent otherwise participating exploitation molecule product otherwise have access abbvie information other confidential information abbvie effective date shall obtain from such person during term license other right necessary galapagos grant abbvie right license provided herein abbvie perform obligation hereunder without payment beyond those required article nbsp style margin margin bottom text indent font size font family time roman invention claimed existing patent nbsp were conceived made connection with research activity funded whole part federal government united state agency thereof nbsp subject invention that term described nbsp otherwise subject provision bayh dole style margin margin bottom text indent font size font family time roman with respect supply molecule product placebo manufactured supplied behalf galapagos clinical study under this agreement such molecule product placebo nbsp shall conformity with applicable style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman specification such molecule product placebo nbsp shall manufactured conformance with other applicable this agreement applicable quality agreement nbsp shall have been manufactured facility that compliance with applicable time such manufacture including applicable inspection requirement other regulatory authority nbsp shall adulterated misbranded under ffdca similar provision other country which regulatory approval have been granted nbsp introduced into interstate commerce pursuant ffdca similar provision other country which regulatory approval have been granted style margin margin bottom text indent font size font family time roman best galapagos knowledge representation warranty galapagos this agreement information material furnished abbvie connection with period diligence prior effective date taken whole nbsp contain untrue statement material fact nbsp omit state material fact necessary make statement fact contained therein light circumstance under which they were made misleading style margin margin bottom text indent font size font family time roman additional representation warranty abbvie abbvie further represents warrant covenant galapagos follows style margin margin bottom text indent font size font family time roman effective date neither abbvie employee agent performing hereunder have ever been currently subject proceeding that could lead such employee agent becoming applicable debarred entity debarred individual excluded entity excluded individual convicted entity convicted individual listed disqualified restricted list style margin margin bottom text indent font size font family time roman during term abbvie employee agent performing hereunder become subject proceeding that could lead person becoming applicable debarred entity debarred individual excluded entity excluded individual convicted entity convicted individual added disqualified restricted list abbvie shall immediately notify galapagos galapagos shall have option sole discretion prohibit such person from performing work under this agreement this provision shall survive termination expiration this agreement style margin margin bottom text indent font size font family time roman abbvie obtained from affiliate sublicensees employee agent from employee agent affiliate sublicensees agent otherwise participating exploitation molecule product otherwise have access galapagos information other confidential information galapagos effective date shall obtain from such person during term license other right necessary abbvie grant galapagos right license provided herein galapagos perform obligation hereunder without payment beyond those required article style margin margin bottom text indent font size font family time roman with respect supply molecule product placebo manufactured supplied behalf abbvie connection with clinical study commercial distribution under this agreement such molecule product placebo nbsp shall conformity with applicable specification such molecule product placebo nbsp shall manufactured conformance with other applicable this agreement applicable quality agreement nbsp shall have been manufactured facility that compliance with applicable time such manufacture including applicable inspection requirement other regulatory authority nbsp shall adulterated misbranded under ffdca similar provision other country which regulatory approval have been granted nbsp introduced into interstate commerce pursuant ffdca similar provision other country which regulatory approval have been granted style margin margin bottom text indent font size font family time roman disclaimer warranty except express warranty forth herein neither party make representation grant warranty express implied either fact style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman operation statute otherwise each party specifically disclaims other warranty whether written oral express implied including warranty quality merchantability fitness particular purpose warranty validity patent infringement intellectual property right third party style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center indemnity style margin margin bottom text indent font size font family time roman indemnification galapagos abbvie shall indemnify galapagos affiliate their respective director officer employee agent galapagos indemnitees shall defend save each them harmless from against loss damage liability penalty cost expense including reasonable attorney expense collectively loss connection with suit investigation claim demand third party collectively third party claim incurred rendered against galapagos indemnitees arising from occurring result style margin margin bottom text indent font size font family time roman subject section nbsp breach abbvie this agreement style margin margin bottom text indent font size font family time roman negligence reckless conduct willful misconduct part abbvie affiliate their respective director officer employee agent sublicensees performing their obligation under this agreement style margin margin bottom text indent font size font family time roman commercialization product molecule anywhere abbvie territory during term style margin margin bottom text indent font size font family time roman development commercialization manufacture other exploitation molecule product country abbvie affiliate licensee from after termination this agreement with respect such country style margin margin bottom text indent font size font family time roman abbvie corporate name logo connection with commercialization molecule product territory permitted under this agreement style margin margin bottom font size font family time roman except case clause nbsp through those loss which galapagos whole part obligation indemnify abbvie indemnitee pursuant section nbsp hereof which loss each party shall indemnify other extent their respective liability such loss style margin margin bottom text indent font size font family time roman indemnification abbvie galapagos shall indemnify abbvie affiliate their respective director officer employee agent abbvie indemnitees defend save each them harmless from against loss connection with third party claim incurred rendered against abbvie indemnitees arising from occurring result style margin margin bottom text indent font size font family time roman subject section nbsp breach galapagos this agreement style margin margin bottom text indent font size font family time roman negligence reckless conduct willful misconduct part galapagos affiliate their respective director officer employee agent sublicensees performing their obligation under this agreement style margin margin bottom text indent font size font family time roman galapagos corporate name connection with commercialization molecule product territory permitted under this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman commercialization product molecule anywhere galapagos territory during term style margin margin bottom text indent font size font family time roman development commercialization manufacture other exploitation nbsp existing potentiator molecule prior effective date nbsp molecule product country galapagos affiliate licensee from after termination this agreement with respect such country style margin margin bottom text indent font size font family time roman study conduct thereof behalf galapagos style margin margin bottom text indent font size font family time roman galapagos product development commercialization manufacture other exploitation thereof style margin margin bottom font size font family time roman except case clause nbsp through nbsp above those loss which abbvie whole part obligation indemnify galapagos indemnitee pursuant section nbsp hereof which loss each party shall indemnify other extent their respective liability loss style margin margin bottom text indent font size font family time roman certain loss style margin margin bottom text indent font size font family time roman shared loss loss other than those loss covered article which indemnification provided section connection with third party claim brought against either party affiliate resulting directly indirectly from nbsp performance discovery activity development molecule product anywhere world behalf either party nbsp commercialization promotion product manufacture promotion product commercialization activity shall shared equally party with respect loss described clause party that initially incurs such loss shall promptly notify other party incurrence such loss such other party shall reimburse paying party amount equal percent such loss later than after paying party provides such other party reasonable documentation such incurred loss loss described clause nbsp shall included allowable expense either party learns third party claim with respect loss covered this section nbsp such party shall provide other party with prompt written notice thereof party shall confer with respect respond such third party claim handle such third party claim efficient manner absence such agreement abbvie shall have right take such action deems appropriate style margin margin bottom text indent font size font family time roman threshold breach indemnification claim provision indemnity defense with respect third party claim under section shall effective only nbsp when amount damage sought such third party amount loss incurred indemnified party exceeds dollar nbsp case third party claim where amount damage sought amount loss incurred indemnified party specified when amount damage sought amount loss incurred indemnified party reasonably likely exceed dollar based nature such third party claim style margin margin bottom text indent font size font family time roman notice claim indemnification claim respect party affiliate their respective director officer employee agent shall made solely such party this agreement indemnified party indemnified party shall give indemnifying party prompt written notice indemnification claim notice loss discovery fact upon which such indemnified party intends base request indemnification under this article event shall indemnifying party liable loss that result from delay providing such notice each indemnification claim notice must contain description claim nature amount such loss extent that nature amount such loss known such time indemnified party shall furnish promptly indemnifying party copy paper official document received respect loss third party claim style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman control defense style margin margin bottom text indent font size font family time roman general subject provision section option indemnifying party assume defense third party claim giving written notice indemnified party within after indemnifying party receipt indemnification claim notice assumption defense third party claim indemnifying party shall construed acknowledgment that indemnifying party liable indemnify indemnified party respect third party claim shall constitute waiver indemnifying party defense assert against indemnified party claim indemnification upon assuming defense third party claim indemnifying party appoint lead counsel defense third party claim legal counsel selected indemnifying party which shall reasonably acceptable indemnified party indemnifying party assumes defense third party claim indemnified party shall immediately deliver indemnifying party original notice document including court paper received indemnified party connection with third party claim should indemnifying party assume defense third party claim except provided section nbsp indemnifying party shall liable indemnified party legal expense subsequently incurred such indemnified party connection with analysis defense settlement third party claim unless specifically requested writing indemnifying party ultimately determined that indemnifying party obligated indemnify defend hold harmless indemnified party from against third party claim indemnified party shall reimburse indemnifying party cost expense loss incurred indemnifying party defense third party claim style margin margin bottom text indent font size font family time roman right participate defense without limiting section nbsp indemnified party shall entitled participate control defense such third party claim employ counsel choice such purpose provided that such employment shall indemnified party expense unless nbsp employment thereof assumption indemnifying party such expense been specifically authorized indemnifying party writing nbsp indemnifying party failed assume defense employ counsel accordance with section nbsp which case indemnified party shall control defense nbsp interest indemnified party indemnifying party with respect such third party claim sufficiently adverse prohibit representation same counsel both party under applicable ethical rule equitable principle style margin margin bottom text indent font size font family time roman settlement style margin margin bottom text indent font size font family time roman with respect loss relating solely payment money damage connection with third party claim resulting indemnified party becoming subject injunctive other relief which indemnifying party shall have acknowledged writing obligation indemnify indemnified party hereunder indemnifying party shall have sole right consent entry judgment enter into settlement otherwise dispose such loss such term indemnifying party sole discretion shall deem appropriate style margin margin bottom text indent font size font family time roman with respect other loss connection with third party claim where indemnifying party assumed defense third party claim accordance with section nbsp indemnifying party shall have authority consent entry judgment enter into settlement otherwise dispose such loss provided that obtains prior written consent indemnified party indemnifying party assume conduct defense third party claim provided above indemnified party defend against such third party claim regardless whether indemnifying party chooses defend style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman prosecute third party claim indemnified party shall admit liability with respect settle compromise dispose third party claim without prior written consent indemnifying party indemnifying party shall liable settlement compromise other disposition loss indemnified party that reached without written consent indemnifying party style margin margin bottom text indent font size font family time roman cooperation regardless whether indemnifying party chooses defend prosecute third party claim indemnified party shall shall cause each indemnified party cooperate defense prosecution thereof shall furnish such record information testimony provide such witness attend such conference discovery proceeding hearing trial appeal reasonably requested connection therewith such cooperation shall include access during normal business hour afforded indemnifying party reasonable retention indemnified party record information that reasonably relevant such third party claim making indemnified party other employee agent available mutually convenient basis provide additional information explanation material provided hereunder indemnifying party shall reimburse indemnified party reasonable pocket expense connection therewith style margin margin bottom text indent font size font family time roman expense except provided above reasonable verifiable cost expense including disbursement counsel incurred indemnified party connection with third party claim shall reimbursed calendar quarter basis arrears indemnifying party without prejudice indemnifying party right contest indemnified party right indemnification subject refund indemnifying party ultimately held obligated indemnify indemnified party style margin margin bottom text indent font size font family time roman special indirect other loss except willful misconduct breach section party breach article party neither party affiliate shall liable indirect incidental special exemplary punitive consequential damage including loss profit business interruption however caused theory liability whether contract tort negligence breach statutory duty otherwise connection with arising term this agreement transaction contemplated hereby molecule product even advised possibility such damage notwithstanding foregoing nothing this agreement shall limit payment either party indemnified party third party claim which party provides indemnification under this article style margin margin bottom text indent font size font family time roman insurance each party shall obtain carry full force effect minimum insurance requirement forth herein such insurance nbsp shall primary insurance with respect each party participation under this agreement nbsp shall issued recognized insurer rated best equivalent better insurer approved writing other party nbsp shall list other party additional named insured thereunder nbsp shall require written notice given other party prior cancellation renewal material change thereof style margin margin bottom text indent font size font family time roman type minimum limit type insurance minimum limit shall style margin margin bottom text indent font size font family time roman worker compensation with statutory limit compliance with worker compensation country jurisdiction state state which party employee excluding puerto rico style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman employer liability coverage with minimum limit dollar occurrence provided that party employee united state excluding puerto rico style margin margin bottom text indent font size font family time roman general liability insurance with minimum limit dollar annual aggregate during development molecule product general liability insurance shall include minimum professional liability clinical trial insurance beginning least prior first commercial sale product product liability insurance party shall mutually agree liability insurance limit product liability insurance style margin margin bottom text indent font size font family time roman certificate insurance upon request party other party shall provide certificate insurance evidencing compliance with this section insurance policy shall under occurrence form only claim made form available party then such party shall continue maintain such insurance after expiration termination this agreement longer nbsp period year following termination expiration this agreement entirety nbsp with respect particular party last sale product expiration termination would considered product sold under this agreement party style margin margin bottom text indent font size font family time roman self insurance notwithstanding foregoing either party self insure whole part insurance requirement described above provided that such party continues investment grade determined reputable accepted financial rating agency style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center term termination style margin margin bottom text indent font size font family time roman term style margin margin bottom text indent font size font family time roman term this agreement shall commence effective date unless earlier terminated entirety accordance herewith shall continue force effect until expiration longest royalty term applicable product such period term style margin margin bottom text indent font size font family time roman effect expiration term following expiration term pursuant section nbsp grant section shall become exclusive fully paid royalty free irrevocable with right sublicense forth this agreement grant section shall terminate style margin margin bottom text indent font size font family time roman termination material breach style margin margin bottom text indent font size font family time roman material breach either party breaching party belief that other party breaching party breach nbsp more material obligation under this agreement subject section nbsp then breaching party deliver notice such breach breaching party default notice breaching party dispute that breach nbsp more material obligation under this agreement then breaching party fails cure such breach fails take step would considered reasonable effectively cure such breach within after receipt default notice such compliance fully achieved within such period breaching party failed commence compliance failed diligent effort achieve full compliance soon thereafter reasonably possible breaching party terminate this agreement upon written notice breaching party breaching party dispute that breach nbsp material obligation under this agreement dispute shall resolved pursuant section nbsp result application such dispute resolution procedure breaching party determined breach nbsp more material obligation under this agreement adverse ruling then breaching party fails complete action specified adverse ruling cure such breach within after such ruling such compliance fully achieved within such period breaching party failed commence style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman compliance failed diligent effort achieve full compliance soon thereafter reasonably possible then breaching party terminate this agreement upon written notice breaching party style margin margin bottom text indent font size font family time roman material breach related diligence single country style margin margin bottom text indent font size font family time roman notwithstanding section nbsp breach failure cure contemplated section nbsp with respect abbvie commercialization diligence obligation under section nbsp abbvie development diligence obligation under section applicable with respect only nbsp united state france italy spain united kingdom germany galapagos shall have right terminate this agreement entirety shall have right terminate this agreement solely with respect country which breach failure cure applies style margin margin bottom text indent font size font family time roman notwithstanding section nbsp breach failure cure contemplated section nbsp with respect galapagos commercialization diligence obligation under section nbsp galapagos development diligence obligation under section applicable with respect only nbsp country galapagos territory abbvie shall have right terminate this agreement entirety shall have right terminate this agreement solely with respect country which breach failure cure applies style margin margin bottom text indent font size font family time roman violation sale representative purpose section nbsp failure sale representative party affiliate comply with this agreement including section nbsp shall constitute breach such party material obligation under this agreement such party promptly notifies other party such failure take appropriate remedial disciplinary action result such investigation style margin margin bottom text indent font size font family time roman additional termination right style margin margin bottom text indent font size font family time roman regulatory reason style margin margin bottom text indent font size font family time roman abbvie terminate this agreement country country other jurisdiction jurisdiction basis within abbvie territory effective immediately upon written notice galapagos with respect molecule clinical study result action taken regulatory authority after effective date unlikely that abbvie will able commercially reasonable basis obtain regulatory approval product containing such molecule such country jurisdiction once granted unlikely that abbvie would able maintain such regulatory approval such country jurisdiction style margin margin bottom text indent font size font family time roman galapagos terminate this agreement country country basis within galapagos territory effective immediately upon written notice abbvie with respect molecule clinical study result action taken regulatory authority after effective date unlikely that galapagos will able commercially reasonable basis obtain regulatory approval product containing such molecule such country once granted unlikely that galapagos would able maintain such regulatory approval such country style margin margin bottom text indent font size font family time roman convenience from after date which party their affiliate have incurred aggregate development cost performing discovery activity amount equal last agreed discovery prior first commercial sale product abbvie affiliate sublicensees abbvie terminate this agreement entirety country country other jurisdiction jurisdiction basis reason upon prior written notice galapagos style margin margin bottom text indent font size font family time roman termination bankruptcy insolvency similar event either party nbsp becomes subject whether voluntarily involuntarily bankruptcy insolvency receivership style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman similar proceeding provided that involuntary proceeding subject dismissal appeal within judicial time period such action nbsp make assignment benefit creditor nbsp appoints suffers appointment receiver trustee over substantially property nbsp proposes written agreement composition arrangement readjustment extension debt nbsp proposes party dissolution liquidation otherwise cease business wind affair nbsp admits writing inability meet obligation they fall general course nbsp becomes subject warrant attachment execution distraint similar process against substantially property then other party terminate this agreement whole part sole discretion effective immediately upon written notice such other party specified section nbsp this agreement basis such termination shall breach lack performance material obligation this agreement subject party retaining right accordance with section nbsp below style margin margin bottom text indent font size font family time roman right bankruptcy style margin margin bottom text indent font size font family time roman applicability right license collectively intellectual property granted under pursuant this agreement including right license improvement developed during term this agreement intended shall otherwise deemed purpose section nbsp united state bankruptcy code bankruptcy code analogous provision other country jurisdiction license right intellectual property defined under section nbsp bankruptcy code party agree that licensee such intellectual property under this agreement shall retain fully exercise right election under bankruptcy code including section nbsp bankruptcy code analogous provision other country jurisdiction right granted either party under this agreement shall deemed exist immediately before occurrence bankruptcy case which other party debtor style margin margin bottom text indent font size font family time roman right debtor party bankruptcy bankruptcy proceeding commenced against either party under bankruptcy code analogous provision other country jurisdiction debtor party shall entitled complete duplicate complete access appropriate intellectual property embodiment such intellectual property which already debtor party possession shall delivered debtor party within business such request provided that debtor party excused from obligation deliver intellectual property extent debtor party continues perform obligation under this agreement agreement been rejected pursuant bankruptcy code analogous provision other country jurisdiction style margin margin bottom text indent font size font family time roman termination entirety style margin margin bottom text indent font size font family time roman event termination this agreement entirety abbvie pursuant section nbsp galapagos pursuant section nbsp style margin margin bottom text indent font size font family time roman right license granted galapagos hereunder shall immediately terminate style margin margin bottom text indent font size font family time roman right license granted abbvie hereunder shall immediately terminate style margin margin bottom text indent font size font family time roman abbvie shall hereby effective effective date termination grant galapagos exclusive irrevocable option acquire exclusive exclusive license with right grant multiple tier sublicenses under abbvie grantback patent abbvie grantback know product trademark exploit territory molecule product that subject development commercialization territory such molecule product exists effective date termination grantback option style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman provided that nbsp galapagos shall responsible nbsp making payment including royalty milestone other amount payable abbvie third party under third party agreement with respect abbvie grantback patent abbvie grantback know that subject license granted abbvie galapagos pursuant this section extent that payment relate molecule product making such payment directly abbvie each instance galapagos shall make requisite payment abbvie provide necessary reporting information abbvie sufficient time enable abbvie comply with obligation under such third party agreement nbsp complying with other obligation included such third party agreement that applicable grant galapagos such license exercise such license galapagos affiliate sublicensees nbsp abbvie shall responsible paying providing such third party payment report made provided galapagos galapagos exercise grantback option providing written notice abbvie within from termination effective date galapagos exercise grantback option party shall negotiate good faith transition agreement forth section nbsp except forth section nbsp case termination abbvie pursuant section nbsp which event galapagos shall obligated consideration abbvie such transition agreement will include commercially reasonable financial consideration despite good faith discussion period least party unable agree term transition agreement under this section nbsp then either party shall have option invoke arbitration proceeding pursuant section nbsp style margin margin bottom text indent font size font family time roman event termination this agreement entirety abbvie pursuant section style margin margin bottom text indent font size font family time roman right license granted abbvie hereunder shall immediately terminate style margin margin bottom text indent font size font family time roman right license granted abbvie hereunder shall become exclusive exclusive abbvie sole option irrevocable unrestricted perpetual right license except forth section nbsp party shall mutually agree good faith writing consideration galapagos shall receive aforementioned license despite good faith discussion party unable agree consideration then dispute shall resolved pursuant section nbsp style margin margin bottom text indent font size font family time roman galapagos shall where permitted applicable transfer abbvie right title interest regulatory documentation then controlled galapagos affiliate sublicensees their name style margin margin bottom text indent font size font family time roman galapagos shall notify applicable regulatory authority take other action reasonably necessary effect transfer forth clause nbsp above style margin margin bottom text indent font size font family time roman galapagos shall requested abbvie unless expressly prohibited regulatory authority transfer control abbvie clinical study being conducted galapagos affiliate sublicensees effective date termination continue conduct such clinical study abbvie cost month enable such transfer completed without interruption such clinical study provided that nbsp abbvie shall have obligation continue clinical study unless required applicable nbsp with respect each clinical study which such transfer expressly prohibited applicable regulatory authority galapagos shall continue conduct such clinical study completion abbvie cost style margin margin bottom text indent font size font family time roman galapagos shall assign cause affiliate sublicensees assign abbvie agreement with third party with respect conduct clinical development activity clinical study manufacturing activity product including agreement with contract research organization clinical site investigator unless with respect style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman such agreement nbsp abbvie decline such assignment nbsp such agreement nbsp expressly prohibits such assignment which case galapagos shall cooperate with abbvie reasonable respect secure consent applicable third party such assignment nbsp cover product covered patent controlled galapagos affiliate addition product which case galapagos shall abbvie sole cost expense cooperate with abbvie reasonable respect facilitate execution agreement between abbvie applicable third party style margin margin bottom text indent font size font family time roman termination more country event termination this agreement with respect country other jurisdiction abbvie pursuant section nbsp galapagos pursuant section nbsp case termination this agreement entirety style margin margin bottom text indent font size font family time roman right license granted galapagos hereunder nbsp shall automatically deemed amended exclude applicable right commercialize file drug approval application seek regulatory approval product terminated territory right manufacture product solely sale terminated territory nbsp shall otherwise survive continue effect with respect remaining country jurisdiction territory style margin margin bottom text indent font size font family time roman abbvie shall hereby effective effective date termination grant galapagos exclusive irrevocable option acquire exclusive exclusive royalty bearing license with right grant multiple tier sublicenses under abbvie grantback patent abbvie grantback know product trademark exploit terminated territory molecule product that been subject development commercialization terminated territory such molecule product exists effective date termination grantback option terminated territory provided that nbsp galapagos shall responsible nbsp making payment including royalty milestone other amount payable abbvie third party under third party agreement with respect abbvie grantback patent abbvie grantback know that subject license granted abbvie galapagos pursuant this section nbsp extent that payment relate molecule product making such payment directly abbvie each instance galapagos shall make requisite payment abbvie provide necessary reporting information abbvie sufficient time enable abbvie comply with obligation under such third party agreement nbsp complying with other obligation included such third party agreement that applicable grant galapagos such license exercise such license galapagos affiliate sublicensees nbsp abbvie shall responsible paying providing such third party payment report made provided galapagos under this section nbsp galapagos exercise grantback option terminated territory party shall negotiate good faith transition agreement forth section nbsp except case termination abbvie pursuant section nbsp which event galapagos shall obligated consideration abbvie such transition agreement will include commercially reasonable financial consideration despite good faith discussion period least party unable agree term transition agreement under this section nbsp then either party shall have option invoke arbitration proceeding pursuant section nbsp style margin margin bottom text indent font size font family time roman transition agreement event termination this agreement entirety abbvie pursuant section nbsp galapagos pursuant section nbsp with respect nbsp more country other jurisdiction abbvie pursuant section nbsp galapagos pursuant section nbsp galapagos abbvie shall negotiate good faith term condition written transition agreement transition agreement pursuant which abbvie galapagos will effectuate coordinate smooth efficient transition relevant obligation right galapagos reasonably necessary galapagos exercise license granted pursuant section after termination this agreement entirety with style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman respect nbsp more country other jurisdiction applicable extent forth this article clarity abbvie shall required manufacture have manufactured molecule product behalf galapagos part transition agreement style margin margin bottom text indent font size font family time roman transition agreement shall provide that event termination this agreement entirety abbvie pursuant section nbsp galapagos entirety pursuant section nbsp abbvie shall style margin margin bottom text indent font size font family time roman where permitted applicable transfer galapagos right title interest regulatory documentation then controlled abbvie affiliate sublicensees their name applicable product territory that subject exclusive license grant section nbsp style margin margin bottom text indent font size font family time roman notify applicable regulatory authority take other action reasonably necessary effect transfer forth clause nbsp above style margin margin bottom text indent font size font family time roman requested galapagos unless expressly prohibited regulatory authority transfer control galapagos clinical study being conducted abbvie affiliate sublicensees effective date termination continue conduct such clinical study galapagos cost month enable such transfer completed without interruption such clinical study provided that nbsp galapagos shall have obligation continue clinical study unless required applicable nbsp with respect each clinical study which such transfer expressly prohibited applicable regulatory authority abbvie shall continue conduct such clinical study completion galapagos cost style margin margin bottom text indent font size font family time roman assign cause affiliate sublicensees assign galapagos agreement with third party with respect conduct clinical development activity clinical study manufacturing activity product including agreement with contract research organization clinical site investigator unless with respect such agreement nbsp galapagos decline such assignment nbsp such agreement nbsp expressly prohibits such assignment which case abbvie shall cooperate with galapagos reasonable respect secure consent applicable third party such assignment nbsp cover product covered patent controlled abbvie affiliate addition product which case abbvie shall galapagos sole cost expense cooperate with galapagos reasonable respect facilitate execution agreement between galapagos applicable third party style margin margin bottom text indent font size font family time roman transition agreement shall provide that event termination this agreement with respect country other jurisdiction abbvie pursuant section nbsp galapagos pursuant section nbsp case termination this agreement entirety abbvie shall style margin margin bottom text indent font size font family time roman where permitted applicable transfer galapagos right title interest regulatory approval owned name abbvie affiliate sublicensees which regulatory approval solely applicable relevant country jurisdiction product that subject exclusive license grant section nbsp such regulatory approval exists effective date such termination this agreement with respect such relevant country jurisdiction provided that abbvie retains license right reference under regulatory approval transferred pursuant this clause necessary reasonably useful abbvie commercialize product territory develop molecule product support such commercialization manufacture molecule product support such development commercialization style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman notify applicable regulatory authority take other action reasonably necessary effect transfer forth clause nbsp above style margin margin bottom text indent font size font family time roman grant galapagos right reference regulatory documentation then owned name abbvie affiliate sublicensees which regulatory documentation transferred galapagos pursuant clause nbsp above necessary reasonably useful galapagos affiliate sublicensees develop commercialize terminated country jurisdiction product that subject license grant section nbsp such regulatory documentation exists effective date such termination this agreement with respect such terminated country jurisdiction style margin margin bottom text indent font size font family time roman requested galapagos unless expressly prohibited regulatory authority transfer control galapagos clinical study specific such terminated country being conducted abbvie affiliate sublicensees effective date termination continue conduct such clinical study galapagos cost month enable such transfer completed without interruption such clinical study provided that nbsp galapagos shall have obligation continue clinical study unless required applicable nbsp with respect each clinical study which such transfer expressly prohibited applicable regulatory authority abbvie shall continue conduct such clinical study completion galapagos cost style margin margin bottom text indent font size font family time roman assign cause affiliate sublicensees assign galapagos agreement with third party with respect conduct clinical study specific such terminated country including agreement with contract research organization clinical site investigator unless with respect such agreement nbsp galapagos decline such assignment nbsp such agreement nbsp expressly prohibits such assignment which case abbvie shall cooperate with galapagos reasonable respect secure consent applicable third party such assignment nbsp cover product covered patent controlled abbvie affiliate addition product which case abbvie shall galapagos sole cost expense cooperate with galapagos reasonable respect facilitate execution agreement between galapagos applicable third party style margin margin bottom text indent font size font family time roman termination country abbvie galapagos event termination this agreement with respect nbsp more country other jurisdiction abbvie pursuant section nbsp galapagos pursuant section nbsp case termination this agreement entirety style margin margin bottom text indent font size font family time roman right license granted abbvie hereunder with respect such terminated country jurisdiction shall immediately terminate style margin margin bottom text indent font size font family time roman right license granted abbvie hereunder with respect such terminated country jurisdiction shall become exclusive exclusive abbvie sole option irrevocable unrestricted perpetual right license party shall mutually agree good faith writing consideration galapagos shall receive aforementioned license despite good faith discussion party unable agree consideration then dispute shall resolved pursuant section nbsp style margin margin bottom text indent font size font family time roman where permitted applicable galapagos shall transfer abbvie right title interest regulatory approval owned name galapagos affiliate sublicensees which regulatory approval solely applicable relevant country jurisdiction such regulatory approval exists effective date such termination this agreement with respect such relevant country jurisdiction provided that galapagos retains license right reference under regulatory approval transferred pursuant this clause necessary reasonably useful galapagos commercialize product remainder galapagos territory accordance with term hereof develop molecule product with respect remainder galapagos territory accordance with term hereof style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman galapagos shall notify applicable regulatory authority take other action reasonably necessary effect transfer forth section nbsp above style margin margin bottom text indent font size font family time roman galapagos shall grant abbvie right reference regulatory documentation then owned name galapagos affiliate sublicensees which regulatory documentation transferred abbvie pursuant section nbsp necessary reasonably useful abbvie affiliate sublicensees develop commercialize terminated country jurisdiction product such regulatory documentation exists effective date such termination this agreement with respect such terminated country jurisdiction style margin margin bottom text indent font size font family time roman requested abbvie unless expressly prohibited regulatory authority galapagos shall transfer control abbvie clinical study specific such terminated country being conducted galapagos affiliate sublicensees effective date termination continue conduct such clinical study abbvie cost month enable such transfer completed without interruption such clinical study provided that nbsp abbvie shall have obligation continue clinical study unless required applicable nbsp with respect each clinical study which such transfer expressly prohibited applicable regulatory authority galapagos shall continue conduct such clinical study completion abbvie cost style margin margin bottom text indent font size font family time roman galapagos shall assign cause affiliate sublicensees assign abbvie agreement with third party with respect conduct clinical study specific such terminated country including agreement with contract research organization clinical site investigator unless with respect such agreement nbsp abbvie decline such assignment nbsp such agreement nbsp expressly prohibits such assignment which case galapagos shall cooperate with abbvie reasonable respect secure consent applicable third party such assignment nbsp cover product covered patent controlled galapagos affiliate addition product which case galapagos shall abbvie sole cost expense cooperate with abbvie reasonable respect facilitate execution agreement between abbvie applicable third party style margin margin bottom text indent font size font family time roman existing inventory notwithstanding termination party license other right under this agreement with respect particular country other jurisdiction case subject term transition agreement such party shall have right after effective date such termination with respect each country other jurisdiction with respect which such termination applies sell otherwise dispose product then inventory progress inventory each case that intended sale disposition such country other jurisdiction though this agreement terminated with respect such country other jurisdiction such sale disposition shall constitute infringement other party affiliate patent other intellectual property other proprietary right purpose clarity abbvie shall continue make payment sale permitted under this section nbsp provided article this agreement terminated with respect such country other jurisdiction style margin margin bottom text indent font size font family time roman remedy except otherwise expressly provided herein termination this agreement either entirety with respect nbsp more country other jurisdiction accordance with provision hereof shall limit remedy that otherwise available equity style margin margin bottom text indent font size font family time roman accrued right surviving obligation termination expiration this agreement either entirety with respect nbsp more country other style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman jurisdiction reason shall without prejudice right that shall have accrued benefit party prior such termination expiration such termination expiration shall relieve party from obligation that expressly indicated survive termination expiration this agreement without limiting foregoing section applicable applicable applicable this section nbsp article this agreement section necessary effectuate interpretation such surviving section article shall survive termination expiration this agreement reason this agreement terminated with respect terminated territory entirety then following such termination foregoing provision this agreement shall remain effect with respect terminated territory extent they would survive apply agreement expires terminated entirety provision surviving accordance with foregoing shall terminate upon termination this agreement with respect terminated territory further force effect purpose clarity provision this agreement shall remain effect with respect country territory other than terminated territory style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center miscellaneous style margin margin bottom text indent font size font family time roman force majeure neither party shall held liable responsible other party deemed have defaulted under breached this agreement failure delay fulfilling performing term this agreement when such failure delay caused result from event beyond reasonable control performing party including fire flood earthquake hurricane embargo shortage epidemic quarantine whether declared terrorist insurrection riot civil commotion strike lockout other labor disturbance whether involving workforce performing party other person omission delay acting governmental authority except extent such delay result from breach performing party affiliate term condition this agreement performing party shall notify other party such force majeure within after such occurrence giving written notice other party stating nature event anticipated duration action being taken avoid minimize effect suspension performance shall greater scope longer duration than necessary performing party shall commercially reasonable effort remedy inability perform style margin margin bottom text indent font size font family time roman change control galapagos style margin margin bottom text indent font size font family time roman galapagos successor shall provide abbvie with written notice change control galapagos within business following closing date such transaction style margin margin bottom text indent font size font family time roman event change control galapagos then abbvie shall have right sole absolute discretion written notice delivered galapagos successor time during following written notice contemplated section nbsp nbsp require nbsp more following action nbsp party shall disband each joint committee terminate activity each joint committee thereafter abbvie shall undertake activity assigned this agreement joint committee solely exclusively itself nbsp galapagos change control party shall adopt reasonable procedure agreed upon writing prevent disclosure confidential information abbvie nbsp galapagos right promote promotion product promotion territory shall immediately terminate nbsp right license granted galapagos hereunder with respect galapagos territory including those forth section shall immediately terminate nbsp solely case change control galapagos that occurs prior first commercial sale product country territory abbvie affiliate sublicensee terminate this agreement entirety which case provision forth section nbsp shall apply style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman export control this agreement made subject restriction concerning export product technical information from united state other country that imposed party from time time each party agrees that will export directly indirectly technical information acquired from other party under this agreement product using such technical information location manner that time export requires export license other governmental approval without first obtaining written consent from appropriate agency other governmental entity accordance with applicable style margin margin bottom text indent font size font family time roman assignment style margin margin bottom text indent font size font family time roman without prior written consent other party neither party shall sell transfer assign delegate pledge otherwise dispose whether voluntarily involuntarily operation otherwise this agreement right duty hereunder provided that subject section nbsp either party make such assignment without other party consent affiliate successor whether merger sale stock sale asset other transaction business which this agreement relates with respect assignment affiliate assigning party shall remain responsible performance such affiliate right obligation hereunder attempted assignment delegation violation this section nbsp shall void effect validly assigned delegated right obligation party hereunder shall binding upon inure benefit enforceable against successor permitted assigns galapagos abbvie case permitted assignee transferee shall assume obligation assignor transferor under this agreement without limiting foregoing grant right forth this agreement shall binding upon successor permitted assignee galapagos obligation abbvie including payment obligation shall favor such successor permitted assignee galapagos benefit under this agreement style margin margin bottom text indent font size font family time roman subject section nbsp right information material intellectual property nbsp controlled third party permitted assignee party which information material intellectual property were controlled such assignee immediately prior such assignment nbsp controlled affiliate party becomes affiliate through change control such party which information material intellectual property were controlled such affiliate immediately prior such change control each case shall automatically included with right licensed granted other party under this agreement style margin margin bottom text indent font size font family time roman severability provision this agreement held illegal invalid unenforceable under present future right obligation either party under this agreement will materially adversely affected thereby nbsp such provision shall fully severable nbsp this agreement shall construed enforced such illegal invalid unenforceable provision never comprised part hereof nbsp remaining provision this agreement shall remain full force effect shall affected illegal invalid unenforceable provision severance herefrom nbsp lieu such illegal invalid unenforceable provision there shall added automatically part this agreement legal valid enforceable provision similar term such illegal invalid unenforceable provision possible reasonably acceptable party fullest extent permitted applicable each party hereby waif provision that would render provision hereof illegal invalid unenforceable respect style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman governing service style margin margin bottom text indent font size font family time roman governing this agreement performance enforcement breach termination hereof shall interpreted governed construed accordance with state york united state excluding conflict choice rule principle that might otherwise refer construction interpretation this agreement substantive another jurisdiction provided that question concerning nbsp inventorship patent under this agreement shall determined accordance with section nbsp nbsp construction effect patent application patent shall determined accordance with country other jurisdiction which particular patent application patent been filed granted case party agree exclude application this agreement united nation convention contract international sale good style margin margin bottom text indent font size font family time roman service each party further agrees that service process summons notice document registered mail address forth section nbsp shall effective service process action suit proceeding brought against under this agreement style margin margin bottom text indent font size font family time roman dispute resolution except dispute resolved otherwise addressed procedure forth section dispute arises between party connection with relating this agreement document instrument delivered connection herewith dispute shall resolved pursuant this section nbsp style margin margin bottom text indent font size font family time roman general dispute shall first referred senior officer party shall confer good faith resolution issue final decision mutually agreed senior officer shall conclusive binding party senior officer able agree resolution such issue within such other period time mutually agreed senior officer after such issue first referred them then except otherwise forth section nbsp either party written notice other party elect initiate alternative dispute resolution proceeding pursuant procedure forth section nbsp purpose having matter settled style margin margin bottom text indent font size font family time roman proceeding under this agreement shall take place pursuant procedure forth schedule style margin margin bottom text indent font size font family time roman expert arbitration dispute expressly stated this agreement resolved pursuant this section nbsp shall take place pursuant following procedure promptly following receipt notice requiring dispute resolution pursuant this section nbsp party shall meet discus good faith agree expert panel resolve issue which expert panel shall consist three nbsp member shall neutral independent both party their respective affiliate shall have significant experience expertise substantive area question shall have some experience mediating arbitrating issue relating such agreement party agree such expert panel within request party arbitration then each party shall select nbsp expert such panel within from expiration aforementioned period nbsp expert selected party shall select third expert panel within from appointment second expert provided that such three nbsp expert must meet foregoing criterion within after such expert panel selected appointed case each party will deliver both expert panel other party detailed written proposal setting forth proposed term resolution matter issue proposed term party memorandum support memorandum support thereof exceeding nbsp page length excluding supporting data party will also provide expert panel copy this agreement amended such time within after receipt other party proposed term support memorandum each party submit expert panel with copy other party response other party support memorandum such response exceeding five nbsp page length neither party have other communication either written style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman oral with expert panel other than sole purpose engaging expert panel expressly permitted this section nbsp provided that expert panel convene hearing expert panel chooses question party hear oral argument discussion regarding each party proposed term within after expert panel appointment expert panel will select nbsp nbsp proposed term without modification provided party that expert panel belief most consistent with intention underlying agreed principle forth this agreement decision expert panel shall final binding appealable expert panel must select only method resolve matter issue nbsp nbsp proposed term combine element both proposed term award other relief take other action style margin margin bottom text indent font size font family time roman interim relief notwithstanding anything herein contrary nothing this section nbsp shall preclude either party from seeking interim provisional relief including temporary restraining order preliminary injunction other interim equitable relief concerning dispute necessary protect interest such party this section nbsp shall specifically enforceable style margin margin bottom text indent font size font family time roman notice style margin margin bottom text indent font size font family time roman notice requirement notice request demand waiver consent approval other communication permitted required under this agreement shall writing shall refer specifically this agreement shall deemed given only nbsp delivered hand nbsp sent facsimile transmission with transmission confirmed nbsp internationally recognized overnight delivery service that maintains record delivery addressed party their respective address specified section nbsp such other address party whom notice given have provided other party accordance with this section nbsp such notice shall deemed have been given date delivered hand transmitted facsimile with transmission confirmed second business place delivery after deposit with internationally recognized overnight delivery service notice delivered facsimile shall confirmed hard copy delivered soon practicable thereafter this section nbsp intended govern business communication necessary between party performing their obligation under term this agreement style margin margin bottom text indent font size font family time roman address notice style margin margin bottom text indent font size font family time roman abbvie style margin margin bottom margin left font size font family time roman abbvie agrave style margin margin bottom margin left font size font family time roman boulevard royal style margin margin bottom margin left font size font family time roman luxembourg style margin margin bottom margin left font size font family time roman attention general manager style margin margin bottom margin left font size font family time roman facsimile style margin margin bottom margin left font size font family time roman with copy which shall constitute notice style margin margin bottom margin left font size font family time roman abbvie style margin margin bottom margin left font size font family time roman north waukegan road style margin margin bottom margin left font size font family time roman north chicago illinois style margin margin bottom margin left font size font family time roman attention executive vice president business development external affair style margin margin bottom margin left font size font family time roman general counsel style margin margin bottom margin left font size font family time roman facsimile style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman galapagos style margin margin bottom margin left font size font family time roman galapagos style margin margin bottom margin left font size font family time roman generaal wittelaan style margin margin bottom margin left font size font family time roman mechelen belgium style margin margin bottom margin left font size font family time roman attention style margin margin bottom margin left font size font family time roman facsimile style margin margin bottom margin left font size font family time roman with copy which shall constitute notice style margin margin bottom margin left font size font family time roman galapagos style margin margin bottom margin left font size font family time roman generaal wittelaan style margin margin bottom margin left font size font family time roman mechelen belgium style margin margin bottom margin left font size font family time roman attention legal department style margin margin bottom margin left font size font family time roman facsimile style margin margin bottom text indent font size font family time roman entire agreement amendment this agreement together with schedule attached hereto forth constitutes entire agreement understanding between party with respect subject matter hereof prior agreement understanding promise representation whether written oral with respect thereto superseded hereby including confidential disclosure agreement among galapagos abbvie successor interest abbott laboratory dated nbsp june amended nbsp july nbsp july extent that such confidential disclosure agreement relates subject matter this agreement each party confirms that relying representation warranty other party except specifically forth this agreement amendment modification release discharge shall binding upon party unless writing duly executed authorized representative both party style margin margin bottom text indent font size font family time roman english language this agreement shall written executed other communication under connection with this agreement shall english language translation into other language shall official version thereof event conflict interpretation between english version such translation english version shall control style margin margin bottom text indent font size font family time roman waiver exclusion remedy term condition this agreement waived time party that entitled benefit thereof such waiver shall effective unless forth written instrument duly executed behalf party waiving such term condition waiver either party hereto right hereunder failure perform breach other party shall deemed waiver other right hereunder other breach failure such other party whether similar nature otherwise right remedy provided herein cumulative exclude other right remedy provided applicable otherwise available except expressly forth herein clarity last sentence section nbsp shall interpreted limit abbvie right seek damage galapagos breach this agreement style margin margin bottom text indent font size font family time roman benefit third party except provided article covenant agreement forth this agreement sole benefit party hereto their successor permitted assigns they shall construed conferring right other person style margin margin bottom text indent font size font family time roman further assurance each party shall duly execute deliver cause duly executed delivered such further instrument cause done such further thing including filing such assignment agreement document instrument necessary other party reasonably request connection with this agreement carry more effectively provision purpose hereof better assure confirm unto such other party right remedy under this agreement style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman relationship party expressly agreed that galapagos nbsp hand abbvie other hand shall independent contractor that relationship between nbsp party shall constitute partnership joint venture agency including purpose neither galapagos nbsp hand abbvie other hand shall have authority make statement representation commitment kind take action which shall binding other without prior written consent other party person employed party shall employee such party other party cost obligation incurred reason such employment shall account expense such party style margin margin bottom text indent font size font family time roman performance affiliate each party nbsp more affiliate perform obligation duty hereunder such affiliate expressly granted certain right herein provided that each such affiliate shall bound corresponding obligation such party subject assignment such affiliate pursuant section nbsp each party shall remain liable hereunder prompt payment performance payment obligation hereunder style margin margin bottom text indent font size font family time roman counterpart facsimile execution this agreement executed nbsp more counterpart each which shall deemed original which together shall constitute nbsp same instrument this agreement executed facsimile other electronically transmitted signature such signature shall deemed bind each party hereto they were original signature style margin margin bottom text indent font size font family time roman reference unless otherwise specified nbsp reference this agreement article section schedule shall mean reference such article section schedule this agreement nbsp reference section clause reference such clause such section nbsp reference agreement instrument other document this agreement refer such agreement instrument other document originally executed subsequently amended replaced supplemented from time time amended replaced supplemented effect relevant time reference thereto style margin margin bottom text indent font size font family time roman schedule event inconsistency between this agreement schedule other attachment hereto term this agreement shall control style margin margin bottom text indent font size font family time roman construction except where context otherwise requires wherever used singular shall include plural plural singular gender shall applicable gender word used inclusive sense whether specifically stated whenever this agreement refers number unless otherwise specified such number refers calendar caption this agreement convenience reference only define describe extend limit scope intent this agreement intent provision contained this agreement term including include includes used herein shall mean including limited shall limit generality description preceding such term language this agreement shall deemed language mutually chosen party rule strict construction shall applied against either party hereto each party represents that been represented legal counsel connection with this agreement acknowledges that participated drafting hereof interpreting applying term provision this agreement party agree that presumption will apply against party which drafted such term provision whenever party consent approval required such consent approval shall unreasonably withheld delayed conditioned unless explicitly provided otherwise this agreement style margin margin bottom text indent font size font family time roman amendment restatement this agreement constitutes amendment restatement existing agreement effective restatement date right obligation style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman owing under existing agreement with respect matter occurring prior restatement date based fact event occurring existing prior restatement date shall governed existing agreement restatement date existing agreement hereby amended supplemented modified restated entirety described herein style margin margin bottom font size font family time roman align center signature page follows style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman this agreement executed authorized representative party restatement date style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width valign bottom width width valign bottom width valign bottom width width style font family time roman font size valign colspan galapagos valign bottom nbsp valign bottom valign bottom nbsp valign bottom colspan abbvie agrave style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp valign bottom style margin margin bottom border bottom solid font size font family time roman onno stolpe valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom style margin margin bottom border bottom solid font size font family time roman sophie morlet style font family time roman font size valign name valign bottom nbsp valign bottom onno stolpe valign bottom nbsp valign bottom valign bottom nbsp valign bottom name valign bottom nbsp valign bottom sophie morlet style font family time roman font size valign title valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom title valign bottom nbsp valign bottom category manager table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center signature page style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center approved country style margin margin bottom font size font family time roman style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center schedule page style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center success criterion style margin margin bottom font size font family time roman page omitted style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center schedule page style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center success criterion style margin margin bottom font size font family time roman page omitted style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center schedule page style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center plan style margin margin bottom font size font family time roman seven page omitted style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center schedule page style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center combination product development plan style margin margin bottom font size font family time roman page omitted style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center schedule page style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center combination product post development plan style margin margin bottom font size font family time roman eight page omitted style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center schedule page style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center discovery work plan style margin margin bottom font size font family time roman page omitted style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center schedule page style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center existing potentiator patent style margin margin bottom font size font family time roman style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width width valign bottom width width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman glpg reference valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center country valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center filing date valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center filing number style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center table style margin margin bottom font size font family time roman style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width width valign bottom width width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman glpg reference valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center country valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center filing date valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center filing number style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center table style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center schedule page style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center galapagos corporate name style margin margin bottom font size font family time roman galapagos trademark style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width width valign bottom width width valign bottom width width valign bottom width width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman title valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center country valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center filing style margin margin bottom font size font family time roman align center date valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center filing style margin margin bottom font size font family time roman align center number valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center registration style margin margin bottom font size font family time roman align center date valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center registration style margin margin bottom font size font family time roman align center number style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center table style margin margin bottom font size font family time roman galapagos logo style margin margin bottom font size font family time roman style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center schedule page style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center schedule page style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center study plan style margin margin bottom font size font family time roman align center style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center schedule page style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center schedule page style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center manufacturing cost style margin margin bottom font size font family time roman style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center schedule page style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center dual combination product success criterion style margin margin bottom font size font family time roman style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center schedule page style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center potentiator success criterion style margin margin bottom font size font family time roman page omitted style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center schedule page style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center triple combination phase success criterion style margin margin bottom font size font family time roman style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center schedule page style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center triple combination heterozygous success criterion style margin margin bottom font size font family time roman style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center schedule page style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center triple combination homozygous success criterion style margin margin bottom font size font family time roman style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center schedule page style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center sample reimbursement credit reimbursement payment calculation style margin margin bottom font size font family time roman align center attached style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center schedule page style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center sample profit loss calculation style margin margin bottom font size font family time roman align center style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center schedule page style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center existing patent style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width width valign bottom width width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman glpg reference valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center country valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center filing date valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center filing number style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center table style margin margin bottom font size font family time roman style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width width valign bottom width width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman glpg reference valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center country valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center filing date valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center filing number style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center table style margin margin bottom font size font family time roman other patent style margin margin bottom font size font family time roman style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width width valign bottom width width style font family time roman font size valign bottom nowrap style margin margin bottom border bottom solid width font size font family time roman glpg reference valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center country valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center filing date valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center filing number style font size height height colspan height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font size height height colspan height colspan height colspan style font family time roman font size valign style margin margin bottom margin left text indent font size font family time roman valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center table style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center schedule page style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center existing third party license agreement style margin margin bottom font size font family time roman style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center schedule page style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center procedure style margin margin bottom font size font family time roman dispute referred under this agreement shall resolved follows style margin margin bottom font size font family time roman three page omitted style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information indicated been omitted from this filing filed separately with security exchange commission table style margin margin bottom font size font family time roman align center schedule page body html text document submission